var title_f18_43_19120="Hyphema";
var content_f18_43_19120=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Grade I to II hyphema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 276px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEUAaUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwKaflR2zirUBXex/Ws+VGjl+YfLmrsYG0lG/KvJklbQ9eN46FqLgDaeCeau28OX5HWs+KKT7/ADgVs6Qd84Eg4461zVPI1jUtoyWOzJbIFblq00cSjk9sCrCQRtKNuK29NSBNrS/MAeRW1GNtLjk01oJpLGNkE0Zy3YCuivYxHEgh+XIHas26aKS8jkjj+QfhWhO73EUa4+UD1rsh7t0zNxbZWhjLNkndzVsJkYI4+tLDbsmCelTNGew4PFUirFSWMjhaII2P3hzVsJ84zzV2OIEYxWbV2bL3UQIBjmmFVGT1NSSp5bYzWfPMwJx0py0KjDm2I9RmOMKTx1rKklbbnuelWpCzZDd6pTuquVlJ47KOlYSb3Nk7aRCARhvnYZPXJq7azxBmEb5x6Vl2kDXbkqCIgeAeC1an2ANt2t5WOCR3pRv0MKrj1ZFeXZUfu+WJwPrT7KzPlNJKMvjPJqZLK2gcFjvcVYec4EcHUjnFVGLb94z9olpErQwkZl5LE9PSrsXQZ/Wo2byowrtz1qFJjMduMAd81agc85cxeWeOLJJ5q/Yp9qIkmIAHQVixgCRSSNua2YbqNWGNoAraFO+5z1KvKvdNCWIBAwA+Xn1pMg8qdvtiqdxqShCoPtVQXy7gM8d629mkcvtG0aYuASQ2BikDq245BFY806M2EPzdsVWkuLgFQGxk9qTVhJ3ZuGOPJZmAPriprW2M8qEsTH15rJtEIlVpdzD3rooJUKgpjis/Y82pq6/IrI1kjTZjjjgVBJAACQue9RwzqM5Pb86e025cZBFN0Oxj7Yh8lW64x34qCe1jOdwGKtRKgbPXParcCxzuF2/L1IrllFo3jNN3OKn0PMjyQrjJznpV7RNP2NtcHPqa9Bj0+F4cKgHHHFV5tHCsWUYY8VCpNPmNPrKnoziNX09GYIF3E9gK4rWNDkklJtoicDkEV7NHpWxjI/3/AF61RvdOQzhlILucDHvRUw6mtS6OK9m9D5zvdMuIi8jKY8H6Va0C/vxcmK13SiP5mXPQev616z4w0BYgY5l3SP8ArXmd9oU+nTmSLejN/dODj3rj5JUZeR6tOrCrC+x1ui+Io52CMwSQHBBrqobgSqCc59c14dskgnEilt+cn3rq9B8TtG6RXTt6V1UcWnpIyq4fqj0KXjK9aijcqSR8p+tVoryKePchyOvWpo8M3BNdd76owStozSgl38MeTVlUJHSsxQVwR2q/bSZ4b8DTTMpw7DZIy5+UkdjxU6WRGDt596nQgPwM598VeLZTgZ7ZqlG+pDujO+zAOAcE/wAq2tKbysKD0OarG23DP608KysMce9aJ8pjN3VjS1CRpE/dffXkH0p91Gms6U9veRj5hznmq0MnzKSM+tXWIGx4znPWrvfc537ui3XU8j8R+ArqK9zZRl42yeBnFFe528Uc0QZlAPsKK5pYCDd0zthms4xSaPhFoUl+XHPvVSW2e3bC/wARxit2KyEl7hcgCrOoacJZFCdR3FcEeZeh1VI9ijp9ufLBZxjupNdN4fs7WQEu6hyQOazItHcw+Yc5/lV6z0y5WLftIHbnmoTtJNoXL0ZvtYIs2ITx/Fk1o2UAk2Ljo2M1gaZLdgurElRxzW3ZXr5yFIxwOOlbwnGUr2NLWVkbMdqrTYPQCr8aBWIGMZqhaStMfTPWr8CgEcHn3rsTi9hWZMAMEnr2puRn9KsPAWXPAqEW7DkUpXHFIkSIFc4zThMIVO4gHrSpIEjwf51mahNkEZxx2NLmUUaRg5PULy6DkjOfSsi5uGySuWX1FNuJJpcxwAE/3s9KdBD+7255HWsb87N21BWQqXcasu1CSenHSoxA6mSaQAeaeB6VN5UsTZjUEd6ngWSeZVkGAv60nHozFy6omtreHyfl4I6etWFtpW/1hG0cCnMqRA5C5HoKhFzywJ61vCFkcNSq76DniCox2qR0qpdyeXGAgCnsRSXF4FIAbryQKx9Ru3kYqmQBVSkoozUpMuPcKNpzuNI8w3AgkDHpVCIAxqSTmpldcfM3GO5ojFyM5VFEtTXCCHCNlvypUuD5Ywc8YqlJJFwB69qjM6gnaeB2rojTaOaVS5ol5GHJIpFb5eece9UheKBkcgcUn28AdqfKu5HMzTt5dpHytin+YN+M1kC+xyMCnC9AYMxHXtTUUwlJo6e1ufk2kYIFSpOI36nHsa51NSGODn6VMuoKXBbI+prTlVjK7b1OrtblGwNxzV0SZHXiuTgvVHAIxmr0eoB+Bjj0ppWJZvxO27g8VraW22T5jjPeuXtrjKZ3EHNW7aadX5bK545rCpFblRvY9Dt5UQcHir0bo57Vxen3j/xn9a3LW6DAZIrMi9nub726uvse9ZGoWaphwcEc5FaFpcDjJyPep5VSXrjFOUboqnOz1OP1PTpb9hNMzMQPlOMVg6loolQh1+Y8ZxXpTRKY8beKy9R04zDKZAHNc06L6nZTrO9jwrX/AA0sbPt/CuIvrCW2mUHOTyK+hr3RXkY+ZyD7U7QvBuk3GsRyawqSxqMrG/3WOOAfzNcrwXO/d0PUjjVTjrqeEaTqs+nMBKWaPpjPSu70e/ivArQuuT68VpfF7wHZaRMl/oiKltIPnhDZCN6j2NeX2d1PptxuiyADkileeGnyz1NYyhXhzwPW029c596njxn5WwfcVzeha5DqMaqGxIOufWt5Pu5z2rtTUldGDi4uzNG3+ZsHkema1o+Ihx0rBs3w4z0rXhmBHP61UWYzRoqQFGfTNSBQygjGKqRzCRMEnNTR7k6kU3U5dzncSYKBn3pjSbCQPwqWJh3xTxAZV3DA+ta8yktDPZ6l6wug0XzNyKKzctH0HWitOcxcNT5VspUe4aTIBbPFdBY2iyxM+BuI49q52zsgWV5cxqTxmutsMAZhOVFeZC/U9dtvVDdMhKzOs3CeldBdRpLbARKAMcVBpUcMs7+cdpUZFJJcCKNhGDtzz9K2UY2ByaZRitTEW3HgnmrEUIc4UVdgkjugAi1et7RQwG3luhrJU9dDqU1uGm2+EwevetPywFyOx7VPbQLCi5XB71YWESKeMA1uoWRi53ZTVyehBH0qyFGORU8FkiMDwfqahvm2R4HpxT9RppuyM29ALkLyTxWJeSFWMQI31c1C4e3UEY3t05rJEZYbpHO9uSelc8nd2R0p8qsWbaI9RySeauiNCvz/ACnrms62uDAQrE4q8XSZlTdkAcgVpC1rGFS/UmAWOLOcqenvUUTFSXYBcnIpjmNcKW+U1Xe92ggZAHSrUddTnnO2iJbyQu+VPNZ0tyxOzPWo7i6Ln0FZ9zcrk9sfjTZhcnmn8ssCd2elUZLgK/JAqndXXHU4681nyTlu+Oe4qQ1ZrvfhT14/KoZb8EcHj86ylcnkmgn+7WkZtGcqaLxu2b+L9MUqTkHJf9az8kD3ppYjHNXz3MvZq5seecctUZn7bjWZ5pH8qcsnc9aEzTlVtDTEuOAx/OnrIxIBPFZqPkVIknpVxkYyg2aiSHPYipw7Ag5rLSXnrVpZxxu4q+a5DgakbkryTVqGVgAAeKy4rldvWrUEo7nmtEYTi76G7aXbR4HGDWvZXXdjn39K5mJyxyvT0rWsGGOe5qWrglZHV21yjKO31NakMo25VuelclDISQOcdKu28pXOSeKhozaudnaXDgA7jWta3YPU5rjbO/BO3OPetaO4C4Kn8Kq3Uhb2OrSYHp0pXZW6dKw4LqRjsxgdjWgM9d3PoKiS8jenZbiTQ+c5bAwOlQTWfyEk9vWtB5Aig8UxY2nGWU7ax5TpUnbyOR1fSFvEdWYso6Lk15h4x0m3tYgiQ7ZDyWHINfQk2lxTxsYAQ4HNcR4k0OCdHjuFxJg8Nx+Iqa1Hmj5nTh8QlK586pdy6bd+dCPunJx6V6N4Y8SR6ogjkYCYcY6Vz/iPRlt53Tbhc9cVyIlksLpZIH+ZTmvKhUlQlZ7HuunGvC6Pe0TkFOcdDV+3bH3vveuK4fwd4lh1GJUdwJ14IrtYjuKsPXmvShJTV0edUhKEnGRp20ectjn61LJJsODzx3plpIMYPWppot5zjj6Vq4KSOR76kMV0h44A9KvWs5jHJyCePb2rNe1PmAgYHTpVqMbQQRWPsmnoEopmkvluMnk0VnHPYn8DRWiTsZch4NrdlbPaWphXYypiqFrZToyhZMR9a2haTB9su4xqPlLHtVuytUkcJg+xzUSTZ1xtYq6aGt1kMjlt3A56VsaaizWrIQDk9xUr6aEUbu1X9PtUUcA8UlBo0UlYr2NhscYj+Wtq2tVUlu/rUsSLtJp3K8Zz7CtVGxPO3oMZt3yoM1bhwifMOgqKKMMNwH1zVoR4A60XDYY0qIpKDOKwtUnxiRyAvIxXTW6W9zMsMziKEDMsmeQB6VxviGeCfUpRZsWtY2wnfPv71FV+7dFUpJO1jKbdcSgvnaDx9KdMgKfLjFSKyoNv8TDjApt0626RyPtJfkAH+fpWcIWVzVybZQl3oyDjHTkVZj2wxeYPvP19zULSiWXcVHFU7u5ZmIBwgOBSSSd7iqVNLE11cFo+P4TVFpsE/P8AnUNxdBB94EdxWTNcseA3XitJSscj94vXN5+84Ymsq5ufnOG564qvPc7cqDk1U3luSahyKUCd5CxHJpCC3UUwHFSR85z/ACoTKcbEsaAdasKFAwBx9KijOBz17Yq5bw7uSMZPWpcmGnUptHk/LkVDImDnmtdkVEPHNY15cKHZec+laRdzGdkNBGO1Ctk1WMuW4PApyuG9q2UWYe110LnU/hmhJCGxkfSoFbnmhj3yKNUbcykrouq/PHU0ofDcHvVaFuCR1FP3859acWE7WLyylRjOO3WrMM5GMkdazFYgYHQ+9SK5GOa3TORpHRW9x0wcVqWFzsJORtz61ycdwQOT/wDXrRtrjbwT+FUmFlY7ayvEYAEjdn861U2uvBBPfFcTbXPKkNt561r2t5uI/eE+oNMzlSTWhsyu0bDaen61q2F7t2hjxWfCFCKx5zUoVSVCsK1jY4ZqzsdTDdDG4HNadndZZS2CPeuPR5oMdxmt7TLncQD1ocb7FQnY7KeC1MEckLAueSBUsShUGP0rIgmIAD8Z9q1om+TrkVk4WNVNtGlYRhYCcD5jn1rN8S6dFeW6F0HHVh1HFWrecxI2PmB6CrFu/wBoidJcFuQR7VLRtCVrWPM9b8OQXVm0aIGIHevD/FvhaWwllfGAOlfUMtuYndeoBwfeuV8U6FDf2MysuZCODjvXHiMNGpE9XB46VJ2ezPli3kns7xZ4GZWHoa9i8IeIk1CxTeyiZevavPPEmnNZ3csYTBUnisvSNRk027jkjJHPI9RXkU6kqM7M9+rSjWipH0Hb3o7nOOetbFrdBwBnjFcToF+l9ZpNGdy4wfrW9aTGN8N68V6tOpszxqtG10dQu1kPIziqcylWBHXHSkgcvGcEirBXeMHtXQ3c4vhZTMvrkZoqea0UkHLdO1FHKyuaJ5PMDIQO3Sp7WKKFhnjNUUm8tVJbIx3qeAPdz7mDLEo6+tTJo0SNm7uVkhA29BjIq1pkeEOQfxqnYRh48Yyo6ZrWgUKh6DtSWo3orEjcKdo/KnRRs3PPA6mmqwPQ4NSpIQdo/lTeuiBXQ2RHjUMvT61DdXoihJY4UDmku70RqULAY61ymoX7zSMsbfIDj8fpWVSXJtubQjzbk99qD3LkKWWPt71TK/7XPp0rQl8PXlv4Zt9beeCS1lYp8rfMpye34GuclvAszREkuD27isFTlD3qm7NE1P4TSQBBjOS3U+lZ91Ez8u/U1LHIzDIU+oJqCWbKFnBDHgVTXMQ58okkgjUbeRjBNZd3dbcgHrzUd/eD5lDEHpWUZdxJJJ+lVblRxzq8zFuJSWwOtVLlzGpA5PrV+1jBUu361UvbViBKR8p6Vk3fU1pRvoVLeJpXA65PpV97VN4UYyOtJbrsI28H1xWjbWbynGNz9/alqbzajsZj2pPA657U0W0i5BHBrq7bTfLX50GfWm3FtEM8AetWkc0qxz0SGMcLmp47kKDu47cirW2PJAHOeuKpXcfXt9KBc11qPnvEMYA4x3rmtWl+ZihzmrV6dnAPbvWTOScjNdNCHU8/E1Vsh1o5b734VeQE4rPh4PtWjE2RzXU4nLSq9GPz79KVW3HFNOME0zkEGspR0O2nUs/ItBW7CnvkEeuM0scgCgEfjS7wTzWUG0zvq04ON0xFPJz0pQ47cmos8E+lMdscg10RV9TzasraFtJemG61aWYBhzisZJDu61djckKe9aWM1Udjegn6En2rStrjGMH8c1zsLEVp2rHAxnrVJBzs73TbwPbqC3PTFaFrOhPIAwfSuJsrlww2ZGK6XT5w6cgFvrVWsYTV2dCk8ZcFgw7ZrRt2UsGR+vQ1gR5K1fswVGQeB3pqRm4nd2cqXtmoZgs6DGKt2U+UCtyOg9646xu2EhOSWFdFYXKSpkHBpN3KR0KYwvNSbjE/mIfwqlZzeYoz9KvLhlIB5qGjROxJdCOSISJjeeKx7sZQgYB6dK0Ixufb37VVv1EcpA5z0I5rOWx0QbvY8O+K2jC3DXcaklzzx0rybUbUW8Yfbt/rX0V8RLM3elyAkcYwK8R1uzElwykZWMcivAxsOWfMj63L5udGzNT4Y6riVrNnJDfdH5V6mkDuwYDpXz9ps/8AZWswThzHGr5JHPH0r6F8PXkN7ZxTBwwcAiujBzUo8pjjoODU+5sWYxHjrVk88jimxr8o6Z9jVhTuXHSu9aHjTd3cqNMqnDbs0U66ttzgkmir94EkzyO0sFe437cqOACa11ZBKEK8jrjoKpWN2ocFSGbOABWskRZQoUb2O5mx1rK5dixbrgADH5VZ+4pBIHemoFijGe1QhyzEkiqSuUtSzGAnJBqpfajHCpCAknuOgqG8uvLhOZOnpXF6vqbvLJFE+31AqZy5DenTUyfW9aiWVVaQYJP41km63hWQAjqdpyaozLHMUWRQ2D1NMMUkFyZLHy1Upt2dd3SuZt3uzsUYWNiW78yNcOzJjlQTt/L1p9rbg5mOWGMDNYUc4kcFBtbftkUHoa6GzDwxhW/hOPxqoy52Y1F7NWRIwYHYpA29R/SsrULoIm3PHpVqSdt0kr9zyM965jVLovI/PFbLY86tUK88jTSZznFSJGWVeME1Wtny2Dg496uoSXAXkdzWUjng7k6N5jpBGo9+KtaogitFXjI7DtVOzKpcllYk5q3dTq6EZzk9TWTOyj8VyOytfMHmMMAAfjXR6TaKkjbh82PXrWfbtG0AYsFx8uBzmr9mZNyyRfwn+LrTSHUluaN4gAyjAHpg1lXgBHHpgmrN3dCVHyMSgcc9a59rh9xzjFWjBJsWVBHHkHrWddzKFPtViabcAM9sVj3z7cAH64q4K7FUfKrmbfyF2JPT0ql1NWZjlifWoduDxXfBWR49V8zdxkfX6Vajbj2qHbxxxTo+Ku5jHRlsNwefekzSDpxzSAHjA5qGdUGkXYxuGFp7oVI9KS0XBFTTjIVR2rkV1I9l2dK73KrcLzUJ+bnvU8tQlcfjXXFnj1bt6jE61fgUlPWqiJ8wq/bjCVVxQ2LMAJArVtf9WMnFUrSMt1+tacERIAximmNIsWr7HAJrXsZtsilT1NZCwNjII4q7EdhU81o9hJ6nXW8u8CtGFysfAJrmdPu8EK/IPQ1vo2YWJbHoOlZjkiV7lhIpUnPtWro+pCNxu4JODmudMuWIPUUJIwfIq0ZM9R0+4GRzweeK6BQPLVgRg+9cFoV15sSgt8y8H2rrLKTIAzx9ahmqV0WZQVGRw1UbmZpJFRYxnOKvz8qMHHvVZomW5UE5HXpWU2dFG27MHV9LN5JskJYdSBwK858U+FUjluJLeMjcQeTxXs00amN2GdxBAxWHqsMNxaLAEy0g2kmuOtSUlqenhsXKD0PmLxTpElvFvyD5Z5xzW34F8VjR9lpfFjEx+QjnbXp3jHwNDc2EiWkYWVV38968zi8Hy3aQ+TGyzoCWB6Y7V5TpVKE/dR9FRr0MVS99+p6zpGswXqK0Lgr7VuNOFT92cn2rx2002/sPNEDmOa3cK4ByM4rqtM8SiSHZefLMnBI7130q0n8SPJrYRJ/u3odtNe7Nu4nOKK5KTxFY7v3sw3UV1KqrbmSwra2MXSrGOMqUwBW6kaj6etZsFpMjAjlcfpV9m2rsHLHpRBaHLLyGTEF+pxVae5SFfXt6VJcN5aZLAHHTrXKa5qWwNh1yRjpVTfKrmkFfREOu6q43RxkF36AGuWZZRG5VvnY5JJpk07G5MjE+mfSnJMVkZC2ARkcdq5G7u7OuLUVoODjZkkDdwG680+0kLxmNiBKrZWsuOXY7hj8itggdcfSp7UrM7EbmlU52n0qHU1NnHQuaXCxvJvMHyswkY+/pW8SQMZPOSe/NZtlOvlSKrEux3KKv3jFIPMJwxHODW1CNtTixNR31MfV7sIm0cMRXJzzs7kHqa0tYnMjkg8CsaMF5MHpWknY8qbuy9aKQAx4FapZY4dyZ3H3qvZKoQZBIPFWJI3VfkBIHSsLlw30IEbZIS2cnoQOtBlMrhRnANPlBiQbly5HHsKLNOQXB61Fj0KcktTTtBtTPIyeoNbyYlgUKSfUmqUDxRr8wUZHSpTdbTiLgVolY5p1OZ2HXEAKDAw2Pqc1mPEMkY6VrJJvyzHmqEzZf5PXmpvY0SSMqcNzjp0rFvQVbr1rfvCRnA5rAvs7snOa6KOrOTFO0TPYZBpntUuevrTCMHpXakeTKQijml280L1p5GAO9AJAD2zUiLk8ZqMA+lWYI9xFKTsjWmuaVkXrZPkGRT5FOcdKkhXantUUrck+9cid2ezUXJBIryqQTUQUk89KnfkDnn+lNHU5rpieVVd2EaDd0q5AuD05qCMEYJrRtUJOT29qtkQNGwi4HHPSum0XS2vJUREJJA4A5rO0S281lAHJPWvZ/hVpaRXjzSICUjO0+hyP/AK9NOxpa+hgQfDq+a2y0LAnmuZ17RZtNfZLGyMvBBr6Vrzv4rWsckcUhUb9hycfWqjO43TsrnjMD7V5BypyCK6KzmMlgrSghjwDjiuZlDmULEpLFtoXoSTwBW9qG7TpF08v8sSj8yMmk2CiWU5wR361Ki4Ocd8VQilwAAeatQybuSeKozklc3dEuTHcYzgHrXcWsmQM9D0rzW2mwwxwK73RZvPt4yWqWVE6SFg6AE5qzdALPhR/CDWdbNtOc9eKnupiZVfODiobNUtSO4J2hRwxOKoRgSSqwXMcXGTx+NS3PmH51Oc9Bn61QjlcIFbhckqoPWuabuzspx93Qnvp1VXVQSzAqMD1rn7CB5ZrojEZUKgGMdjWzMfIt5ZnyCqkgY4qDTYpbe0eSc75ZsM3GMVEruRvC0IM5HxHCIEdljChgWMmO+OhrmLbS7qcyNBDLOyruconGO9ey6dpFtqE0iXADYIZh61paxd2HhzSZWVUQlSEjHVjj/wCtSVBNc0mbLHctoQjqfLWoW2+5YqGAPSitbWYsXWSrANyAvGOaK8KVaSbse7CKcU2d6ysoyDgCqc8ixHIOO5qS4lHJYkD61zWt6usUTqpGPzr6V2irs+ZgnLQZrGsCOJhkDtxXD6hdme5VVbduHp0qDU9QaeUs74x0GayUvFafJ+Q/zrgqVbs7oU2lojV+9EwYEkHn0/OoxGd4Mu4FuEIPf096SK5V1eIPhWOCegxVyVxHbFQoYhMDn1o0YKTTsZyqZbtzkFQMNnjPbH61f0mOP7Wrll3SJgg9iuf50/T4Ukjk3Kpx69Rx2NMSEFSAi5V+uexrPls7mrq30NO0UJM8kaKCxwMDAzyKXUpBFCBnsevaq2kKxRo14CSnnPGKTWX+U7uvOK7Kfw3POxG9jk9Sk+Y4NQWRw/ryOtF8+6Q+mcU6y5ZiMH61EjgludBZopUDPJ/StBIwDtzyB1rNsiPKGScnjiteEKMgjmsy4sqywl9xbBB9ulJ8sQ3AD2FWzlVYdT04qjPESpJyPahHRF3J0mUn5SMn1q0kgKndye2KqQQllBxwKsBCn3Vq0ZS0ZPGxVySeMfnTHlUDjg1DIcQkFvm9jVTLKMOTSsWpjrhlIPPvWJe43fhWjK/NZtxzkdq3pKxzYiV0UCnJxQFGOacw/SpFHTNdVzzuXUhVMZ96cq8d6m2A4wMU5UAOO/rSbKUbFfaM5q3bHBHWmeVzxVm1jy4z0qJyujooR98urzGMCoJh8xNW1wF46CoZsZ6VyxdmezWScCoQc56inIBSkVLGvQ11RZ5E43YKo4rSslyn9KpqOelaFqDt/HpVuREYHb+D1XdyuRnj+dezfD/G+baMDZ/WvDfD159nIB4GeTXrHgjVY7QG6kYlHXDL6D1prUrZnp9ee/E992xQcbYzn9TW3N410pIi0bSSMBnaBXnmv63LrOoARKN8rBEX3zgZqkrbluSexjeHtPitxqOt3qA29opSPccbpiDjH0Az/nNcrJdSTTmaZi0rHJJ/Wus8d6jGqRaLZNmys8byP45sHc3vXCM2H68+tDfYqMeVG1DMCCSec1egmx9DWBbSdiea0Ynww546VS2MJLU2YXJfOeK7nwxOPs4XqQa8+ilOMjnFdd4PmJlIz/FUscUdyhx1BpE/e72cHAHfinKSvU5xUMhbLAk89KynpqdNLXQR3aVyqnEaAndUKRILdJM7pBkqM1DNJKiFFBG87c1W827svMVot7E4iYdK5XKx3RhzLc0LiRL6DysMpcckimQ3a3MLRsAHiYxvjp2xVOCznWctfXBCMMDyzimzyQWsUgtjuLtvYk8k0uZvVlOnFaLUgvdWudPkeW1k2vg8gdcdq4uae81DU3u76Z5HYZIPQH0A7d63b2RZFcyN91+a5a9kW3GWdhuYsCOOPSuWpOTilfQ9HD04xWi97uQaw6pOqqw4HPFFUhbSXTNI/wA3oTRWT16HXGKirXJdS1Hy4neSQL6DNea67qoklYAnjpzU3iTV2uZSiH5c/nXO3CKWHGWPTFa4jE875UefhqSjrISS4SVvmOD04NSIUluoljI/unvxUIt02jKjGPmyeRWhbaesMnmQMeBkDPX0rCKcloaucEtS7arFIu2RAxibkdjV6S3WN1mjUFwRhR0rPsLdbiAu+7zckNtODmp0iuSzRpcMF/hGOR+NdUdrpHI9Zb2NRPLaIsuEYcgr245BqhHLGq3BYuyqBge3pUJE8Nzt2ljIMDPQ+9LarJPcTLIijGAcd6nnu7WNowsrtm9pIC2e44yzbgo7A+tZmtFgj57cg1r2UqmNhGuMcdOtZfiFv3fBHTJx+Nda0ijzarvJs4q6bLj1qWw6nnnNVLtiHOPWpLNizEVlJnG1c6iyflcHkdK1bX/WFMhjnkisrSYySh4retAsZyfXkVHMaRRFKu0HqBUBjLHk5z7Veu5Y+dpzmq/mIiLtPP8AKgtaaksA8uHpyP1qCeX5DkgUkk52Ek/NjFUpHLd6qIpakc0u/gcAd6jMucZNJKAATmq7Nhua1TRjZp3HySZGO1VZDk9KGkAyM5/Goi3Wri7EyVxCADmmgHd1/CnZzjFOUEkD05rXnVjH2WooBHbilzzinMvy1GTU81y+SxOg7nrVqEYwaz1faKswTeprKbOzDpXLxPHviq8p5pTISpJNRSPnB6VnF6nTW+EXGepqeEcCqymrMLDrW3McNrssRgcdvwq/ajke1UEPTNX7dumDxirchKOpq2blSMdvTvWzbX0sSbFkYIeozXPwybTnNWxPlsZ4q4yFOJqzXxHAPHSprS/FrHJckAzHiLnof71YLSbs5+tRyXJc44wOBWvNoZK5YecyM5bknJ5OeM1RlJEmc08NjPPWoJySfwrNSN5LQnt2Pmrjp0rWtxyNxPWsq0GXX61rx/dFaxZhJF9PlX5etdL4UcxyJ6k/nXMRtwACSa6nwvGDOqs2AOfXmlJhFHoinoT+NMfc0wOOB0pVGEHOfqaLffNOtupyzfhisp66G9JW1ENtLIsUiqfKU53dM1G0myWHDZUMciumvYgumyxRYG1OK403TNcNCyLgd6wqRUbHVRbmn5D71y3zIDhck4rLuNjK7LnpnrWnMQInCNkkYrJusLbtnhzWM32OqnoY89uY5QQcl8sc1j6jbI+EccqOa6AkRJIGAbPIJrB1jhWAwHIyT61hOPQ9ClJ3sczeXaQSCMOwA7CiszUGAnwSSR1ormctT1FRTVzzS5k2gs3WorUPdHzGbaB90VVZ5bljGFIjHVquWsccbhOdoxii3Ktdzxn7qsWwGYmQ4QquMY6irlpccRgK2E+X8KlngUWEbrwV59yKqXySwLJsbMb4JHoPWt/Zun7yOZVFU0Y9pJLS6/dNu8zLD2NaVtOHZMPkuO/Y1zzzKsiSFpQoztyM4FaNvcwTKkUfVvvN6ClCo0zSpTurGlM4a8jffwF4x9aq+dMsryIAAGCtup0KKJT5EZyD3OcVHKxjZ7TH72QlmfPAHrRJt6lwslY39NmZo13EE89Pwqvry5jbHXGabp7+VuQkna2fz6f59qn1ePdahxzkEV1wfunn1l7x5/eL+8wD34NOs87zz7UX4xJz29qZZv8AvMHA71jN2Zy2Os0yUqBkitMykMORg9a52GYRkEnFWlvd3cfU1FykjQuLjrg/mKg+0HGAfyFZ81wW+6etRiX1bpTuNI0WlGOTSNKMYrOMwpjTn1xT5h27lySUYxmqjS8kVGZcjrURkG70rSLImiQsMmm5/Kmg5NPP0xW6MeoZp6PyM5pnQGkV9ppNlLUtF8jjvULHHfioGlwetM8z5hzU8xpyrqWR+dSxNg+9VfNA96XzhjiocmzamoxNDfwKTr7jrVJJt3fFTCQDjIPFRc6HZrUsoex7VKjYPFVQ/A708Pg5x+tac7OeUF0L6yfKMGrdtJjH9KyVlOetWYJcUOYow1NlJRng8/zqZZDtHODWXHL15qYTc9auNQU6ZfMvX5qi8wE//Xqo855x1/pTRKMZPX2rX2hj7O25oCT5etNY/LVQTr0P86eJQ3enF66hLY0LRxkHtWukm0devFYFu+GFasbggAZz/nFapmbibFvk8966vw4wVhwSxPXPvXJW7bcJJlHXgjHOa6zwmpkmRACdvJx9RRJ3FFHotnbS3e4Rj5VHJNR6Zew6fe3DXIYuRhcCryX8On2C28RDTkZY+hrD++53nH1PesqtSzSjudFCF077E1xfXM8sjBiglbJHoO1UoP3TylgWOck1JNLzgdT1NRFxtPXJrCTcndnbG0VaKsEZaRC+Dt/rWLqlyfMiRT8x4+la0kpjQgHk9qzJI1+2oGXcVBJJHSpaNqWjuzM1F2t4l85skn9KwL648wM0rfKwxVrxTebLwKMnCgDjqTVG/haG3Uk53LurlbuelTp2Sb3ZzF1GWmY9B2zxRVrUQJJV8zJwuBjiisGtT0Yy0PLbW3AdCp+VhxUt3FtkIxg8AGoLCZhgdQtaGrssf2aQchgNwrdRTg2fLXftNSeNkEIR2+Ujq39KqS3aSqY5AcbSFI4zV2a0M20jaUI4GelVJomht9rIpA5X2q5qSVugqco3va7KGn/6QY42PAz19B61tJFbk/Im3GMY4zWLO265a4to2XGCVAwCPWpLI3PMwyTuPyv6dselZwaj0udU4uWqdjpIYhFt8t/nPBFUrmUC7kDodrbXBHtwfzzVVBOP3kbyNcDkjPGPSrNvL5907tkRqAvTHPWqnK6tYIRtq3cvadMXnmycBsbQR6d60rgmWB1yO5+lZ9sdk67+B2q/HkhlZuCcg10U9rM462rujhdai2TNnvWVGxVsjiuk8RW5RiWwTjtXLsSp7YrOcdTmtqa0Vz8tSGcYwDzWQk2O9SeefesHFmkUaYn+U859KQzDI5P0rNEvvR52DRysqyL5ueKYZyTzxWc03PXpQZcjrVKLRLZpCU7c54oVssM1Qjm4AzVmNxnNaxZDRsWlo0ygg4BrZXw/dfZvOMMgj/vAHB/GsbR5sTKGb5Qc47fjX2f4NXSdX8F2EVtFC1ubdUdABlWxhvxzmvQoxi1dnLPmvY+PNQsjbhYxySOc9RWVcqYmIFd/8VbO10nxHd2lnIGSFyo5zx1rzy5uAzZyD71GIpqDsi6LvuRNjBJPajcBjvxUEk3FRF89TXE5HTuWS/XHBoDZ71VEmRjNPVjjg1DkUlcspIUPGBUyOzY54qojVNGRkY470c6KUS/E2RUykAVSVj61LvwOvJo5i7FkHFWISRnniqKtgDnrVmN+D60nM0hAuI/erAkGOvFZiTYNTLIR0PFOMhWuW9+TwetBf/Iqtv5PNPU5JABP0raMmY1IdSZTjPJ9h61sWmj3j2YvHRUhP3d7YJHrio9JUWcguJUjkbBAVxkc1Z+1MVAZiRjAB7fSuiMkkc3K2x1jBGl1G12GNvnLhOGK+1azTWiTSPZo0cQYtHuOSB2BPtWE05JPP056VoaDYXOs6vbWNgm+eVsAZ49yT6AZ/SrUm9EVyJK7Ol8M6XfeI9WEFuGYkhpZG/g9z6fSvaBp+n+F9FEEQVrhgfnI+Zj6/SmaXaab4F0NIFIe4cZZv4pWx1+lc9eajNePJdTZLfwgjAFXOSprTcmnCVV36BHcEyhWzk89aklcmIt3xwKy1uSG8x8Et6Uguy6k5OV7VxbKx6apdloWJpnLDBIwMmnw3BEQckmqcMm9+eVHJPSmT3artRGG5jgD0qUzTlvoaSOCzOxJzziqs0pAkduppsVwPMAbp060y7kVGbP3TzVyegorU5i8thPcefITgtkVFqqL5Cc4Gc885qK7v2e+EROF3dqZrMoMaKT2JArkck1oemoyukypOI2K9OB1xnNFVDJgDgmijc2V0eR2BUMQcbg2Tmp9Qn3QZXDZOAB61U1FWjuiE43CpYURID5nIzwfQ0O691ngpJe8benyytaoGVg2PyqtcqHXEzkhjj2AqSxbbKURwykbsselQzssrKDIDglgo6Vs37hhGPvtoseSsFs8rMWGMY9MdKltApiUbQWI5z2qWV0u7VFXIVuD2FVLecRIytgFeMn+KqaSatsF5ST11uPG62lZsqY+/t70huEe/VQUCgFtxP04ply5mRtyERkYz0zVb+z4/sbPKSoRSxbdgnjisal76HVT5d5bmu9wsqkQyLv5wCKu2ufIUkknHOTXP3cltFp6nesd2AGUZ5PT0rTtLtXARzscgMQRnHFaU52epFan7ug3XEEkfriuCvR5cjA9jXody2+IE7ckY4ri9dttrMQOa2mk9Th8jHMoB5pftAB4xVKZsGq/ndTmhUrlRZptccUn2j3rLMxP0+tAl/L0qvYl7miZ+etOE2COetZvmg8GnLJx/wDXp+yFymqkoJyKsxy84B/GsZJDwATj6VaWTLdee9ZSpk2ZuW1yFIwffFdbo3jTUdJhdLG9mhVwQdrkZrzyOTnjtUvnNn6ehpwqSp7GcqXPujodX1Z76QyTSM7tySTmseWbmqjzMR1IqNpOTzwPxpSnObuzSFFpaFpnJOBSb+cGqpm9DSqzEkgZxUchtGiy2rc4qZOmKrQ9M9qtxLk9M1lLQ0WHl2JEBxUynHPBpUi9DUoi9qwckaxoS7CKc8elSA80ojxmnBDnGKn2hf1dgrenNWEPHFRRxHJzU6JwRzQqgKjJDVJzUwfjj60wR8ZPGO1W7exaQB3G1a0jMj2TQyINIxVBk+taltCtsN74Ln1qAMkK7Y8DHfvUbzkjrg1qp2B0W9y5PeZ4JAqt57ZqlJISevPrUkClzwTj1rZTsYqld2RoxsT3wT1rq/COu3Ojais+nInnBSu5lyMH/IrmLS3MnCjj1rsfDdiocblxWSxEpStTM6lJT0ex2VjeXep3b3WpSmWU4PPbjoPStCe4+Qp0wOfesWOcxOBEOcAHFV5ruU3alyVycY9q1crep10aHUuQs8kAj3cbz1qwqKrNht2R61l3LG3I2sSrNuqSO/RUJLZNSjqadtDReQ+WEQ455qCYIjox+8KgtrmOQkg4brippLyA8E5PTAptxjq2QlK9izNPEighvm/nVR7pp4JPUUR2U92g8qMgDnOOtTvo93FARHGcEc1hUrNL3UUlFdTlzZo85d224OevSotRmjldQgJwMD61qy6Vds5Vo9oPOT2qe18N+djecc1wRrVv5Tsc43vJ6HNyzENiJOB1NFdlbaBDBHt2kknk80Vi41ZO/MNYmC6HzBPfLPqHykntWlbxp5QZn+Y8la5+CHy5A6g++a2bDHmBn/DivWqNJ3R5s6aSXLsaFpb75mZ1Cg/dGOtWba1gUlnYAKcYFOg3yxPtO1l71LpduJQTIN2TzmqhbQ5Zc2rvoI3mBFG1vs65IHrVWZGuJTcOoEULY2/1rYubdktnKvyOFHpUbW6LbLGMk/ebPU1q4vqZxklsVNr3VsTnMZPCkVFcWckUb4d2wOfp3A/StGxVWWWJflR+nqKkYny0WQYdMrgj2NZuCaubRqNMzdNtIIVSZk8wnqZOSTWhJCCs00ZKkj5gO9QrEkcKkNzt+YH1HoKdGC9nJI0pVSOw71cEl7tiZuXcah2xbMqMDHzcHpmsnVoRNCGAOCM896sytKzBZXCqsgVt3cYz/SppokaF2jUYJJz9f89KunLmXKY1oW1PPNQt/LY8dayzGoyMY7V1mrQZDEDgiuWuVKOc/wCRW1J62HCUbbEe1QaeADUBejca2saKcexYCrShVBqAPShualotTj2LS7e4qzG4GeOfWs5XIOQaeJW5O72xiocLj549jREw2g9z1pWmUufTtiswyEjBNAlIOQSD6il7MpTj2NEyKTkZI6YxRvzx6+1UBNgYxThORntx2o5DSNVIuHk5POKnifDc1nCXIHapYZOcjkdKTjobRqo2IiOmatxFSfWseObOfQe/WrsM2PpXLUgbe1RsxEYFWE2k1lxTAjBNTRT7GwRkVxygXGpE09o20gUA1DHMGHWrEUckhyg4Pc1g00aqUWJ8ueQKswRyTYCLkevapYbSKMEytuYdu1TPdIF2qQo9BSKsmEUCRNmQ7yOeOlSTzljwcCqElwMnJzjgYpjTgdz9KpSYnGKJpGBJFQu+PpVaSfn8etNRmkc4reF7HLUnFFiIbiK0rVNzBV6etUYBk7VBzW1papkL/ETyamUnN8iPNnV9o7QNrS7faB8vHWuosGAVCPvdMdOKx7MogXAOF61pGaMSxsrcV2RioLQ1pwNGOUrevt5GMZxVO6lL3O0EYHJqGK6IeXBPXrWRqN/5Jc9B60OSSuzrowcpWRszXgIwzZUe9Zz6gqE7eSawpL2SRcJkA1YsreSZwPmJJ6CuCrjLO0Nz0qWDS1lsbNrLNczgISCTxiu68P6CAiS3ADOeeeaq+FNCKAO68+9egafaBFA9PWt8LQlUfNUPNxuJUPdgRWsSQ/LswK0BCrJwBz7VZS2VhyKnjhCLjPSvTp02tDw6la7uYN1pquuStRQ2SxAALiukdFwTVPYvpU1KCZccRJmHLZMXJAOKK3Qgx+tFZLBxH7aR8PweUYwNoyeKs2VqJnaMnBzxxWbZSI8QBOcVejugsiMvDA+lc6tf3jpfMr2LhhktJMZJXp6Zq3p8jLN5SnAz1AqWSRJrdGOMjGc1WuAIJY5UJ2N1xVuCh70diYS51ytalu6icxyvvJ46k4xURMsEaSO4PGT7Uy5lXzFjVyVxuKg9agnuk8qRHJJI4HcUpSW5UIOxd0pGmSV2K+Y5Bqa6mDSMSoGF2k9jWbb3Lqy+WdiOuMkdauXMipZ+WxG4jIzRCacbBKlyyHJ81wfm6DJ9qVgblhFjyxGeSG6gVFaOI5PMLAyEcD8KlCpHLM4X5kQMD0yT1oi3YtrXQylhRDG03mNI0u7e2cMOx56dcd60pXOzYqkE4GcVTuZyZIo7kFiqhgnUdsZ9q1LARS2Kg43t1PocmnSkr2Ir020mzBv7ZNpXO5gcGuO1W0ZWPH5V6ZJaJskL4BBLZz71iXtissbNs4/nXVc4HFrVHmEi7Tg5qMn2rp9S0yNXOYyOfWst7GPJCswAraNWL3Fdmbux3oD4HWrhsTtyHBHpVeS3kUgBM59DWikmDbQ0PjrSGSmtDKP+WbUzy3JPyscdeKqyJdWSJPM96BJmoOh60oBzjrT5UT7aRZ307f6GiLT72ViI7S4YgZOIzwKk/s+825MDqPViF/nUtJGsazE3U9XI4HHrVyXQrqBYDLNar50bSKFmDEY7MB0NQR2LYBeRR9Kzbit2bRq3HpNnp/Op1uBuA3DFJDawKuWkZmHpxVpBbxdEBYDqeawlKPRGqmx0MrtjAJ9K1IELAeYwXis5bkckAU1ro/w9RXPKDltoaxkzoIJooegyR3NWhfk8AnHoK5uC4YrgnrU6y7Tkn9a5pUNdTZVeU2mujnPNRm4JOSc1nLLkUFwMGo9ki3irdTQM/fPWo5J/TBqj5metSQKXYZ+7VqCRzVMVLuTpucgDoavQLwAoqGJQThela1hbFmGRz0rOTbfLE4KladZ8qLum2jOynHWunsrSOIKuwdck+tVLRFiAHFaCTKp4wAO1dtGjGnHXc6KSaWhc3ouQMYFZ95cKiMQTkVUvLwAtk1k3F0XOASe1ZV6ygerhaLlqzV/tTbDsXqf1qnJIZVJkyc9MGqcY+fHOa2tN097llJBI968qrWnV909ulRhH3g021edgFXjpXo/hTw4QA0qjqMUvhXQFyrsnFen6RpqkooQBR1OK7cDguZ3keVmOYqPuxINJ0tgnyrgA1rm28s9CK140VFCoAAPSmTx5GR19K9+FKMVZHy060pO7KEUe4U5oyCe4qUIUyR+VMJOCPX2q7WM+ZsqSA8jqKrPlQSMnirl0u0AjjPWq7gsF68HoO9ZSRtF6FcNuJ5oqcWj45wD9aKtJW1K513PzwtLx4COcr6VsxXayBXQjjrXNjI71JFIyH5WIrkqUVLU9dJS3O8trgGNSW5PBFT3EvmWrKpyy9K5CxvSXAc8etbP2+OOBwTziuSUZR91k+zs9C7Bcqkas5zJ3zVuyKLE0zLuJOeRWNprI8gablWPc1vylEjATAj9qx5Ls0m0tF1LR8prJi3C9R7VRtplxvuQxdumeeO1Na5kuIhFFGdrcDIqySIcI6AyBcZq7pkRXKrPcSRg67o8q3UcUxt0jxnzWOfvccU3LOCH+Vx+VN+0/MkarmQEjGOKLXNEhpcPqLyyhvLx/EO2KveVGt2rW2+FAc8Hgn8arzqWeRCCSExwOhq7Z7PJfz3LHHCnoeKIJ81gqNNXZckA2iSaTzCnY4ANR3AR42KZAzn6e1NWFRCyEln7g/wBKs2u1bdv4geCB1FdkXZnBUhdaHMarZfvDmP5iMiuYvbXYTjg9a72/SKP5Ud5JG4A9axr2wO1lxyAcgDJpSVnoYyhpc4eYlQQeM9qqSvtYbc/l0ra1CzIyehHasW4QqzBgQfWtaTUiOa2jIWmY5OTmmiU884z1qNvSkP8AnmulInmJjKemR+VOS5ZQMHoc1WzSA+tFg5vI0TqNySzNPKWIxkuc9MVF5zFt2cVVBwDQrClyopSReNw5Y8kAnP1pGlY4yefWqoanA8daXKjWM0Th+vWn7yCSD1qvux60A56daViucuROQD1p245yc4qsr4UjqakDDdgjNQ4idSxejkyRx0qyJC2PTFZYk2rgAjPepRMSQBnGKxlTuZuqzTSWnCTccevaqcAZj8oNaUEATBblqwmlEzlXsSQwknL9PSr0SZ4A46CoohuPArQhUJgDr6muWTbdjFc1d2RYs4AWHH41u2UYjIHA/Gsy1cQr7Gp3vFQ5Ddq2pRjTV3uehTouOiRrSShCzbug9ap3WpEnC4zisa4v3fIBqFZH46k1lWxDfwHq4bD3L0k7SMdzGpLcNKwVQeagtLd5nAwTXaeH9AeVx8pyecflXnyvJ2WrPZhTjSjzTINF0d5GG4cmvT/DnhsbUZ15FWPDmgpAgLIN30ru9Nswu35ePpXo4XBfakePjsy05YvQbpmlFIwyLxXQ6eAg21Ja7VhC+lQg7JSB617cKcYbHzNSo6j1NDIpahQk1JnjIrSxFxCvzZNMmiVxk9qkzUUsgKEDNAiu8CsACc/U1JDaqrZI4qCIkOCQSPerTy4XqBSKdxkzRo5BIFFZl1K7S5T88UVPMy1T0PzhIxQKvz2bqc4yaqPHg4PX0rBSTV0z3nAarYNTpLnvUG0U4AZ4603Zji2jXtrwBVXjg9K1hfF0RA3UYrllOOtXbOQbhlj/AIVyVaC3Rpbm1OxtCqKhL5I561Zgk3yl3/i4zXNwTKuw7iR3FasVwrxkFuBXMtNGYSjJGw3lHCEZ9M1TmkjgmaRVwnbjk44qsJTMpVG5HA5pXThV3bnPXPaqcr7DhF9TQtHWeQytnYSB6VeSIMGkyS3ZcZH+etZunod3lM2SBk81qxBUkJDYAremtNTKpe+gWbmeQjHAbknjHFPkji3tLGGTGD7GmLFtjDDdls9KlcFIMgkMqnj14q46Gcld7kVyftNyhVkKRDA28cmq17btsXyjmVyeOv41b0aABcSth3BJ461Yt4A94XBz5Z24NVHa/cicWna5y8+kqA2IyOOM9QfcVzl/pe8My43cZXP616nc2JuJVK8dsev+eKyLnRt0BlJwQxDbeec9v8av2dtjknrq2eRXmnNE+Oc+mKz3Qj7wxXqWq6EjSKWJwV5YdRk8Vz2p+HHg654yMHrWkZTWjMG2upxbIVPJpuPXitm40iVDzz61QksynXI9fStFJdRKRV4oBH0qyLMk8nP0prWuMYajmQ+Yhz70o9akNv7il8gDqwx9KLoamITk8VMAuADSJB15wCaf9mLsMNk+1S2hOoNJ+TC0m/GR0Poam+wSOvJ5qxDpeW3OxzjvUOcVuyXU8yrErMcAZ7Vp2tmBy/51YS3SMcVYhhMnqB61zVK19jF1HLSIRhUHyirMQZvYeuKkjtAvv9aVlIGdw/CuRyvsbUsJOprItQIiqMmrDyovIIPFZbyxqvLc+9VJZmbhWwCKUIt7Ht4bCO1om3LfDBCnioPtLP8ALnisyGNjnLZrVsrB5nHpU1Eo6yZ69HBX6klvl2+UVt6dpzysMjI64q7o+hlivBzmvQPDvhhjIpYEDPfvXE26rtA7W44eOrKnhfw2ZXUsuBnk4r0/RtGjt0UBAKn0nRVt41APNdBBYkD7xFethcIoK7PnsbjZ1W0noLa2saJ2zitO0eOPioY7MlgCxx9auPYDaMNk16cY2R4s23o2iZZFBxnrUc+Mgg0yO0O5Tv7+tOmtDtAD8VZlaz3JIZcDDGpFmGcZ4NQQ2OVyWNTfYxtOWNMTi+4rzhc4P4VX85ieeh9qaLbBIMg6+tD243cOPXrSGo+ZI0i7hk1XubmMnCn8uarXUBYn5z07Gqz6ew53tu61m5djWNPuzVt1Vkzux7HFFUrO3kWM75GzRWiM3B33Pg47XHFVLqzEoJjHzjtU8ZPHan7sHgV4sW4O6PfWhz7oVYqykMOxpuOa3bm0Sb5znd65rNmtmjyGHIrsp1VI1TUir0460AkdKcVOM0hGM962Q7D1kZehIq5HqEiAjHH1qhjJ5FKPlPrUSpqW6HvubFvfFVGW5J9a0rW85LFst2rlw3HAqaKSRcYPFc88Ot1oDpp7HYRzkSgq4BPU1f8APckKW+br1rjYb87uami1EmQDOW9zWaUo9DF0mzv4JyInQn5uv0pJ7sNBsU7mYbfzrlotWwRzgkcj1qxZalGxVZNwGc1oquljB03e511qn7pJAeVHT+dW7RS0jTyA/vTkL6CsSDUElLASLjABxWjYajG29QdqocAD0rWMo3Wpzz5rGyYy8YVS2CcHaOQPXNRXjeRbiP7qgbRx0FEd4oHysGB7ZxTZGSViPlwcjrXTZW3Oa2upFb6d9pspTINxb5s+oHQVmTWPnpE3BbByf6YrVuZ/Ks8IxBGANvf2FRDzM4hRY05A3DJPvQpLYzlTucrqOlKwKRI3y+vGc1zt5onJ2gbR19TXoNzbnfmdg7Me3GMVWv4okYP8qr2XFJ8r3MnTa2PLJ9MkUj5WBqjJYzKcg8Dn8K9LubWJVBJBB+5VGXT4yWUqrdz2yaz5orZkuEjzt4JQSGVsChYHbJ2kD1rtzZW5Q8fOODzU+n2ejoc6lPMEzzHAuWP0J4rP6wr2RLg10OJt7KRnHBJzjj+nrXqfgP4O+JvFMKz21j9ns2wVubo+XG3+7wWYe4GKtaD4t8P+GgkmleGYLy+ClWm1Q+aucghlQDAPHrWtrnxu8XarA0QvIbGMggraRbDz/tEk/qKr21Jayd/v/wCAKNKpPdWLHir4VeHfBOltP4o8Ub79l/dWNhEGkY/i2dvGMkD+leQTkSzMIEMcecBSefxqxqOoSXdxLPcyvLK5yzyMWZj6k96zJbzB6gew6VlOftX7sbHRTy7md5FuOMIck5Ppmp/NVevFY73pHC5NVmldzl2J/pUKg5fEejRwUYI2ptQAxjgehqlJeysTtOB7VSBzmp4kLEAcn0xWsaMI7no0qC6AC7HJYmrVvC8hAQEmr+n6RLNgspUV1ul6CflAQ1z1sVCHux1PVo0ORXkY+k6PJIVLiu60fQ2JUbOCa2dG8PlQp2n8q7/RNIQBAV5FcSo1MRK8xYjGwpL3TI0Hw8qBSy12umWAiK4BGKuWtosa7dtX40VAOOa9WjhowWx89iMW6r3HxxHjBPNWEJXqf/rVXL7cn8KfG4KFia6VocFr7lpZSTwatrOSm3PPpWUkigE1PC2SD2NO5MoLcv8AmARkcg1PG26Llic1UjId+nfpUkh8rgnA9qpNmUoq5PFKFbaGwfSllnHPNZrk53AmoN2T1P1p3fYapJkktwWk+VjgGpTL8oyxzVeMIP8AWEH3qtdzqZB5Z49ajVGtlJ7FssMgFutSCRcYLH86zfMIGeT71BJdBOh6980kw5E9jbW4VRhW4+tFc0b456/rRTVVjVHzPjmaNQ2QOTzVWT5ScUUV40Ge00rjkJwKS7VTHyKKKr7QNGcVCqMDqaikUCU8CiiulNlWGzIuVwMVXYdaKK6I7FdBqjrUgdgOtFFDHEkHOylKhZMDNFFKJbQrOy7sE8cVo2UreRHg9qKKzrxXLsZ1EuUsw3Mv2iQBsAkDitJrmRoWfdgrjGKKK4m2tjGaWhdgvJhsIbBOM1aN9OWUbu5oorZTly7nNOKvsVbjUbncjF84IAHYVrR3kpTJIOf/AK1FFOEn3IqRVloRXV7KJCo24QFh168f41HPO8zQh8dMnHeiis6knfcxcV2KkszB8AL9cVRu7iQEEHrxRRWDbFZXKDzPtA45OKqzOyj5Tjv+tFFaQKjFFcuwzg45zVQ3MnzHI64oorqgkdUIrsVWndgSSOaiJ5oorpitDWKQ4CnKOc0UUzWO5ZQAkV2OjadbgKdpJIByTRRXDjpNR3PUw6VzsNFsYWk5U8Gu90mwt22kpz/+qiivPwnvN3DGNpKx2NlZwqBha2rOJEHyjvRRXuUYq2x81XnLuaWMDikzgZooreyucyZJgEciq0pK9DiiitHFW2KQkbE8n1xWlEB5ZooqVFBLcdbEgnH+eatg+YG3c4FFFVZGM0QXXyIAvAzVSb5Ycj1ooqXFW2CmZ8jsZCCTSNwpxRRWSSudT0QXDFbfgn/IrJLE5z6UUVVSKsVBsoySMGOD3oooriSVjouf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A layered Grade I to II hyphema inferiorly is seen as well as an area of active bleeding from the superior iris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Kathryn A Colby, MD, PhD, Massachusetts Eye and Ear Infirmary, Boston.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19120=[""].join("\n");
var outline_f18_43_19120=null;
var title_f18_43_19121="Prenatal ultrasound of ARKPD";
var content_f18_43_19121=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79653&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79653&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound of ARPKD transverse section",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 287px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEfAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5dZjuPJ/Om5J6k0rfeNJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU47vU8U2t7wtppvb+OV0LW8JDPx1PpQAyDT7myWOS+gmiEyhkEiFSVPIZc9QRUx1B7Sbam9kxuAkGRXq8urnV7FrK7jivrKAbVSRPnjHoCOijpXL32i2ItRNbP+4c4MMvLR4p2JuYXh7xDc6dMLiOUPGXDGLeQFrtbXV7Jon1HSbkpdZxNaEcY9R2auI1HTYkKPEiBSOWXtUd1G0aqjwTQyEcMeAfSmFjrA+g6tcuLhp9MvWOUuYYwqqfdR/OtCSDXNLtyUZNWsD8rrGAwYfTvXnUmtyRMFnVHwvO4YzWpoXiiQSLF9re1XPyqT8o/HtQFjTk0vwvrEvkytcaNfdhtwjH6H+hrNv/h1qyq0mmT2+oRdR5T/ADEfSugk12G4UWupRw3KjlJOMr6/MOlWJTokBD2F9qNhLxgRuJc/QDtRuK55dqOk6npzlb2yuoMYGXQ4yRnr0qhls9TXuEeqa4FVbbUbLU4BwiyKEkB91brUEsF1fKJLvwjZXSqxyYUwc/h1pWHc8W3N6mjLepr0260bQpFYS6Le2bliSVdgR7DII/Ss9/D/AIddHCSXsTEfKzyqcf8AAdg/nRYaZwW4+p/Ok3H1Nd1beENHuGKxardGQdQYFx/6FUz+EdBtmH2zW5gM8qIwCR+ZoswucASw7mjLepr0V9G8FIN6y6xKueFRl5/8drStbXw/tMul+CdVu0A2mScsVz60WFc8oXe33dx+lbWm+Gdbv1VrbT7nYTw7qUX8zXpVpda15K/2P4c0nT4/uebLtDL9c0y6g1O4dG8QeLrSAOCDBZjzGHtxwKLBc5aLwT9lwdb1S3tlwCUiO9/XGOK2NJTS7GYR6DpVxqF6p3LK6F9v6VaiuvCuip5k1sL+VeQ11KQzH1C+lVdS+Jer3Sm30OCz06Ert2WqBCfcnrTEbOo6fq11GH8S6u+l2bfP5EZVGx6YznNYsms+D9Hgf+ybA3EnRZrqQu5PrtGAK546Lc6hOr6nqW7I3k5LYrrPC/gXQREuoeJrz7LpkZJ2BwJZx/sg0DscZf69f61ceXZ27bF6JDHuz+FOtdD1BmP2iYWiqMlZ+CufQV6Rq3xC0nTbN9P8BaPa6NYkbZbpgJJ3HruPTNecXepPdPIzyvKznmVjmlYLkyRCE/Z4l8855kYYDetc7rESx3jNDkRucqvpV6W7dtoaWSTj5UjHJrpfB/w38R+MrkxabZmONvmeeViIoF/2m/PpRdjPPtx9TRuPqa0/E+izeHtfvtKuJYppbWUxmSJtyPj+JT3BrLpDF3H1NG4+ppKKAF3H1NG4+ppKKAF3H1NG4+ppKKAF3H1NG4+ppKKAF3H1NKrHcOT+dNpV+8KABvvGkpW+8aSgAooooAKKKKACiiigAooooAKKKKACiilUEnAoAs6ZYT6jdpb2yM7secDO0dya9V8NafHZzCztJlhuFQ+W7/cdsc5rD8IaPNZ2vmozR3rn5wvVV/u13Wn+fp0kUy2cd/AQd6YHH+FUibkWhWQWWVZGhtL/APijc4jnH+yelT3uj2mpkS2zokokwgViSv1BrW03VNDnSRGt4zvXbJb3PQeynPX6VZ/4RDTL4N/YGsSWNwBua2mbdg+zCnYRwni3TFtYWguI2jKqCTEpCn3we9UNL1LVbewM1mtpf2cJ2eVMm8ge+elenz3eraDMIfFukpqumuoXzCmScfxK+P0rPu9N+HesI1xpuoXOju3LJg8H/d6EfjQByWneL9GnmMOreENNlgkUIyJlee5Ddc1vDwP8MfEtvG1pf33hjUJB/q5/30Ofr2+uaxvEvwq1K0Hm6bdw3sEvzRSQceb9R2P0rh76LU9Kk+y6hazRSLwBJ/LmgD0N/hB4i0EPd+HLzSPEent8rrDOCSPdex+lcjqGhm0nZJtI1DTJmOGaKXKA/jUWlaxfWZDRXLW+BztcoR9K6zTviH4itID9kvkuowMNHdxLICPqRmjQDkJ7GaHyzp2ticg/NDMnlsPxPX8DVRNX1O1/1d/dRlSSAsmQK9Dt/Gei39ykmq6RpsMqj5sQ5Rj+GMfrW1DP8ItYi8u50iaxus/61ZTgn2GaT8gPLoPHmv2/krJdm4ROizAHmtVfifeeUI7zRrCaQH/WmBQT+NdTqXgP4aeZJMNcv4ozyBHHkj69qwJvBHgq3VXPi+V4iMiN7c7vpwTRZgY9x43t72V2OhwBiefKyv8AKpYfHkMM/mnSdPllxgfaUDY/z71etfCngqZ2WTWryFR/EkJwfrVs/D/wIW/deNGIYdHtyGX9aNQMaX4mal5yNbWukWzjIxHar0rEvvHuu3ihZNRuAo5AVtqfkK7m0+HfhK4jDL4qsIrc5AZ1YOxHrW1o/gf4e2Uim/12F8jO/ZkKfUDPNFmB4u2qardI0775E7nmrNjaa/qAH9labeuTxvjiPP417+uq/CPQGEgTUNXuV6eXBtTP0OKyvEnxmvLiFLXw1ZyadZr1eXBPsMU15jueeaZ8JvFl2yy6hHb6dE3JlvZ1UD656Vpf8Ib4Z0fzG1nxLb3FxCcGOy+bP0boaw9T1S61S4f7VdtdXEvzGMuxDH6elUfsJguUGor8xGUjSPGSfekFzQ1W+0qC5eXSTJbwhcJ5x+Zz6+1c/qF/JqcxaeQyY4AbkVYntd9yxe3YIi43EZxUtvpyMCIsjIG3jnNLUNCgllJNhURQAMjb2/Cut8OeApNUkil1LU7fS7A/665mIBUey9SaLPSpIl3r8hUZ3e9VCkrCTJMj5O7fngegp2Fc7y1vvAHhLzBo9m2t3C/K1zcHaHPqB6Vka58Rdd1u0OnWjLYaYCQYLX5EYe/c1zP2ItDHPIyRQJn5CeWPsKm06BOXJCjqFY4Bp3Aw9U0mObT2khUteKSzMM8j0rkSMHB7V3M94QHijYIHfsa5jWLUI/mxDKHrj1qWUrmbRRRSGFFFFABRRRQAUUUUAFKv3hSUq/eFAA33jSUrfeNJQAUUUUAFFFFABRRRQAUUUUAFFFFAAOa6jwVo0l3cPe7FkS2+ZUPO9vp3FZHh/S5NX1GK1jbYrHDSEZCD1OK7/UbJdPXydPGzy1wCOCRTSFclsp5DcShJpI5tuSQMZ9jW/wCD01K91HzdNlBmgGWiY43D8etcZp32pj58b4ePgq3B+vvWtYXlwkzStvhnYcqQQfqO1Mlnfa9o9pq0avfKmj3yk4nVd0Uh/wBoD7h964+y1i50PUHSUBpIwUYqdyOK6HQ9Uu5LcWGoPGIrjlJ5DghvQmuf8UNF9uEP2L7NOowzRSB4396dwOifxpfGzMFk08Vq8ZUQSfvRz1A9BWOJIWiMl3psVxFgqHjBG38qzNG1CXTrkRyyZU/MrAZwfSugtNZ0+d/Muku7KQ5zNCAY2zx900AX7LV9EuLG2ila7gMEmQyudie4r0Ky1WxvUEdvNoerwyDaYL6IBzgdN/8A9avKIdFtZ7g/2dfS3qS5yhj8sN7c96YFsbaZVku5tIuvukTRZTI9TTA9Bv8ARPCF7dCPVvBt7absjzdNufMj/wC+axrr4a+Ep2Y2Wt3On55WO9tmAUe5Fc3D4212xk2Jc2t5bxNw8abN3uK0h8UrmXamo2QkiB5Il2sBRcCtc/Bu6um26NrmnXTg5D7yqke2RWNqPwZ8X2alns/t0JGc27Bm+tdIvxD0aXU4nGpXtugwBHOgaNfxFbs3i68hvWl0rXtOntQu9TCx3HP8JGaNAPJX8KatpzgTW+oQN0BlRsg+mKPs94UkQGLcRglrclvzr2c+Nb2TJnhSRsAkvF04+9nNPi8fuWCjSrGQkHBTGfx4pWA8Qh0O9jQpBKkwY5yOCPwNP/sPVLeEXE0LlByJWCjb+Feyr4rkmiZJbEyE8mONUQgfXFJ4avbd9bmMttEseOY71Axf2FOwHjKWx3kF4nJ5+cAn8BVggRqEgKuwGCfLH9ele2eJLvw99qSKTwfaiYHJZcLx6giud0u/0mK4lmGkRPbxsVETQs+D2JPpSsB5C3nA8rcsxY42gn+VXLXQ9U1NgWhlCgEjeDyK990fxBCLdvsFjGX7vHbrsB7jms/XPGV3Pcm2itIo4dpDcKCT9R0FFgOG8E+H9Q0eE39raW4uwxPn3SqyovtmmeKmnv7tXu72OaSQcGOIZA9sdK1dVTVbi1j+031n9mXpbwEuR9T0rn7q31Ga4EVkQk4XBZVHSiwFQwwxkeaCFAAw3JOO5FQveWCE/wCjPM+SNyjaTU9v4Y1W5fnG4DMjjj826CprrTrTTAiteRTOAGZUbIPtmgDOa7ZGhGBEw4XBzj6iqdwQjSHmTa27OMbiaqzSwXEzXEuII1JCc55qOWS4nV1RWSNf45hjP0FIB9zKXmUtEAwHG/oPcCoLuN0kDQtuc9cn+QpltbiZ/wB5Ng9nY9Km1WSGC2WFCW+XBIPJPqTQC3Ip9PjtWFxO+Wxkpnr7Vi3s3n/ukj+VuCFHQVYjEs7YQbUQcsW601pVRnjQk57ryaTLObuIWglKMMDsajrXu43uY9scYXbzuJ5rJYEMQRyDzSASiiigAooooAKKKKAClX7wpKVfvCgAb7xpKVvvGkoAKKKKACiiigAooooAKKKKAChQSwCjJPAFJWrpNmWUzswUj7oNAGzoi3Glwl7YjfIo3c4z3xmugu/EcurMialCkcqptEirjd7k9656KTdGw+9jkjpTkuhtAOT2KnsPWqQrHUaNrX2DYjwQzxZG7cua77TPEfhe6jjW/wBPWeMthkHG33z1ryC3ZXRhE3ODxVqDarGSMsgwARjIoJPYp/DPhrWI5V8M6y6Todxsb4cj/ccdfyrg9T09IruWIxhpYzxIjEgj6dqp6XftbTrMd58vleoNXNT1c3cv2o3HmMwwUxtb8cdfxpgUrBfKuxFcQxzwHkHOMfjTprmRNRVrGJvKHAhY7lHvUUsokiQNHscnOY25/EURX1zZth3ZOMncBSA620vbyKGKzL28iTOG8pl5U+x7VqvrN9piy2/ibw7ZaxaIMBnwGRT2BB/nXLaVriR7RdKjjO4PgE10sGl23iOVrrTNWRLg/M1pcEYb6UwKq6J4T1+NG0Vb/SLsn/UzsGT8DWTqPhC4spQRewXKPkZBAYfmKNd0HUtPlRpbN4ZS25ZEyVHsajsdev8ATJlt5GUh88fK6/XvQBSe3aEJbFIJVfhmZQPwNUbvRo4rwQLbxWzEbz5bnH1rsItbtbsIdS0mGREPEsTlefpnmjxNqFhfW8CwxeTsGCE4kH1PpQwOctLWWJxmaeVHXaAmDj3NNF5dwxT20ULeXjllXiooYbiCeTyb2IRuccE7qvtJPZWBMdyJN3U5P5UgJrd08kEXc8LBOdwyAa1tN1RobKXyLmFS6YLSLucH2zXH3Wo3MpKyoFeTHyoOoqzZWl5eOBYwBpOMgjp9TTuB3uma3cw2jq99ZuuAVMigMfxxWdc6jOL6S6tJMgnjb0J/Oud1nRr/AEgob0IGlHc5Ue3HeqFnLcWUbTwBXGO+cJRcDro78yy7dUaNI87hArEbT7/WtW11iJkkhtbe2jERwWYDp6k9683eWeW1d5ZTMpOSVk5/xNWLS5iTyTcWsjRvwADgsaLgd3rOqx6hp7R22y3hQfeA2B29vXmsLQ2lDvAA3nSngSOFBX1NNvdRadIxJbGWGEfLGQ2E+p6Vg3WosGARTIrnKsBkoPQUXA6nxXeT6csFtLcRwI3PkxNkN/vYNcHfW/2q+kmllIgUZLAbQfoK0GuphGJTaRKqn5ZZGyxqi13DJHKLmdpmlOTGgKgGgCmuqRWTr9ms1llA4eQZzVa71G6ukCzqd27ccd63tJsvtkkFrBbMZ5TtB+8cfTt+Namt+HrfSspdSq7IeQOg/KkPQ4qLcHO1GO7rmleMzF2kcyFeo7D0rYnIeIAusUbH5SE/rSraIkW9WTGcYHJP1oC5mWlrPcube0gkkYjJVB/Wqt5p11YTlmAjc8lcZrr0vFstOMsE6xOD0HGfqa5zWNQklYy3MgPoAMZoYIzBncGZwfUEVmavAjP5kIPA+bjrViSVUIdydrdvSoi8jeYFxsI70mUZFFSXEaxSBVcP9KjpAFFFFABRRRQAUq/eFJSr94UADfeNJSt940lABRRRQAUUUUAFFFFABRRSqCzADvQBLbQmWTp8gPJraj8tlAUEBeB7VTjQRR7I/vdT71NG7mQHITAoAnR0SYDA3NwDjrVmUhGGE2sOnuaqu/nFRxkdwKn3BlVN2CPWgCzatyPlUM3XnFXvLPlIYiBG3DAnO2qMMUjAFiNoPWnZCM2GyDwcd6pAXTKyY3csffqKJp8gNgZbtWZIsnmEklkAp/mlMgKxz+lBNjRM5lQHO1lGcY5NKLnzCBOrEjv2xWfFMSQHDqCafKJFBjWQlS3Q0BY0dsDbtjEFufl7GrNu8kAWZZiGXup2msyFCrhgpG0fdHerPnSFMCJWOc7s4IoEdrpPiTWYPJ8jUrlc8FWG8Ee4NR6hrv8AaySxX1paMUJxMkIiYH6iuQWWbb5qEsw/hV8YoN2w2eerDPfPWgDotEu7WKcrdwJLADlmLnJHpXRC/wDDMzsbiC7to2GA8Thh+R5rhkuZTblY3jKt2ZMmnRQyDDZZPVu1MDs7uw8NSiEQauxRjkq0JDD8RUb6TayWrfZL+3uEj/hkPQew9a5BpJIpS+3cMc7Vxn3pIJ8uBCohkz95jgH86LgWdR0e6RJLgKVgXoVOQTUEN/fwwiKyaRZWOXZSQTjtUlzdTRExySurYyFBwp9xTYZZggZmYb/Q0ASTzXdzJGLyKcsDk80lzdFreSCKB416sD1P506C9uDIQshz/eLdKn/tAiSSV2jMirgEnNIDJtraLfHuSXzDjaM9fwru9F1S40opJNptqhTiOSZBIfqM9K5E6/cSMoVI2lAwHVRkUk2rXXlsLkrJnnc65I/GmBu+Jb281Nz5w2I5yUTADe+BWHb2xFyscUUkjg5IT/PFVG1GYgFdoI/jPaq8l8Y4mZXcSMcYRsD8aQHSX2jPIBJsBiK5K7skGodK8NWs9wkl5eQ2cT/M3mNziuft9Sn2sHlaKNOoV/vVBc3ZnfLIWHrQB6lfa5oOh2scHhqR5JQuJbuOPG7/AGRn+dcRq2rHVbxpSkioPlGTzmseK6jCEHLDvnt+FWH3wwCUqDGfu80AWFAkjVpYw6g9zg/jUN5dxRvhSzMeiqOPzrImkl2Hy87TznsKa0JeElpuSOx60DsLdXGZGVOQfUZxWYWLyMd29h3fp+FPMLkbSx256DjNVgjCUqFBx79qTZQPKDEd43HPYVXlbcpIXa1LIWUnHGT+VJJ8oHO8mkBE0JkG6RwM9KpEYPNankSC33tHiP3rNk+9n1oASiiigAooooAKVfvCkpV+8KABvvGkpW+8aSgAooooAKKKKACiiigAq9aw7E3v95untUenW32iYbmVQPXvWs0JUfvRtbrQBXRecA4NOK8Enk+lPIUsr44NEi7juTcPegBsCIp3H5T6ipgWDYZVb0B9P8KjimAO2TnPep0WQuFLBVP3SfWgC7ErCRNgGD0DdvWo710WZSi7T1I6D86rTl1BCnkdweAaoiK9mOOWHsKdwNMyMwJRdu89jU7CRVVYwpYcA96z4o5U2AkZU5weKtRxsGAiQEnn71MVy9HHvEYyImwQfrUwVfKIZP3nYnnNVY43Vt7eWAeoY81oRQPKB5TqwI/hbp+FBJEJiJQm0KcDODkH860LSBbhX82dEcDjecA1WktnhXMjoxxggjH5VCmEkUSBieoBoA1Es5FVkh2yJ1ynIH4GoLZXW5zJtVhwC/QVUNxcQuwgLpxnANQtqc2AH5bsG6GgDoQssEbS/Zy8ZGCw5ya3LSze/sVS7tcOq5Uo+GI9xXHWWvS2siyLEMdCpOQa1oPE2nSycpLDP3ZWG2gC1JpMyvlUlCH+NW4H51CunIOJHDRnoVxkGrtn4qtElKSIjKvR26gfSt7Rv7EubJ3XV7QORuWGYmPafrTA4DVLZIPkR2kB9V5FNETJboruWZuVXFdRdabFMHkWe0kG7Hy3AOaz57DyjsVnVP7xGV/OgDAkhEQDEM8x7Ljj2qGQSCT99HsYjIHHNa0SQZkxNsjTggDO40kuizz2wnspop9xztz8yikBiySOzBeVUDoR/KmNcho1RQ2VOc0+W2njLicOAOee9UAfnKou0N0oKRa34J2tg9TuqGa6LL8wyp9u9IxLABQCehqGQsh3HBHQUDGrKAcEbG9RUiXO4soDbfrVRgrFgdwb1pke5GOPmHqeKVwNMXYQK5QqR06UyXU53TDsNmc9az153sTnHt0qRXUxkFs/0ouBKbh5WJlZnUDhRU9nLGYiszbGJ4GM8VmNGRgq7Fc9c8U0hlcHJOelIDZIijkwxDr0HNR6haW6IpjkJkbsKy5A3UYOPWnJKY2Rz2PSm2BLJp+FDzvGB2QdfxpLZoxcgMF8odven3EzXMm6QBV74qs5Q8I2FA645pAX9ZkhZUZJgQPuoBnFYG1d5LHI9aGYtJhSSAeKsm3LqAuPoKAKEi4JI+7TatywMODnAqow2nBoAKKKKAClX7wpKVfvCgAb7xpKVvvGkoAKKKKACiiigAp0UbSyBFGSab9K0LHECkuCGbv3H0oAuRxIgEbfKmOXPUVOzNGyqWDD88ioFk3Z3808wblDxNsJ656UASRrvV1jVcdfen7WkwwG4LwVPWo4LaYKpJ3Z7ipoIxGCDuD5655p2ATYW4MalOue4q1Fp0dwyjzxz91WqN41JWQHb6gVOYcASQzqwHJHcUwHnTRCxBmUv6gdK6/wb4Ev9YZWtbq3gYHIaZwBj1rioZYpJCJJCpz1rQtbm7tctBdh0HT58ED0oJsesXHwe1maCSWW40mfyxklJBuI9RXOxfC66nKD+0tOs5HbYEmkI5rlB4kvolGZpIFPG6M4P407StehkuVTUZ5JQRgM55X3p3QrHd3/AMB/E9lbfaHis7yJeS1vIXOPXHU1zNx4dt9LynmvDdL/AAsOn+Feg+E/HWqaNDDtvJ57BThJFkDDH+0M16HqFroPxS0kSW8tnBqKfK25AsgP1HrRZAfMlr5k1zNC7CU9ye9VZWW1u/L+zG5QcgDOc11/jnwPrvgzVVaaCR7V/uzxMDj64ro/Bms6bFp6/wBr6ZZSSgHZJKnLfjQB5cL+4GSNK2k8h3z81XtO1/QPMEXiLR1IPeFypFbOreIrOLV5Li2hjhUNj7O5yg+ld/4Iu/CviFHttf0KxmeQZV1wrD3FAHDQ2Hw3v4xJFqOp2jtyUyDj8+tNuNA8D2+7ytWu7kkcK0OCPrxV3x34Z0zTNWdNIs0SJOnmDkZ6VUgsLxbRCyREN0aIbj9MYosBUh8PW04xaWEzKSNjEcMP6V1+l/CqfVbR1srKJGQd5RvP61hG4MKpKjO00XDLggfiKI/GtxE7LI0gYdDF8uPrigCDxB8MbnRi32qG6Tnqq5GfqKwrvw9e20DGPUJ0iXqG7Gusu/iTNc28MN7C0ix9fmJDfrXM6tq0eoNLJBbynJyCeAKAMCS0vYeY72OY9wV605Ly7RVBMkYUYYLxgVciuFCI04ZueiEc+1TXj2r8x2rlMfd35NIDCe5aefCB3X1Y1FcZhI81Of4QKvPb2ksheMzrIBkrjAH41k3UZ2ljvx2yc0FIkjlLktuwB2FDqGjzyT1waqIrCJivysOx7017uRIwWUClcZcjAA+aP5aWW1Z13RDcp6LUEN+ki4fI9geKnjn8vgFh+NGgEDRynKPEwA7dBSGKHb0OfTNXInDByQRmq5jIPzKSw6Yo0ARY/MUquCPUnGKsSaPOyKy3EAyOm7p9apgMZMFfqB2qZUEalmPXjANICuLeYv5e5XIOBgcfhUtxYywx5mKIPzNT27eWN/UDnFLNcC4P7wfjnOBTaAyGG3HVv6UjfMpHer98hhiDow2nvWWJW3NvHHrSAsWkBkXIKrGOrYq5Ncx2sJitELORlpMVFbRF4lVSFU9QetQ6kfIUxw4AP3j3oApG6fzGLEkn1pz28jQefKcBvuj1qKOKQspC5JPGa6C4tILW2Sa9kLyYyqA/doA5ilp0ziSVnAwCelNoAKVfvCkpV+8KABvvGkpW+8aSgAooooAKKKfBE00gVRyaAJ7KEud+AQPerLkxnJUsB19qkhjECjeOOgZe31plxchThVOD196AJLWYbvubu+B1xV+1lDRtvXC+mKp2MBOJ7f5J1OQD0YVtxBZrct5flOOqnofcU0BDGoQP5QaSDgjB5FNd4/vxqy+tMceS3mRPsDDBHrSskiJ50ZDHuvYimA6JsxNtbLehpYf9WUkOQw7DBqnvjLDzUfGfvL1FXI5hGSQwKdA5HegDKuWWOTbGcp79at6fIhUu+7A6cVHfW00zLKUDLnkp3p8SxjaoUqvfmlqAl3NJJKI1kAjbkB+lLBBHbsDcq/sw+aoLhAsxSNlKdvUVYgRSVWSRUX1zxSAsWk7pM32R3jBHRSQG+ort/D/i9dJjj+1wu7dnRtpz+Fcnpy29nMR5gcnnPWrlxcxyR7VkTZ/dZMH8KoVjQ8X+I9Q1KXz47meW2J5BYjA9MZrlrfVbmMmMM/lMeAxzVm/YxRDYQ6dsCovD9ub/AFCOGVAELDLge9PcGjsrDw5qV3pf2+1j8+EL82+MHFUmvFsNvkkxyKcEDj9a998BS6ToegS2k0SiBkJZgcbuK8C8e3NpNrlwdKBFpuwu05x9aBIrXGu38t0XW43KOSsh3V0tv43uEsBGkMKSDo6p1rz4RSSMfmAIHUd6db30iuYWIJAzxii42jY1HV7u5lL5UM3XHf61E8Um7zHkUEdQGqk185jAhWQNnuKh8+ZuGtxjuc80CsX12tODbsOeMu2Bmo9Y+0QMkE84KHkCNsg1CL0om3ZFnHBK81Rv76d3AdgB67elIEiwrxxjahYgdQe9OOrOg/coq9m29hWA5aSYqS3H8QPWtHS4PMOwR8eg4JpDsXIpWmWQrJuTGcMe9QSwzsu6UhVA4IPFXYiELxxweUB1zVa4eBUP+kBtx5U84pjKTqrKu9mdj0PSql9CkjBUJDdTk8VqQyRldvls0ZqlewjzSVUgdhUgZMilT8+SPbinR3Dr3Ptmrl0jeUBswD0JrMP3vb2oA3LC/wB+1XKg+/erdywbkAb/AEBrmRjI2sQfWp7e4dG2gkg9TnrQBt7GUBioUt6NkmrkUcMUJDZLP3qJFS6gTa6RbRzuPJoMyo+0fMF6sKegDoo1jkPGRjvUMawiZiy5GeT2PtVmK6jnJBdV+vpULxAzKYssueSeBRuBFq80DlfKUM46IOgrOQiRvnXDEYUdMVq6jBKkBIjATsFHJNYdwSCvmK25aQG48UFrYjY++dvTtWX5MhDEIxZu56Z+tAuN8Q3ZK+h5ra0xZdQKCdlit052jvQBX0rSGeNru5mCInCr3JrL1S5WeQxoTtHpWrrt+skrW1mdsI4LCsHAiPyg+5PegCuyFf8A9VNqWVmIJPSoRQAtKv3hSUq/eFAA33jSUrfeNJQAUUUUAH860bNoI7fOTHcdmPT6VRiKq25ufSld89Oc9iOlAF8amys2VBzwwxwaZGFuLlCgHJxtzVKFPMlVSCMntXQQWIs0WRlyuchu4NFgJpI3iVQnXr6EUlncHe6GQMD2zzV1bmKXa0o3HvgcmkudNtnAnsslhyUP3s1SAhuv9IjMLDEnYHvVW1knhkMEo2Y6EnqKka63Sos8TjbxuxginXUhTYs8JZD918f1oA0dJ08NMMOu5jwSOKua3YpBEMwvbTYwSP8AVv707RJIIIvnnKx9SoxuFd1cyaRc6UII9QtrlXA2rcR4ZG+tBLPKvsVwtqwikUoeSQeBTrNGng8tIgW6Z9a2r3Sm0u4eK7cIj8opPBFZrskcxe1j3Adc8UDuZr6c8c+Gco2eFI6/jWhaw+XC22PzE652ZqGO9uTMTJB5gHfv9K0TfM0Y+xMsQPDBu9FgI3OnzsrIjIwGCE4xTkt4Hn2gs8Q/vHFI9vaoge4jLSEZ3xPjFDWdu8o8qVhxkicYH5iglMi1CKSFmW3kR4iOF9Kf4ccRXZBCo+eAeBUE6GKUhGCg8nccg/Sn2UbmbcVwvXdu60FM6nU7tiVa21LcFHzRAkkGufjnBkdZNyKx5OKrXLESFljCjPLhxzWpo/liJl81Sx6iUcY+tBJk3VxaJ8kSyHsX6iqUsFuqhoZzJI3O3bjFaWqw2Pm4yyMepA4H5Uyz0ouons76KZwfuHCkfiaBplGFrpmWPDE9gAc121hc6FHor297p5/tDoHbIIrIls9QndQyBSq53o4HT6VVg3Au0tyZJB3YbqAbMjUlf7Zm3B2duO1RtbTmDzpIv3Z6s5ya6nSYNJu5WfWZbiNV4U2yA5/Cr0uleD3UtDfaozHjy5F2j+dJoLnDWlgk2ZBL8vpiug02wSNRLLH5KAdS2Sat2WladvJ+3vBEM8MmcitjR9M0STzmvdSfyY+diZy4+p6U0FzltRvE8tordQzMO/NYJsZ8AmNFVjyc81v67qOk21zKNMhljhHA3PvJ+prnElku5CUDFexekxosnMexAzbh/CKWaBmUu+7Ht2q5pWngSCR0Lnuh61JrMTqNqxPGvYk8U0FzIhMU0bqxzjuTWNOnlysqnIrbijniJdULR9yVrJv2DTZUHHqRUjIF2dGzmnAJkYfFMpKALBZf9on61fs75FwjIuOnNZHPagEgg+lAHQvHHE/mAAL6rWhHNEbfghm7ADpWFa3aeWsW1mFX1RjjZ8i9yaaA0WuCsQDIT/drGv7dipbYMd89a0X3KuVO8gdTVMQ3Fw5VASSckdhQwKlhbyHcx5Udqs3F2dnlhgg7beTUpsrhVKblBPUA0RWUULZnALZxgUrAVLaCd3OxS2OfUD3NR32xMIp8w92HSte6llitfJRkhhbsvVvqaw7gY6dKAKnDAjmmbeuOlTEDt0qAnrQA5Y3dGdVyq9TTV+8K19MtyQofJ3EfKKTxBo8mlXkYcDypl8yMg9vSgDKb7xpKVvvGkoAKKMZIxTpBtAXuKAGt14FGaQUd6ANbw/D51yB37e9dJcN5ZKOqlu6EY/I1U8JwrGRKVVg3VG7/AErW1Q+aQoI2j7jt/DTQGGqvCzSxRGWInle4q3azJO4JkAYcYBwwprLdebiOMeZjlVPDU1ba31CTy5U+z3g464zTA0Z447iFkeTbIOu4cGqNhZukgtbmRTBIeGPIX8aumK80pFiv42ubdhwSOQPamqtusbfZbo+W3PlSryPpQSzTt/C8sOpwRXTYgJBJQ5BWvS/Gnwr0SHwwuqaVqkkM+0NtJyrH2NeUJqF40YRJxIic7c4xUs/ibULu1Nk946xMfuMcjNMRnazJqkdoI7h2l2jCMy5xj0NYVprUqkRyxRv2zXSy6zNaokF2nmRqOAORUFlY2+u3Ba0jRZ+oU8bvapsO5YsQ93ZrJBbMzZ+8o5FVzYMZGl8xUYfeUnBFd5oV9/widiLibTCG7o/Kke1ZPifxFpmuTecNNjtLx+fNiPBHuOlMRz9tZSSgmKOV5c9Y1yv5VV1C4nhcLcLIrr1JTBNdH4d12fSrnzLecL2wMYYVrahqV1rEbtKtsSw3YdR8340AecvOZyqoD83qKuJZywLkEcjgZp19B9mnyYth9FPAqpqN/IyBTlRj7woKuQeazzNGy455BHWtmGN40UpD82M+1c/azOGHm8nP38V2OmxzOyGOMyDtg4ouDKJF9MyhYjz6rT2ttsZWQGJz97K4rSvpr22mD3GHC9AHBYVmXmr/AG3CbniYHhjyaCSa3iuoIv3EhKkY69qxX3rM7eW6LnkgZB/CrgkmjACXZyT2FWNPupUuSJ8uv97ZkH60AmZ7PAqjyUfzD/tEDNNnM0UokM+3joOSKf4ju/MuAEjUemwbf0rHtnczAk556E80FLU2YoWn2+WJnJ53VAtte20zAC4CHqNh5rf0K6KOGuV2xDpuHH/666f7fY/ZFZhcTP12h8DFArnnENisz7ruMhAc7W71fiv7WyfZaWUcW4bSxXcR9BXcT+JtNtof3PhyKTjh3dmP8q5Ke+bUrslNPELHnZgjI+tArkRnAYy5lA7EgCqs8jTqW2pt7FjzU1w6wSfPEiE++4imeStxJ5hBYDgFjgflQO5FbsvlOm5ce+awNVC7OG47cda1b9mimATOOhVf4qzpLeSXIkULSuUYnNKBk4HJNbB0yGKMvPNjjgCr2kadbBw9wpAIyoYdaQDNC8H6pq1u9xEqRQL/ABytjP0rTbwM8SFnvIpG7qoPFbVtrlzIVt7ZSYo+FQLjNbUCTb/OusbiOA3A/KqsibnD3Wh/Y0XZ5bOOvoKpFpwx8xEVF9uK1vEr3LzlLUFh6VzN3dyQfu3DGTvnpSY0yzcyOSAjbh/sjirVkLuVREkwijI+Yj0rF+2EgHcR6gVpaXqQEg3DIHrQhmh9nktzuTJjX+9yWrMuJHefM5bcOwrWvNRfyMooVW9qyRDNcSK5UBf7x70MBss3mLtYnHaqUxy3y5296tXJQS7I8kj7xHSqc2MbVJ96QELdQB0zTkjBcZ/LHWiMbnA9OafKWXOwfjQB0mhlluI1RFlnPESA5wfpXr+p/D7TIvA9xNrzGbV51DQFWKrbt2Pv6GvNPhhZCHVobqZlO07+a9b8V+JxNCvlx+Y6DC7uEX396pIlnzE33jTaVvvH61ItvM8DSrGxiBwWxwKkoksvKDHzsjPAb0ptxGYztyGXsfatOwszNan5Qwx2rOu4vJOzJP1oAr/rSxqWdQBnJpKnslDXCA569qaQHonhG0jnsWjc9Bkccg0kwkW52QBN/wBOG+oqtpF5daaySQAOh4ZWFR6tqTyXYuYVCuOo6Ypksivbk2l1FIIjGd3J6r/9aumTTl8RWguo7ZJLhPvBO49+4rjdS1EXURS4IG4Z4/nTvDOqTWM5EF26Y6EHj6UCPYLPwXaal4eDWV89veIPnsrs/uyf9l+1eQ+INMn0+7kheKWCVSfkPzD8D3Fdgdc1dbcyRyNIhH8A5/KuT1DW7i7lJu/3uDx/eFA72MvTywkBkZo2zycVqXEIdfMYCUZ4YUxbxJipWBWb6da07W2a4G63RkPeMnigLlO2tbZirOzQSfw9wadbkxX2+2kSGZTwVGM1Pc6dLJOgVjBJ3EnQ/Q1ft9JiKH7R5ZcDoWxn6GgQ3Wb/AFLUIEF+d5jGFkjHX61kRpbw7fOiMjn7pVqvz28sTERLKsRGRg5GKhWERFZGVSp6H0oASGbTrvKXKyW7DgOo7e4pr+bbQPFazR3MPuMHFWrhSEDJEpPUMpzVI3T+ZmWJTnj92m38/WgCI+a0ca/ZGwT94npVTULYqMhTuPTnpWtFMI4cxmdB/dbkfnWbeTyyniMHPfNBVyjY28kUy+YqshPSuwtpba3ts7pEfshOD+FczpltIZPmk2dwOua14reVicyqTn+9/SgGTsDJIZZkugh/iI3Zo1PCWgljuBIp/g2jIqJbmaCTbOEdenBxSTxWE4xNDMmTztegkoafcy/aFlEURjBwxK4NdXrl3pS6aDa70lK/NXPA2cO6OMOCD8p3c4+lNCytlGwyHu69RQCRhS3iSuyLDK7k9c4GKmtNGnf995ZTvnrW1ZmCymBEcYJPV03VtS2s1xB5kXlpH35AB/Cgd7FC1t5xAgW4Z2zgZXgVdmtbmQhRIkZUbmYqcj6Uz+xp49s0kyqCNyorgGrEu4x4DNKcc5zxQJmcupXGnr5X2oMrnkkcmlLx6k2+a68sDhmxzj2qJrGKd8B52Un5gBwK24PDM81oRpthJMoGTKwwBQBmmzs1XaimUDoxUAn+tV722IO+JG8vHCr2pssM1pc7bm78uQcYC02S5klUq9y7jtjigDCviYJ1Mrsh9B1p6XbiB1gRG/2261Bq9uyMGAJQ9ycmq4lQR+UuPc5pXLFgTdukmcytnOzrWlp/2ueVGEJEeeM9KfpDJHtijgR5GPUnpXTQ2f2bDzL50x/hB2haLCYywlNm7eSyo7fekbgD6CpZ9UaadCs6zMDjO3OfWqeoW80sXzIiJnJ2jJFP0i3CMA0BEQGS7uASPpTJOyt4NLuLQNLcx/aG4y+Afyrzvxj4djSRpbeUvjJyBxXWJa2dxIFs3RHxnbn9c1DrmlXD23ll0Eaj5ipzQxo8dYFWIPUVPZyiGTcxH5U/UrcW126KDtzwTVeMAvg1JR10TQ3ECyMwAXt0rNuZWknID5U9qhs1klXyw3FSTIIZRzyKAEeBliGSFFVXjbBCnAq95ck5G3nFOeBUX942W9BQBmLEyttAPPtV2KJGKRqvz5pAjOTsHA7npVjTSkdwHB3uOhPQU7AegeGLmHTYlVo0EhGeavzNFe3YlkLuI+dg6VymnxvcXK5YHnls8V30diY9NeaRDHbIOWPG4+1UiGfPTfeP1rd0DWWskMEiK8BOShFUtPmtozIl3HuD9Se30qO7tvJbzLZ/Mh6g9x9ags6q2ihm3PpbeWT83knpn2rnNYJeRvMQxzA/Mp4qfRmMrYVyr+xxUmtvLsKXaBj1Eg607gYNT2L7LpD71BQpwwPpSA7s3P7lAqn86bqAt7uEMN0dynQ+n1qppsnnWKsh3Afez2qSaKUKGZR7OhwR/jTQGcbEXDAS5Qj/ADmrttpECTqG3Dd0ZTSk3JIIwUA5JHNIZXjGJS23s3pTFfsblzaX2mhXtbnzIzgrjqKpT27amN7BVmB+YoME/hS6VPJdj7Ok4bPQMe9JcafeWlyCwdSp5J4/GglliOKNI1T5RKvXjmtO2u5bVS8SRzKOSu3qKqJaG6IbZucDlgeam+xmN1KziMnoSf6UAQXurPeMpjhVG9COlYGtXkysFlIXPccV037+2l81pFyOjFQQfqK5LxXdPdSqZYUAB6xjg0D0IrW71CEAwyShAeOcqR71v22oGSBftVr5jjutctZX0sSBEJaPPRh0rc09TfSiOMlSfQ8UFGjNOpAa2iMZA5BbFRSxS3WJSrADrzVyTw3cYJkKrj1zz+VYt1PcaeWSKY46bSaCdBt9erbHy4XYMc7vmzms+3ndwwbO7PBrNv53mn3MB7gVJab3mVQvHrng0rlG3atsbj5c/wARGa1LY2kkgVrhY5j91yp60llp7x2+4bhnk45FVrk7eWkVkHbHemJ6mgdNMkpUsJR13R85psemTyO4gWVynYisuyuvLnDZlAHTy1wRV99al3MDNIVP/PT+tAlcoXUJtrlmkUFu4mOCPxFamn2kt2oe2hmGB2OcVUhkiuph5hST2zmt/ThBBlbFryC47ASbQfpQJlcadKHVZZ9rf7aYIqeewngt9oLyNnKuCCKSS91CG4PmzszZ48zD/rVK4uL0zebPllHocD9KAHYkgQyTSqrdDuFT2twGgb9+u09ix5+lNivJLiRDiJlUcf8A181buNYg+ysJrhFT/nksS/zFAGPPqH2XIRpWTPKg9a3dM8Y38Wlm2SKQw4xgsQBWLaXtnJKR5ChD3bmp7j962LVoyf7q0BYhvr9ZIsm1zMT2BJrPjkaOfMkQOeQOoq3IHHXLSjvwMUkQAV3kDKo/hA6n3NAGbr8hmjQ/dx2AxWNBAZCqgYH94mpryZ7m9dVGI+wzmrFnAPOBUnjsegNSUb2iaf5Pl/dMe7J55rrL65IiVYdm4dR1P51g6DvbPmRI2Ohx0qa5nZJwqs2SecciqJLcFpcXmUYBQTkbjimTQJbyeVw7gche9P083MnmERiSPu27kVNFLas/lJErEDBk6nP40ALonlozPcfu5HOFXbwK1ry6CwTbpI5BjHyrWZbwxAHqoP8AE78/gKcttulxbo8xI6GgDkNQ0tbtnlkWOJR/E7D+Vcpe6eEkb7O+9QeWAwPwrtddsbu4lYGHyyv3gB0ritTkmiuDCGIHTHrSY0RWTSK5RZNvvVqXy0bh9x96pI4ixk9fSms6zOFAOB+tIo27HzrgkKQsfvWlFZwxpJLcSZAH3F/i/GszTYhEyhSXJ/hzmtXWZjHbqkyrEMcKOv400BgXt2ZpNijav8Kr0ApElVMIBmo5pIFQ7Gy56n0pLNEzu3/Me/rSYHc+BCJb6PzFBCnIDcj616L4pvmureOFGCqg5JHA/DtXn/hK3TzEjiJeaTjK9hXfajpb2llsjQtMR06s/wBT2/GrWxJ89Xlq0ErknK54NV0crnBrSjnE6bZMHmq89kQcwneD271BQumTBLtTt/Kt7Vwk9mWHIA54rm7YmG4XdlTnBBHSu2s1hurZQ6qGxjcpyDQBwR4orQ1m0+zXbYGFJrPp2A2PDd+9rdhANyN29a7RYWeNpLYfun+9GwyB9K80RyjhlOCOmK7vRdT8+z+ST516+tCE0PSKb5vLVW5yFIxUM0UQX54wr90ZqtGUysDvCt+VSXEUzwDeEmX1PUUxbHO3fkRsHti0cg6jP612vhnxM39nG11Kzhv4SMAsMMPoa5C4tPKZt8PDcjccg/jTrKRopNtuCmD3FAep1qQQm6L2rTWqHkKecf41NGIzchJruNyTxvXr/hWRHKzhTcbsdxna34VeTRlvFZ4ZiO5EuQR/SgRbvrdo23xQRtxgsrZBH0rmJ7aJ2cBCCOcEYArdihbT4/3+VB+7LG25T9ajk1BWO17UuBwXA60AcY9qy3geGVRzyp6Guw0aKF4N4eKOcDoRis+U2Zu8tb8HkVLeX1rbJmCOaJ/Y0BcnvtWulQoJgccHFcjrH79wzynPU7RVi9vTcvudyfQ9xWW7FWJUFlPXmlcqxVW23SYJNbWnKifdUEj1rJRiWxCpGTzk1raRbySlhv2ODyfahAzet7h2G1CxU9cCtKz0KO+H7xJmPqp6fhUVhZQxshTUovN/55ucV6Fp1lO9ir3NsHjA/wBbCw/xpknl2s2H9mSfublyOwPBFYr3t1KdrKsq/wC6K9C8VaX5yndCmzs+cce9cBcWU9hJmBSYz1Gc0xpk2lxxyS4kgEf1z/StiRY4WB3OV/uq+ayIL+4sws0ErxN/dxmrs+u6nfRhWgExx/CoBpDaFuJlaTasboO+WxVeN2Sb95cSGPsCSR+VQGC/nBVoJEY92WqYtr62kJlIZBz97mgSR19lcxbgqWqvngllIBqzc6csy8WEMTAZ+UcH8zWHpt9mPEkjKpHQPzUksgkYrDJMV9XPNAmZepxSxMV5UZ5GAMfSnWFuB0kwe+TzUjwq1yVkcEDsaniaO3O+I42+lA0x9wdqA9FHcriqd3d74PJXHp96kvXmujveT5fXPb6UWdvCo3DJPrjNA7IrQQCGEsUILd6t6dbLM+58kgdAMZq6lvLeskafKp6ZHWtM6XdWShS6umO3FFguM0omGUxjeqNxtXkmtSZljt5Bb2cob+JnOfy4qnp++OTCtFknpkEmtO4aW5XyciJB2JwDQSV9NG6HDXEkUTcleBVhEjSBpb1zBCDwFALMKjdQoVHKuBxhRmpQEVfMwjP0XzcjFAFG5meeYG3WZIeiZUZNX9OiuIEcvciB2GAM5dqikRZB5lxOoYcjGamsHjblfLVB1YvljTAXULa7SBgCu1h82Tya8y8S2b+f+7Tv3616vMTKhVViUEYJdtzVzOr6IWSSVdzkdlFJq40eYSkjCMBkd6niQHAi5Y9/Sl1CBre5cSKcmn22WXcxAAHTpUlHRaTfJpELSRrG9ww4ZxnBrE1C4ku5pJZ5N7NTY1aZuPu+9S3BVFA2j3oAx9pGSRU9j81wqjNLcOJPuDAq5o0bOwWJN0pOOO1AHpHgaNoZlKtmZhwo7e9eiSaisKpFJEZnPrwCffua4bwddrozBTEr3bDJZuQK3ri9kZnnZ1Bb+LHT6Va2IZ8952uxBI9KfHO6OGHOKtwyRn70fmLnnHVa000e0vo99nNsbujVBZteGf7A16L7Hrm62lPEdyvVT7+oq3c6FeeGrnyhJHe2J+5KnIwa5GTS7yyf7m1uxByDV3S9YkaQW11M8anj1Ap6CZo+JdPW4tBPbAtgcqeoriGGCQeCO1euppNzFYCZk861YcSIc1x/iTw+yFp7bEkZGRjqKGJM5Gruk3rWV4kgG5f4hVNwVY5BH1FCg0ij1O3Flf2S3VsyyIB86DqlYd/dLbyFrYkj2PX2IrktP1C4sJxJbsVOckdjXW6drGnaoyreRC2nbgyAfKfrTQWKj6gs0eNhUHsOcVq6bbvOgktsSEckAfNTbzT5bWbZsimhblJYzTYYFaZQu+GQd1bGaZDOshge8sdkjW83b5xtZKfb2eqWKARLFLH6BwVNLoNtEoKyzeY5/vjJ/LvWXqcbQX+JFbyieNjYoAmuoLiaRt8ADdSkR/mKr2y28knkTpJHL7nAapXtHba4eYDqGJyRSzzDgfaPOxyd6cj8etAFPUtP+zOPLdoweckdPxrn9QJzhpC49dtdO0q3MZRp/wB2eiunArHuNJ89HMM43L2LdaAOXeLM+V+73IFSvZxqVdGLnvx0ras9MmBIEicHlWalnjt0ypcRv04ORSsVcyfscBj3ZwRVi3vI4JFWNvMYdBinussQ+ZI2U9GDVPaQ+cflgUv2IBz+FMGX7a3F2PNkheNsZzt4rUsLi5Vwjyp5WMADJNWtHu1tTHFPOYQeodM1b1+C1VBLbzqxPIaNCKCShPPLJuiklXy/7uOKyZfLZyJGJj9qnggnnGZE81c8OCQR9aW5torc7HKMT3APFAGXe2m6MNAxIH9+pNPRVjxLGyMP40qW4DQxuTKrAjgcVSKSoN823Z/s4oGrsuTIxcO05lUfw5KmpypuYQkUHloOpd85/OqkOp2kSKEUF+5yR+lST6srKMW7n3YA0A7ojitgLgKsa5HvVq4EcQBndQwPCp1rPGqFZPktzn0Y4FEt15y4FsFfvg5oET3OoRAgCIFSOrLzSwGzMe9Xk80/w7eKpCJ8bpgQOwrRstNur5lSBMDt7/pQBlXELSXSB2cKT0wDmut0Lw20+HkSSOHHVxtBrQ0TQI7a4Xz4WlnHOAM8/Wuovr421uY7iZVVR/qwAD+OKdgMmO2ish5UPliU/dwvSqV/Eyxu104b0IOaf/aFrAjPGh81uSMZrD1IztukLOA3qu0UAUFvhHM4gTkHkkYra0q4jOXutpz6rmueDDzdiMrMav3Ju4IFyoBPPFIDRnuzNc7LYqik8ZFSS3RAWGOLMh43OP5Vl2l+zYFxGxx2UAfrWzbmE4kdcnHAZicUAVb4TeT5TSpJJ3C/dA9zVFpTboI4EVierKK0bmdcMuYYV64AJLVFatBEDJIvmHso4zQBVsQZJNkUbGQnk5zWrfXg0yyZbj72MKB1NJFqrxFjHbxRkjqRyBXOeJNTilClHMjnoP60DRy2rNDcXJlkIUntVMIijc3foCanuIGdt8wX1qLarkbl49qTKEhH7wEYA/lS3JLE7jtUfrV+GJIYtwUbu2ax7yUtOcEsf5UgIgVklCg7Uz19a6TRUWKRVhAJPSuadgvC4J7muo8D6fLf3mSWEYOScdBTQrnp3hDw695KjuS7sc+Wh5b6n0rqdb0jT9OUHUbyI3A+7bRkBI/94+tc3e6/LYQrYaDstgwCvL952/HsP1qpY2+lRSB9Qnl1G+Y5WBMlc/7R71ZJ4rBHG1w4DEDPB9a17W0COGWRlB6lTUVlpzLIySISSeMV0FppLKA+5gnuOntUWKM6W5vbDiXE9sehHI/Edqjl0z7bE11ZDdx86DtXVjQT5WT88bDJx1FTWugCCPz7G42OOQex9iKYrnN6RrWp6XCYlDtCwwUzkVOuqyPkiIgHqp6V0FnGDdhbiCMluHC9T71avdL8h/NgWOVepRxhse1AXOF1GCynUyCIoxPOBnH4VQPh+aaLzbFllXrhTk/lXexRWl1KyC22E9hwy/j3qE6VHbTKY5HVuzhdrfiKGg5jzSW2ZTtdWDjgjFORCkQCDJPXmvV2srO6Tbf2oklPSWH5Wx7rXOaloFt5jBJSEPQsuKVg5jlrTUruICIvIFB49q6DS7h70GObDE9ytVJdAuFizbskqj+Gq9lbzwSASl4+eCD0NND3Ni5RoJgrGaKTsVarEN7cSRlZ5HlVeAzfeFbMCQX9kq3h/eDpKo/nVJ9PktpC8ZEkR7igllaxvp47hdk3B7N6VuzWM04+0QQCRTyzRtyv1FYktqpZWyoGejDH61taYQoVkcFRwwY8/hQAsVvthIkhikXr84IP6Vj3huEkKRpH5f8AdZuR+NamviCMb4JmRv7u2uNuJpzJ8zH86AL2blZeFQ/hUJTMhLqSxPQ1JZgSL85x/wBtMVOsIDfu1ZvxzQAWfkqzeZasf901q2r2CAyA7cdAwx+tZE1y6/u3VlH+0MVCJvl+Rwx9MZFAG3JNFdyAMMRjurc0XWzYFtLucN2zWNAJdxZgV9gvWntdyR8NG3PQkUAa1pc30T7WgW4Hqowfzq003nyYu5bq2UDhNoYflWHFq135DRJDCw9xzURju5wCm1GzyCxoAvakkLHbbyvKvdmj2gVTi0x7lNrKir/eJFTww3RGyZ93sOa17HQrW5jPn3W5h/BGGFAGAunWsbFZZo1K9xzSMLBDiJJ5z7AhfzrrdO0OwllKs8ileArDrWp/Z9pYyLsx/wBsmU/mKYHEWOl3N25aG0KR/wB4rnFa0GiSNJ5fmxue+wYIrqEMdw5G6RI++07VP1rW05LC3f8AcSwqwHI5bH5UWA5eDw1bRIsszE4PPBb9K2Ft7aKHfaxsoA5w23P4CrN87NMzxXKuB12I2AP5VUju3RsYRo+5OP6UAQwtGn75ImSfou4k0ySIyxuZ1jLNzlh1/KrKzTXDMSU2j7qqu7FUbm7eBmEgbfnhQmM0wJI4PKg/cqkXuVyfwqnLbi5hZmKFsYzIADVT7S/nnzJGJb+Bc8VJd3E7x7Aq7PZOR75pXA5l4Viu2BjBOeqGtW3s3aIv5qIMdGfJpt0xSILgIxP3WXJPvmmjDxqfM3beq42j86QBHAkbEg8eq85q6YpGUSeZLj+6Tg0y0uZjmO3EEUfd2fmnW1mrTOwuS5P3ivGaAJofLZWUgZ75XkCozJ5gZYgI0XgN2NWxpqMg3q2O25uDUWo29tYW+7crzkcKvagDn76dII2y6qT3HU1zcqNPNuWXHuTVi5EU11uuWO7PG7+lDRxlWIzwO9JjRTlSNTiRpH/SqhuI/MIhXCL60TIWfCqQvuaGBgUiJEDe3zH8aRQT3LsmOSv5VnvnDHBGe9LLcuGIxz3pjXLtxwKAC3hLuNw+UnrXpvgzTTdbVaRoosfdQcmvP9JLI+9lBGeMjNel+HNVe3tGjhTMjDkoOfzpruSxvii4isZjb2UR3/deQ9aj0XUorLkg+ceA2OaDZyPO008bSOx4Mh4zVrT4Eg1FJb+NEA53OMgfSqEad5odrbqfKlBUn5S/VTTLO5ED+SwTfjo/3G/+vTmlGo2+UZRMOqk8N9KztkYfcWMbIcEHnmgC9JqX2Vm/0N2hP3gvOP8A61OtfLcefZFtrdVPf2q4r2k0AF1EFyMCeI9/eq0ObSY+WwliBy20c4pgUr22jlJZ1MLZ+8DkD6jtU0U9zDb+VcYkQD5ZMZwPqKnvLmGUgMFlhbowPK+xFFhJLDkRoJIe4YcilYCLT50Mv+pidfYc/gRVuZICdyfut3fqh+taEBtEO9olhZuTx8hNU7iW0eRlA2BvvL1U/RhQAxZArrE9pCQTxubKt/untUt5aRTr/oyeTKoyYmXINJA1rCcYLp+YHtRexw+WJImcD0Bzj60wMiXTklTMkBhkPdOM/hVK70pBEWcPnHDFeldZpwkkVt7KFbs44P0NQ3MNuzNG4G4dGjOMfWkBxMEtzp5Cx3UbIf8AlnKMqaHuZo5PNFryxzhc4P0rqW0+2kjKzw+cvZgeans7SCHEcZZAT90tg4/GiwHDPqTNKyiyCk+5Bp9pLMjkC2mUnn5cnNd5d2EDFT94jjJABH1rT0/SrZYTLLIpXHVSNy/nRYDzC5eRny0bmPup6VBLBHtyNqp7gmvQ7/ThFI0ltew3Eb8bJVwRWDPaLuchBE3+w/8ASgDjWyhwAr474p8MsynOxyB3TtXSpCIIirLburc726j8qz7tYY5AymH6qDmkO5nTNc3e4ee4H9x13frTrKwljYMxBP8Adxwa2rKWA5EjHPbYK1bMuz7oFV8eq8imIyLfT5LuZVG5P9kNt/U1vRaLFsCG7uYWzj96FdauiTzl2vI6MP7iYNIzTxY2XU5HoQD/ADoASLwyYiJEZrhRycRYq09tbtGY2t4Qy9dz7SDUX2udY8SPHjuBwaiil3ki1Az38wZH4UAUTpUbXHmpO9ufd+P0rY0y9ktMpG0Uq+vlKSPxNYk0hiusiSMP3DR8VN5MU+3zVYynvHwKdgubk8iXhIZ45WxyixbWH4imWemRZZljxjn95j+tV7C1NqC8dzMH9Sw6Ul+LmVTvkZ/cAEfqaAFAhikkeeTI7rHHvwP5VHG9tNdZjSQrjh3O0fSoEm8sDzm3enlYx+OKnQxSktGIEc+rHNAFt74Wi4jjt9mPusmc/nWNLcpLKZZSqEHgKgAqbDJOSztL7HkD6VM0cjqD5UfPI3LmgLEUTPIu4TTFf7kZBz+FOH2pfmeGXZ1PmAU2MX4mAygXsEXb+tE2m3PmebdbdnYSSkj9KAC4Qzps8+CJO6RYz+IrMNuICxJYDtgYrbiW1hhZo/J346hP8a5y5uro3PyTwtEOm7bmkBXu4w8u8uzZ45GDUKNgFRbbx/ezkitW5Es0QMk6JHjJKDrWXEAJvlkbaOrZxSAnsjefvPJhD4PBk4x9KVnuC+WdIznleac9ykLAxSM7HjbuJ/pUamKeTJmYZPIzQBt2d3BGiiS5j87GQCDmqWrSwS5fducjk4wBUMk1layDyTulx/Dx+tZ17dK55QFj+A//AF0AZV1DGclPm5+8arpbIf8AWSsi+o61LdEyH5mO0dT0qJJY1YYQk/7VAJXNvS9BguoTIjJDEPvSzHrWVrcWnWSsttK1y45z0UVFcy3E8e1d+PUnGPwrNkhgiObiVpG9BSZSVjJKNPOxKgD0q2qQWyhpCC3YAVcTbsZygRe3HNZ0u2aXHytz1JpDNKyIkYOw2L6V1mlXrwIApihX+83NczpdnJNjAGwdDWwYYoj+/Zmb+4KpEM6uDV4YoiYnLyY5nccj6CufvNQaa58wZbB+85zUXzSALt2p/CB1/GlezY4LArH/ABHoKAOktLWWBeI8k9/Slkt4rtzsfyLpf7w4b2qlFqNxEu13bg/xjBH1rRgmivgFlKrN1DDjPvQBUEd3Zly0ZYfxIvIb3AqzZhb2MNZSlJ1PML8Z/rUc5uLZsSF3QdDVKaTDeYsbY/vKMEUAawCMxWaJY5vUDg1OQmQCXVx02n5TWan2tQkoBnQ/xen19K0InWRSph2k85B5z9KaAe2oLASjFgrfeR1zn6GmWgUSFkhYZ6ODgj8Ohq3b2zSI3nxpKg6r3HvTJZbS1wMsYSeo+8tADFuJvtTJI6xtn5cIPmH0qG686OQO9tGy/wB9CRn6il1K1eaIPDOk8H8O7jFOsnZLb90JCw6qGBFMBjzSld9mGj/vRMc/iKpushzcwyyBhw6OKuRXCSFgrNG/o3IP50scsG4i4iCSd+cZouA6yvXKpv8ALmU8BgNpH1FbPkzTbCYoGUdGYg4rGsvKaTdDcYTupGcVrJPamMoVWRj/ABoaAK15DAkoaXhhxsBIB+lPP2BIg5a6gOOnUVHtblXLAH7qsMiqzTLBMI0mKMf4W+7QA+5PmR/uPMlibruXH5VRazmkh2mCLaPVsEVrC9vIukKMp7hxiqWqw3c0DSJbyLnurcUgMO4aS2DBkYqOvzVml452IVcn0bipbmN9jBy8bDnPUVkNIyyY3u2O6jFIDQt4GWXKq6ZPTbkGtmCUx4WaGQehHGay9PulTG+aYjuuRzXSWmsWDBYgsuT2boPxpgOgvpYU+SKWUDtuBxUd1F9sQNDGyv1KjccGi5u2MwWKJcdmXk1ajllYhWnaE474GaYFMRXQ2h53jK/7B/wp6SymQnCynHLtxU63TR79kgdvVlyP503zzcRkbdrHuqcGkBH56sjF9npuCbgKkgiQRlleJT2AJ5qpM8Q4S7CyDjbsP8qbAylgLmSQgf3AFpgWU8rzCXZd46BVptzd/vFjnYOh/hBxVlryyKeXCZo2PG4oP51Wkt7clGWQvL/fLjApAMWVTOFinWFAeFUDmtiIWxI81Zd397gCssm3SVAXgdu+Uz+tWro2vlrwzN7OcD8KAJb9YPlPlecqnIy+MflUYktgxeQmP1CEtVe2uYHPlyMoweAEYmprm3jkB+zuwJ77CP60wIIFtp5i8BLEHowJNXJJpIFYxwE+pxyPwPSqtrpTqrsxIz6HH/16bFbTPO8YMzR4wcsCuPxoAryi2ujh2n3nnBYYpAbOKMbbWad+uUyR/KpvMt7CXylt97H+MgLj9amu2lmTLXQRQOVL8/pSAxXdLstuWTaP+WYHIqjMI+U+Zcf3Tk1ZnjKMfKlWRvpgCqUslyzE4HHoOKQE0SiNf3TYJqK3O2VtxUqfReajku3CEzOzZ7A7aat9AyDy4Ap9+SaANFoV2eYuyNf9ocmqVwm/krlR6DAqCS9MuQikAdyMYqvKJphyzlR/d6UAivOilzscGQ8bR81Oh0q48vzGAC/3nbFLAk6v+4QIO5K1LLGCS97OAg7E5J/AUD9CjLaSf8tblcf3UycVLa6fHGDJMQAOcvxTZ9ajjHlWUChR1duprPlvZJzmTJX9KVxoNYubUnZHumb0HAqDSbSGWUSXbbQDwoqYbGGdoQeuOat2Nu0rqBHknoMc0bhc2hexxQ7LKEfVqrRq8kgAYvIeSwFa8WnRRRq2oSLCv90feNJPqCKphsYxCo/ixz9aZLNTQrS2hTzLmMMw7ynC/lVLxDqFtMwSItO4OFVeEFZ8UT3D4aSR/Uu3FW9lvbkCFPMlPU44FAG3e/a7eUpeQow7My5B/GqQuYYnCXFnxngA9PpWjHJewuypMJoc4w9NfT4L8sgDQSDnCn5aYFc25lXdYXDEddjnke1EBudrJISrjqjDhqiurO8sfvMroOA3QikTULkBUmRZVzwTwaQEtkczMqTNDJ2XH9e/5Vowz+RKqXPlsf8AaHB+h7VmXESOyB4zC8h+Rw27mteK3SSFbfU4sv1jdTkN/hTQG5BJptxGqs01rN/CykMv41Qura8tWaW3Nvexn764G6s2+tBblJbVijr1PqPQ0y4kuWKAqinqrpxj8KYErz2qIVe18rd95RkZqlAkUc3mBpFGf4fT6VdS9ZlEdwnmsO44pnmMBuRowP7jpk/nRYDP1AxySlre5i56pIKS0aSVvJe4jDH7qlv5GrccEV5INkKJL05HBq3NpTLHiS0jDg9m4/ClYBD9q08AX1qmD92UDGfx71ajls5Iy4kFtMR/y0+6T9RVRoLtUAWUrCOChYsPyNTSaMwgE0rFYm6kYIb8O1AGVfLcTylI5WZO+xs/kaSOztWASa4kLj+GQ4P4VpWdkiFvLYlew6UySGGedo2IaRezryPoRQBmXNqsH+rlkUehJxWfPczwpm3mmU+m/NblxG8MRzGfKHXL5rMkjWVcqqD3GaQHOvNc3MjEgyMfU4JpYLF2Oduxu4LVryaXuG+Mjd+VVFiKS7ZDk9geaAEhtdzLEYgW/vc1vafYvbyDeoKeo5/SqNusyL8zME/2Wq158yhRE7Nn+/j+lMDpIUtn2/6pWH8QXFSXAijANyY3TsSRWCxvREDIsTIexc0yGQs23yYR9cmgCXURbxSCSIMmeR5JyP1pgknldTEVlU/39o/lTbmyCnzCVfvhRtP51SluEGd9ux999AGxLFcOoP2ZWHrGygiks5WhbYRsI/56JurIEg2b4oxH9Of61YsbvUGLCT5lx2YCgDameO4jIlMansQgBP6VRmhdUKwvGFPdhj9cU9bpY9ovIN7HoQ+f0xStd2jjKxOoHoBTAzRDcJkx3A3dscD86sQy3aDMk4nboBxxT7ieAR5jkdOeQEBp0ccUkH7hFOeu4c0mA03UifPIQmfTt+lLFPGkob7S0i9SC3P5VHNPd28ezZEEI6Ek5rJNwRJuaCNeeoHNAHRvqdtvwkLE9zmp7W4mlP7janoHft9KybfUgMIYFI9zUlzKpjLLDED6jNAF69ju2JfzrZAOoVdx/Ws2V4l+aWKRz2OMA1Jp00BVjNHKG9S24UkptppMoJZH/wCmjcCkBTlubdky0DL6Kvf8aoNFcIGkVTGh5BY1enTy380y+WR0VVqjd3Jl4cmU+/FAFGSeEbtwDv35rPa5Uudgw3tVu4QkHCIi/TNUBcxW8nCF29SAKB2LMUyo2+4MkgH8PTNaH/CSpHGES2SNe3HNYlzfzz/LGoQevFVjbmTJyWbvk0mx2Ro32sGVD7+lYVwXnbcxfaPXirLI8aYKqp7d6q7J5ZQCCfoeKQWHCMlPlwAOpNEKu7ARMAfU1M1owwJBx3APWr1vZzSMsdqgXPfIzTQXFgs4IQHuJ1eQ9F61s2BEEZaEcn+NuMVu6R4GL2ouL+YIMZwPmJrO1qzt7NhFErDnGWOf0p2sSys0iFzIxMkncmp1tnuI95Xy4/U9T+FR21gzJvTj/aJrVsYbeJg907vjoPWgDOWLyiFQsc9Cau2qqgZY9m89WPAFLqGpiRWjs4EiQfeY8k1hS3DSuqclCcY6ZoA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Autosomal recessive polycystic kidney disease (ARPKD)-Bilateral massively enlarged kidneys. Ascites is present, but is not a typical feature of this abnormality.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19121=[""].join("\n");
var outline_f18_43_19121=null;
var title_f18_43_19122="Carotid sinus PI";
var content_f18_43_19122=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    Carotid sinus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 550px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The carotid sinus is located in 1 of the arteries that brings blood to the brain. This artery is called the internal carotid artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19122=[""].join("\n");
var outline_f18_43_19122=null;
var title_f18_43_19123="Focal liver lesion algorithm";
var content_f18_43_19123=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Approach to a solitary focal liver lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 605px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AFP: alpha fetoprotein; OCP: oral contraceptives; HCC: hepatocellular carcinoma.",
"     <br/>",
"     * Serum AFP is normal in the majority of patients with the fibrolamellar variant of hepatocellular carcinoma (HCC) and in up to 40 percent of patients with HCC. Some authorities recommend a biopsy; however, the risk of malignant seeding of the biopsy tract in patients who turn out to have an HCC is about 5 percent. Thus, in good surgical candidates in whom HCC cannot be excluded, resection may be the best course of action.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     A central scar (typical of focal nodular hyperplasia) can also be seen in patients with fibrolamellar HCC.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19123=[""].join("\n");
var outline_f18_43_19123=null;
var title_f18_43_19124="Procyclidine: Drug information";
var content_f18_43_19124=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Procyclidine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?9/9/9364?source=see_link\">",
"    see \"Procyclidine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F213906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      PHL-Procyclidine;",
"     </li>",
"     <li>",
"      PMS-Procyclidine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F213934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anti-Parkinson's Agent, Anticholinergic;",
"     </li>",
"     <li>",
"      Anticholinergic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F213909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Parkinson's disease or treatment of EPS:",
"     </b>",
"     Oral:  Initial: 2.5 mg 3 times/day after meals; if tolerated, gradually increase dose as needed; maximum: 30 mg/day (given in 3 or 4 divided doses)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F213910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Initial: 2.5 mg once or twice daily (use lowest dose possible), gradually increasing as necessary. Avoid use if possible.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F10356619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; specific recommendations are not provided in the product labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F213911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; specific recommendations are not provided in the product labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10356621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, oral: 2.5 mg, 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elixir, oral: 2.5 mg/5 mL",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11236685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F213892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be administered after meals to minimize stomach upset.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F213891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relieves symptoms of parkinsonian syndrome and drug-induced extrapyramidal symptoms",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F213932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Acute toxic psychosis, agitation, concentration impaired, confusion, disorientation, giddiness, hallucinations, lightheadedness, memory impaired, restlessness, slurred speech",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, epigastric distress, nausea, parotitis (secondary to xerostomia), vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Dysuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, mydriasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F213895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Angle-closure glaucoma; myasthenia gravis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F213878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anhidrosis/hyperthermia: Anticholinergic agents may cause anhidrosis and hyperthermia, which may be severe; use with caution in hot weather or during exercise. The risk is increased in hot environments, particularly in the elderly, alcoholics, patients with CNS disease, and those with prolonged outdoor exposure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May be associated with restlessness, confusion, hallucinations, or other CNS effects, particularly in the elderly and generally at higher dosages; intensification of symptoms or toxic psychosis may occur in patients with mental disorders. Dose reductions/discontinuation of therapy may be necessary. May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Weakness: When given in large doses or to susceptible patients, may cause weakness and inability to move particular muscle groups.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with tachycardia, cardiac arrhythmias, hypertension, or hypotension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; GI obstruction: Use with caution in patients with obstructive disease of the GI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture or retention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Frequently develop increased sensitivity and require strict dosage regulation - side effects may be more severe in elderly patients with atherosclerotic changes.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F213883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F213903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: Avoid ethanol (may potentiate CNS effects).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10355724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safe use during pregnancy has not been established. Potential benefits of therapy should be weighed against potential risks to fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F213914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F213898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken after meals to minimize stomach upset.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F213886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptoms of EPS or Parkinson's disease, pulse, anticholinergic effects (ie, CNS, bowel and bladder function)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F213899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Emadrin (PK);",
"     </li>",
"     <li>",
"      Kemadrin (AE, AT, AU, BB, BE, BG, BH, BM, BS, BZ, CH, CY, CZ, DK, EE, EG, ES, FI, FR, GB, GR, GY, HN, HU, IE, IL, IN, IQ, IR, IT, JM, JO, KW, LB, LU, LY, MT, NL, NO, NZ, OM, PT, QA, RU, SA, SE, SK, SR, SY, TR, TT, UY, YE);",
"     </li>",
"     <li>",
"      Osnervan (DE);",
"     </li>",
"     <li>",
"      Proimer (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F213877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Thought to act by blocking excess acetylcholine at cerebral synapses; many of its effects are due to its pharmacologic similarities with atropine; it exerts an antispasmodic effect on smooth muscle, is a potent mydriatic; inhibits salivation",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F213894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 45-60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Significant autonomic effects have been observed up to 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 1 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism:  Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~75%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~12.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (predominantly as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Brocks DR, &ldquo;Anticholinergic Drugs Used in Parkinson&rsquo;s Disease: An Overlooked Class of Drugs from a Pharmacokinetic Perspective,&rdquo;",
"      <i>",
"       J Pharm Pharm Sci",
"      </i>",
"      , 1999, 2(2):39-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19124/abstract-text/10952768/pubmed\" id=\"10952768\" target=\"_blank\">",
"        10952768",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Feinberg M, &ldquo;The Problems of Anticholinergic Adverse Effects in Older Patients,&rdquo;",
"      <i>",
"       Drugs Aging",
"      </i>",
"      , 1993, 3(4):335-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19124/abstract-text/8369593/pubmed\" id=\"8369593\" target=\"_blank\">",
"        8369593",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rogiers V, Paeme G, Sonck W, et al, &ldquo;Metabolism of Procyclidine in Isolated Rat Hepatocytes,&rdquo;",
"      <i>",
"       Xenobiotica",
"      </i>",
"      , 1987, 17(7):849-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19124/abstract-text/3660855/pubmed\" id=\"3660855\" target=\"_blank\">",
"        3660855",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Whiteman PD, Fowle AS, Hamilton MJ, et al, &ldquo;Pharmacokinetics and Pharmacodynamics of Procyclidine in Man,&rdquo;",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1985, 28(1):73-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19124/abstract-text/3987788/pubmed\" id=\"3987788\" target=\"_blank\">",
"        3987788",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15559 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-200.215.4.194-785DB895A1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19124=[""].join("\n");
var outline_f18_43_19124=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213906\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213934\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213909\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213910\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10356619\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213911\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10356621\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11236685\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213892\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213891\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213932\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213895\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213878\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299947\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213883\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213903\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10355724\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213914\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213898\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213886\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213899\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213877\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213894\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/15559\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/15559|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/9/9364?source=related_link\">",
"      Procyclidine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_43_19125="Meprobamate: Drug information";
var content_f18_43_19125=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Meprobamate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?15/17/15636?source=see_link\">",
"    see \"Meprobamate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Novo-Mepro",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F193119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antianxiety Agent, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F193087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Anxiety or muscle spasm (TMJ) pain (unlabeled use):",
"     </b>",
"     Oral: 1200-1600 mg/day in 3-4 divided doses, up to 2400 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F193103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Anxiety:",
"     </b>",
"     Oral: 6-12 years: 200-600 mg/day in 2-3 divided doses",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F193089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute: Administer every 9-12 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer every 12-18 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Moderately dialyzable (20% to 50%)",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F193090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Probably necessary in patients with liver disease; no specific recommendations.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F193065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 200 mg, 400 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F193050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F193121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-IV",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F193068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of anxiety disorders",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F193116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Demonstrated value for muscle contraction, headache, external sphincter spasticity, muscle rigidity, opisthotonos-associated with tetanus; treatment of muscle spasm associated with acute temporomandibular joint (TMJ) pain",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F193128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Meprobamate may be confused with meperidine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Equanil may be confused with Elavil&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F193117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia EEG abnormalities, hypotensive crisis, peripheral edema, palpitation, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Ataxia, chills, dizziness, drowsiness, euphoria, fever, headache, overstimulation, paradoxical excitement, slurred speech, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioneurotic edema, bruising, dermatitis, erythema multiforme, petechiae, purpura, rash, Stevens-Johnson syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, proctitis, stomatitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, aplastic anemia, eosinophilia, leukopenia, porphyria exacerbation, thrombocytopenic purpura",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Impairment of accommodation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Anuria, oliguria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F193071\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to meprobamate, related compounds (including carisoprodol), or any component of the formulation; acute intermittent porphyria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F193054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Allergic reactions: May occur in patients with history of dermatological condition (usually by fourth dose).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depression: Use with caution in patients with depression or suicidal tendencies.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in older adults; use associated with excessive sedation and high rate of physical dependence (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abrupt discontinuation: May precipitate withdrawal.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F193059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the therapeutic effect of Antianxiety Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F193081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13205878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Meprobamate crosses the placenta and is found in cord blood in concentrations similar to those in the maternal plasma. Maternal use may be associated with congenital malformations; avoid use during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F193092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F193075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Breast milk concentrations are higher than maternal plasma concentrations.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F193074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Meprobamate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (100): $140.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg (100): $183.11",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F193062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mental status",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F193066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic: 6-12 mcg/mL (SI: 28-55 micromole/L); Toxic: &gt;60 mcg/mL (SI: &gt;275 micromole/L)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F193076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Andaxin (HN, HU);",
"     </li>",
"     <li>",
"      Ansiowas (ES);",
"     </li>",
"     <li>",
"      Centryl (TW);",
"     </li>",
"     <li>",
"      Dapaz (ES);",
"     </li>",
"     <li>",
"      Ecuanil (UY);",
"     </li>",
"     <li>",
"      Equanil (AU, FR, GB, IE, ZA);",
"     </li>",
"     <li>",
"      Meprate (GB);",
"     </li>",
"     <li>",
"      Mepro (BE, IL);",
"     </li>",
"     <li>",
"      Meprobamat (DE, GB, HR);",
"     </li>",
"     <li>",
"      Meprodil (CH);",
"     </li>",
"     <li>",
"      Meprospan (ES);",
"     </li>",
"     <li>",
"      Miltaun (AT);",
"     </li>",
"     <li>",
"      Miltown (ES);",
"     </li>",
"     <li>",
"      Oasil (ES, LU);",
"     </li>",
"     <li>",
"      Oasil Simes (ES);",
"     </li>",
"     <li>",
"      Pertranquil (BE, LU);",
"     </li>",
"     <li>",
"      Praol (GR);",
"     </li>",
"     <li>",
"      Probamato (PT);",
"     </li>",
"     <li>",
"      Probamyl (BE);",
"     </li>",
"     <li>",
"      Procalmadiol (BE, LU);",
"     </li>",
"     <li>",
"      Quaname (BE, LU);",
"     </li>",
"     <li>",
"      Quanil (IT);",
"     </li>",
"     <li>",
"      Reposo-Mono (BE);",
"     </li>",
"     <li>",
"      Restenil (DK, NO);",
"     </li>",
"     <li>",
"      Sanobamat (BE);",
"     </li>",
"     <li>",
"      Sedans Tranquilizante (ES);",
"     </li>",
"     <li>",
"      Tranquilin (LU);",
"     </li>",
"     <li>",
"      Visano (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F193053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Affects the thalamus and limbic system; also appears to inhibit multineuronal spinal reflexes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F193070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Sedation: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 10 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (8% to 20% as unchanged drug); feces (10% as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19125/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hartz SC, Heinonen OP, Shapiro S, et al, \"Antenatal Exposure to Meprobamate and Chlordiazepoxide in Relation to Malformations, Mental Development, and Childhood Mortality,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1975, 292(14):726-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19125/abstract-text/1113782/pubmed\" id=\"1113782\" target=\"_blank\">",
"        1113782",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hassan E, &ldquo;Treatment of Meprobamate Overdose With Repeated Oral Doses of Activated Charcoal,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1986, 15(1):73-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19125/abstract-text/3942359/pubmed\" id=\"3942359\" target=\"_blank\">",
"        3942359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jacobsen D, Wiik-Larsen E, Saltvedt E, et al, &ldquo;Meprobamate Kinetics During and After Terminated Hemoperfusion in Acute Intoxications,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1987, 25(4):317-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19125/abstract-text/3669117/pubmed\" id=\"3669117\" target=\"_blank\">",
"        3669117",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Timmermann G, Acs N, B&aacute;nhidy F, et al, \"A Study of Teratogenic and Fetotoxic Effects of Large Doses of Meprobamate Used for a Suicide Attempt by 42 Pregnant Women,\"",
"      <i>",
"       Toxicol Ind Health",
"      </i>",
"      , 2008, 24(1-2):97-107",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19125/abstract-text/18818186/pubmed\" id=\"18818186\" target=\"_blank\">",
"        18818186",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Volturo GA, &ldquo;Meprobamate and Bezoar Formation,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1987, 16(4):472-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/43/19125/abstract-text/3826824/pubmed\" id=\"3826824\" target=\"_blank\">",
"        3826824",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9611 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-3033BD7A4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19125=[""].join("\n");
var outline_f18_43_19125=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193085\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193119\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193087\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193103\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193089\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193090\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193065\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193050\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193121\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193068\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193116\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193128\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193117\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193071\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193054\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299671\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193059\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193081\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13205878\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193092\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193075\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193074\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193062\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193066\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193076\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193053\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193070\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9611\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9611|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?15/17/15636?source=related_link\">",
"      Meprobamate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_43_19126="Infectious causes of dysuria in adult men";
var content_f18_43_19126=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Infectious causes of dysuria in adult men",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Heidi Swygard, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Myron S Cohen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Arlene C Se&ntilde;a, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19126/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/43/19126/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 14, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysuria in men (described as pain, tingling, or burning during or just after urination) may be localized to the urethral meatus, the distal portion of the penis, or anywhere along the penile shaft. Dysuria in men may be a presenting complaint of urethritis, prostatitis, epididymitis, or urinary tract infections.",
"   </p>",
"   <p>",
"    Urethritis is more commonly seen in young sexually active men, whereas urinary tract infections occur in older men with prostatic hypertrophy or history of prior catheterization. Dysuria is also reported in the majority of men with symptomatic gonorrhea and over half of patients with nongonococcal urethritis (NGU).",
"   </p>",
"   <p>",
"    Both acute and chronic prostatitis can occur in young and middle-aged men. Chronic prostatitis can occur as a complication of acute prostatitis or without any recognized initial infection. Urethral instrumentation and prostatic surgery are known causes of prostatitis, but many patients have no history of a precipitating event.",
"   </p>",
"   <p>",
"    Isolated acute cystitis does not commonly occur in men. The much lower incidence of cystitis is men, compared to women, has been attributed to less frequent colonization around the urethra due to the drier periurethral environment, increased length of the urethra, and antibacterial substances in prostatic fluid. Most men with acute cystitis have a functional or anatomic abnormality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute bacterial epididymitis is a relatively rare disease, but can cause serious illness. It can be seen in conjunction with acute prostatitis, particularly in older men who may have underlying prostatic obstruction or recent instrumentation as a risk factor. Acute epididymitis can also be due to a sexually acquired infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough sexual history should be obtained from all patients with dysuria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link&amp;anchor=H2#H2\">",
"     \"Screening for sexually transmitted infections\", section on 'Taking a sexual history'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Painful urination is usually the chief complaint in men with urethritis. They may also complain of pruritis or discharge at the urethral meatus. Discharge may be present throughout the day or may be scanty and only present on the first morning void.",
"   </p>",
"   <p>",
"    Some general principles can suggest different etiologies of urethritis secondary to sexually transmitted diseases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Since the incubation period for gonorrhea is shorter (less than two weeks) than for chlamydia (which has a variable onset of 2 to 35 days), a urethral discharge that is described as acute and frankly purulent is suggestive of gonorrhea.",
"     </li>",
"     <li>",
"      Patients with dysuria alone are more likely to have chlamydial infection.",
"     </li>",
"     <li>",
"      Dysuria that is accompanied by painful genital ulcers is probably due to genital HSV; patients with primary HSV infection may also complain of fever, tender local inguinal lymphadenopathy, and headache.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Detailed information regarding these infections is available elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The typical signs and symptoms of acute bacterial prostatitis are similar to upper urinary tract infection and include fever, chills, malaise, myalgia, dysuria, and cloudy urine. In addition, swelling of the acutely inflamed prostate can cause obstructive symptoms, ranging from dribbling and hesitancy to anuria.",
"   </p>",
"   <p>",
"    Patients with chronic prostatitis may have complaints of typical cystitis such as frequency, dysuria, and urgency. However, other subtle symptoms may include perineal discomfort, discomfort during ejaculation, deep pelvic pain, or pain radiating to the back. The diagnosis of prostatitis should be considered in men who have a history of recurrent UTIs in the absence of risk factors, such as bladder catheterization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with acute epididymitis often complain of irritative voiding symptoms (dysuria, frequency, urgency) and pain in one testicle. These localizing symptoms are often accompanied by a history of high fever and rigors.",
"   </p>",
"   <p>",
"    Acute cystitis is indicated by dysuria and other complaints of urinary frequency, urgency, suprapubic pain, and cloudy or bloody urine. The presence of upper tract infection is suggested by systemic symptoms such as fever, chills, and malaise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include measurement of temperature and assessment of the general well-being of the patient. Specific attention should be given to a full genital and rectal examination and assessment of tenderness in the costovertebral region.",
"   </p>",
"   <p>",
"    The physical examination should include lymph node palpation and inspection and palpation of the testicles and penis. The skin of the entire pubic area, scrotum, groin, and penis should be examined for lesions or genital ulcers. The testes, epididymides, and spermatic cords should be palpated for masses or tenderness. The foreskin should be completely retracted and the urethral meatus should be inspected for crusting, redness, or discharge.",
"   </p>",
"   <p>",
"    In patients with suspected urethritis, penile discharge may be mucoid, mucopurulent, or purulent in appearance. If there is no apparent urethral discharge noted on physical examination, the urethra should be milked from the base to the meatus by placing the gloved thumb along the ventral surface of the base of the penis and the forefinger on the dorsum and applying gentle pressure. The hand is moved slowly toward the meatus to expel any discharge for specimen collection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The typical signs of acute prostatitis notable upon examination include high fevers and chills. The finding of an edematous and tender prostate on physical examination should lead to a presumptive diagnosis of acute prostatitis. The digital rectal examination should be performed in a gentle fashion when acute prostatitis is suspected since vigorous examination can induce bacteremia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    .) The physical exam in patients with chronic prostatitis may be unremarkable.",
"   </p>",
"   <p>",
"    In patients with epididymitis, physical examination is usually notable for induration and swelling of the involved epididymis in association with exquisite tenderness. Urologic consultation for possible torsion might be necessary if the onset of pain was sudden and severe [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=see_link\">",
"     \"Evaluation of the acute scrotum in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with an upper urinary tract infection are often febrile and uncomfortable in appearance; in severe cases, physical examination may be notable for hypotension and flank pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Urethritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonorrhea is a common cause of urethritis in the United States and Europe, especially in urban areas and STD clinics. In 2004, rates of positive urethral gonorrhea tests were higher in HIV-positive MSM compared to HIV-negative MSM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, up to 25 to 30 percent of men with gonococcal urethritis also have concurrent chlamydia infection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/2\">",
"     2",
"    </a>",
"    ]. When N. gonorrhoeae cannot be detected, the term \"nongonococcal urethritis\" (NGU) is used. Although most cases of NGU are due to C. trachomatis, other etiologies include T. vaginalis, Mycoplasma genitalium, and Ureaplasma urealyticum [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. In some areas of Africa, T. vaginalis is the most common cause of urethritis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/5\">",
"     5",
"    </a>",
"    ] and is also identified in 10 to 20 percent of urethral swabs from asymptomatic men presenting to STD clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    .) Urethritis can also occur secondarily to primary genital herpes simplex virus infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prostatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute prostatitis is most commonly bacterial in origin and caused by gram-negative rods (eg, Enterobacteriaceae, Pseudomonas, Proteus) and gram-positive organisms (Enterococcus, S. aureus). Gonorrhea and chlamydia can also cause acute prostatitis. In the absence of instrumentation or anatomic abnormalities, isolation of S. aureus should prompt the clinician to consider hematogenous spread and the possibility of underlying endocarditis.",
"   </p>",
"   <p>",
"    Chronic prostatitis may be due to some of the same bacterial organisms especially the gram-negative rods, as well as some fungi (depending on the host immune status). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Epididymitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In men under the age of 35, C. trachomatis is the most common organism responsible for bacterial epididymitis, although gonococcal infection can also contribute to some cases. Sexually transmitted organisms may also be responsible for epididymitis in older men, but bacteriuria secondary to obstructive urinary disease (eg, prostatic hyperplasia) is more common, involving organisms such as E. coli and other coliforms. Men who engage in anal insertive intercourse are at increased risk for epididymitis due to coliform bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=see_link\">",
"     \"Evaluation of the acute scrotum in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Urinary tract infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;As seen in women, the most common causes of urinary tract infection in men are enteric gram-negative pathogens, such as E. coli. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexually active men with dysuria should be evaluated for urethritis and its associated pathogens. The presence of urethritis can be confirmed by one of the following findings [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mucopurulent or purulent discharge on examination",
"     </li>",
"     <li>",
"      &gt;5 polymorphonuclear cells (PMNs) per oil immersion field from the Gram's stain of a urethral swab",
"     </li>",
"     <li>",
"      Positive leukocyte esterase (\"dipstick\") on first-void urine or the presence of &gt;10 WBCs per high power field of the first-void urine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Micturition just prior to examination may hamper detection of sexually transmitted infections. Generally, it should be avoided for at least two hours priors to obtaining specimens.",
"   </p>",
"   <p>",
"    A Gram's stain specimen for examination of PMNs and any organisms can be collected from expressed penile discharge or from inside the urethra. A calcium alginate swab should be inserted gently at least 2 cm into the urethra and rotated 360 degrees, with care not to force the tip past an obstruction. The swab can then be rolled across a clean microscope slide for air drying and Gram's stain evaluation.",
"   </p>",
"   <p>",
"    More than four PMNs per high power field is abnormal and is seen in 60 to 90 percent of patients with urethritis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The presence of PMNs without any visible organisms is consistent with NGU, whereas gonococcal urethritis may be diagnosed by the demonstration of gram-negative intracellular or extracellular diplococci in the urethral exudate. Because of the specificity of the urethral Gram's stain, a confirmatory culture for gonorrhea is not necessary in men, as it is in women.",
"   </p>",
"   <p>",
"    Inspection for PMNs can also be performed on the first void urine by spinning 10 to 15 milliliters of urine and examining the sediment. All men with suspected urethritis (by symptoms or the above criteria) should be tested for gonorrhea and chlamydia, which can often be copathogens.",
"   </p>",
"   <p>",
"    Due to the discomfort associated with collection of urethral specimens, the preferred diagnostic tests for gonorrhea and chlamydia in most centers is a nucleic acid amplification test (NAAT) from a urine sample. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Trichomoniasis and mycoplasma infections may cause symptoms of urethritis in men, but their diagnosis is more difficult. Although wet mount preparations for trichomonas can be useful in women, microscopy is very insensitive in men [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/2\">",
"     2",
"    </a>",
"    ]. Endourethral culture and cultures of the first-void urine sediment can be considered. NAATs are more expensive than culture, but have superior sensitivity for T. vaginalis, and are the preferred methods for diagnosis of trichomoniasis in men.",
"   </p>",
"   <p>",
"    Patients with genital ulcers should have cultures taken for HSV and have serologic testing for syphilis. Patients presenting with STD risk factors should also be routinely be offered screening for syphilis and HIV infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=see_link\">",
"     \"Diagnostic testing for syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In male patients with suspected urinary tract infections, a midstream urine culture is recommended to confirm the diagnosis. Microscopic or sometimes gross hematuria is occasionally seen in urinary tract infections: white cell casts are suggestive of pyelonephritis. In one study of 422 men with symptoms of dysuria, urinary frequency,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urgency, a positive nitrite test had a positive predictive value of 96 percent when compared to urine culture results [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute and chronic prostatitis require careful distinction from urinary tract infections in men. The majority of men with prostatitis are diagnosed based on their clinical presentations and rectal exam findings. A urinalysis should be performed to determine the presence of pyuria. A urine culture should also be obtained in all men suspected of having acute prostatitis; Gram's stain of the urine, if positive, can be used as a guide to initial therapy. Blood cultures are recommended in patients with a history of fevers and rigors to rule out bacteremia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In male patients with dysuria, other diagnostic considerations include reactive arthritis with associated urethritis (formerly Reiter syndrome) or endourethral syphilitic chancre. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .) Non-infectious causes of dysuria that should also be considered, include chemical irritation from spermicides or soaps.",
"   </p>",
"   <p>",
"    A history of recurrent episodes of cystitis should prompt consideration of chronic prostatitis, which requires a longer duration of antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial treatment for dysuria is usually empiric and the choice of therapy will depend on the suspected diagnosis based on presenting signs, symptoms, and risk factors.",
"   </p>",
"   <p>",
"    Treatment for NGU is usually targeted towards chlamydia as the most likely pathogen.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     Azithromycin",
"    </a>",
"    (1 gram orally) is the current recommendation from the Centers for Disease Control and Prevention.",
"   </p>",
"   <p>",
"    Some patients will have recurrent symptoms. While it is important to consider reinfection or antimicrobial resistance, other organisms should be considered. Emerging evidence suggests that nongonococcal nonchlamydial urethritis (NGNCU) is frequently associated with M. genitalium [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Fortunately,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    is effective for this organism as well [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19126/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current guidelines recommend that patients with persistent symptoms associated with NGU should also receive empiric treatment for trichomoniasis if diagnostic testing is not available. All patients with suspected gonococcal urethritis must also be empirically treated for chlamydia due to the likelihood of coinfection. Men with urethritis secondary to STIs should be advised to abstain from sex for one week following therapy, and to refer their sexual partners for evaluation and treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Men with suspected acute or chronic bacterial prostatitis should be treated presumptively for gram-negative pathogens. A delay in therapy for acute prostatitis can lead to gram-negative sepsis, prostatic abscess, or metastasis infection. Men with acute prostatitis should be instructed to increase their hydration and bed rest. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .) Men with chronic prostatitis may require medical therapy over one to three months.",
"   </p>",
"   <p>",
"    Medical management for epididymitis secondary to suspected STIs includes treatment for both gonorrhea and chlamydia. Bacterial epididymitis in men &gt;35 years of age and men who engage in anal insertive intercourse should be directed towards gram-negative rods. As an adjunct to therapy, bed rest, scrotal elevation, and analgesics are recommended until fever and local inflammation have subsided.",
"   </p>",
"   <p>",
"    Men with suspected UTI should be treated presumptively for gram-negative pathogens until the culture results are available. Men with acute cystitis should also undergo further evaluation for underlying urologic abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The appropriate topic reviews should be consulted for recommended antibiotic regimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dysuria in men (pain, tingling, or burning during or just after urination) may be a presenting complaint of urethritis, prostatitis, epididymitis, or urinary tract infections. Distinction between the syndromes should be attempted in order to guide diagnosis and management. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A careful history must determine the presence of irritative voiding symptoms; systemic manifestations, such as fever and chills; or subtle complaints, such as back pain. The constellation of symptoms will suggest different diagnoses. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Males with dysuria should have an appropriate physical examination with specific attention to the genital and rectal examination. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the male patient with dysuria and purulent discharge, or suspected epididymitis secondary to STIs, we recommend a Gram's stain of a urethral swab specimen and specific testing for gonorrhea and Chlamydia with nucleic acid amplification testing (NAAT). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In men with prostatitis and suspected urinary tract infection, a urinalysis and a midstream urine culture is recommended to confirm the diagnosis; white cell casts are suggestive of pyelonephritis. A urine culture should also be obtained in all men suspected of having acute prostatitis. Blood cultures are recommended in any patient with a history of fever and rigors. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urethritis is most commonly associated with gonococcal or chlamydial infections. Bacterial prostatitis and urinary tract infections are usually due to gram-negative pathogens, such as E. coli. Epididymitis in men younger than 35 years of age is most frequently due to Chlamydia trachomatis; in older men, E. coli, other coliforms, or Pseudomonas species are the likely pathogens. The choice of therapy for dysuria depends on the likely diagnosis based on presenting signs, symptoms, and risk factors, and suspected or confirmed pathogens. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with risk factors for an STD should be offered screening for syphilis and HIV infection. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     McCormack W, Rein M. Urethritis. In: Principles and Practice of Infectious Diseases, Mandell, Douglas, and Bennett (Eds), 2006.",
"    </li>",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/default.htm (Accessed on January 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/3\">",
"      Krieger JN, Jenny C, Verdon M, et al. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993; 118:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/4\">",
"      P&eacute;pin J, Sob&eacute;la F, Deslandes S, et al. Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalis. Bull World Health Organ 2001; 79:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/5\">",
"      Watson-Jones D, Mugeye K, Mayaud P, et al. High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study. Sex Transm Infect 2000; 76:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/6\">",
"      Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/7\">",
"      Price MA, Miller WC, Kaydos-Daniels SC, et al. Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi. J Infect Dis 2004; 190:1448.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/ (Accessed on October 18, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/9\">",
"      Bowie WR. Comparison of Gram stain and first-voided urine sediment in the diagnosis of urethritis. Sex Transm Dis 1978; 5:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/10\">",
"      Root TE, Edwards LD, Spengler PJ. Nongonococcal urethritis: a survey of clinical and laboratory features. Sex Transm Dis 1980; 7:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/11\">",
"      Koeijers JJ, Kessels AG, Nys S, et al. Evaluation of the nitrite and leukocyte esterase activity tests for the diagnosis of acute symptomatic urinary tract infection in men. Clin Infect Dis 2007; 45:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/12\">",
"      Gaydos C, Maldeis NE, Hardick A, et al. Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics. Sex Transm Infect 2009; 85:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/13\">",
"      Taylor-Robinson D, Renton A, Jensen JS, et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD AIDS 2009; 20:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19126/abstract/14\">",
"      Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009; 48:1649.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7602 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-B007036579-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19126=[""].join("\n");
var outline_f18_43_19126=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Urethritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prostatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Epididymitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=related_link\">",
"      Acute bacterial prostatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=related_link\">",
"      Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=related_link\">",
"      Evaluation of the acute scrotum in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_43_19127="Biceps tendon tests";
var content_f18_43_19127=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F61303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F61303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Biceps tendon tests",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 575px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Injury or inflammation of the long head of the biceps tendon can cause anterior shoulder pain. In addition to direct palpation, these two simple tests allow for evaluation of this tendon. Either test is considered positive for bicipital tendinopathy or injury if it elicits pain in the bicipital groove.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19127=[""].join("\n");
var outline_f18_43_19127=null;
var title_f18_43_19128="Paraesophageal hernia: Clinical features and surgical repair";
var content_f18_43_19128=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Paraesophageal hernia: Clinical features and surgical repair",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Michael Rosen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Jeffrey Blatnik, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Jeffrey Marks, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19128/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/43/19128/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H16016779\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A paraesophageal hernia is an uncommon type of hiatal hernia. It includes a peritoneal layer that forms a true hernia sac, distinguishing it from the more common sliding hiatal hernia. Surgical management is indicated when medical management fails to control symptoms of gastroesophageal reflux that may be related to the paraesophageal hernia, or when there is an emergent complication [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The general principles for the diagnosis and surgical management of a paraesophageal hernia will be reviewed here. The anatomy, physiology, types, and symptoms of a hiatal hernia are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7527?source=see_link\">",
"     \"Hiatus hernia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16017360\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hiatal hernias are classified by type: type I is a sliding hernia and types II, III, and IV are paraesophageal hernias. Paraesophageal hernias account for approximately 5 percent of all hiatal hernias and frequently are asymptomatic or associated with vague and intermittent symptoms of gastroesophageal reflux [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7527?source=see_link&amp;anchor=H3#H3\">",
"     \"Hiatus hernia\", section on 'Types of hiatal hernia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A paraesophageal hernia, a true hernia with a hernia sac, is characterized by an upward dislocation of the gastric fundus alongside a normally positioned gastroesophageal junction [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The gastric fundus and abdominal viscera protrude into the mediastinum through the defect in the diaphragm. In contrast, a sliding hernia does not have a hernia sac and slides into the chest since the gastroesophageal junction is not fixed inside the abdomen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H549701910\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with a paraesophageal hernia are asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/4\">",
"     4",
"    </a>",
"    ]. Approximately one-third of patients have endoscopic evidence of gastritis, gastric ulceration, or esophageal reflux. Gastric ulcers result from poor gastric emptying and torsion of the gastric wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7527?source=see_link&amp;anchor=H6#H6\">",
"     \"Hiatus hernia\", section on 'Symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serious complications of a paraesophageal hernia include a gastric volvulus, gastric outlet obstruction, hemorrhage, and rarely, respiratory distress secondary to tracheobronchial compression of the left main stem bronchus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44793?source=see_link&amp;anchor=H13#H13\">",
"     \"Gastric outlet obstruction in adults\", section on 'Gastric volvulus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016787\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a paraesophageal hernia is often made on the basis of a chest x-ray, usually performed for reasons other than gastroesophageal reflux. A large air fluid level is seen in the posterior mediastinum on the lateral view and as a retrocardiac mass in the AP view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50767 \" href=\"UTD.htm?25/22/25967\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients with symptomatic gastroesophageal reflux are typically evaluated by an upper endoscopy (",
"    <a class=\"graphic graphic_figure graphicRef54169 \" href=\"UTD.htm?36/36/37447\">",
"     figure 1",
"    </a>",
"    )",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a video",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    swallow (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50536 \" href=\"UTD.htm?15/36/15939\">",
"     image 2",
"    </a>",
"    ). Endoscopically, the hernia can be visualized on a retroflexion maneuver. If organoaxial rotation (a twist along the long axis of the stomach) is present, the endoscope cannot be passed into the duodenum. Prior to surgical repair, all patients diagnosed with a paraesophageal hernia should undergo endoscopic evaluation to rule out other esophageal or gastric pathology. A barium swallow can provide information regarding gastric anatomy, the length of the esophagus, and the presence of organoaxial rotation.",
"   </p>",
"   <p>",
"    Our preoperative workup for patients with a paraesophageal hernia includes a history of current symptoms, previous medical therapies, cardiac",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary diseases. We also perform upper endoscopy, review pathology from esophageal and gastric biopsies, and obtain a video",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    swallow. Esophageal manometry and pH analysis are not routinely performed by our group. These tests can be very difficult to perform and the results are often unreliable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/11/16568?source=see_link&amp;anchor=H2#H2\">",
"     \"Motility testing: When does it help?\", section on 'Esophageal manometry'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016794\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SURGICAL REPAIR",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no medical treatment for a paraesophageal hernia. Treatment is directed towards symptoms of gastroesophageal reflux (GER). Indications for an",
"    <strong>",
"     elective repair",
"    </strong>",
"    of a paraesophageal hernia include failed medical management of GER, dysphagia, early satiety, postprandial pain, anemia, and vomiting that is associated with a paraesophageal hernia. Indications for an",
"    <strong>",
"     emergent repair",
"    </strong>",
"    include a gastric volvulus, bleeding, obstruction, strangulation, perforation, and respiratory compromise secondary to a paraesophageal hernia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/1-5,8\">",
"     1-5,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prophylactic paraesophageal hernia repair is rarely performed, as the mortality rate from elective repair is estimated to be 1.4 percent, while the probability of developing acute symptoms requiring emergent surgery is 1.1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/3\">",
"     3",
"    </a>",
"    ]. The lifetime risk of developing acute symptoms requiring emergency surgery decreases exponentially with age after 65 years.",
"   </p>",
"   <p>",
"    For symptomatic patients who are too frail to undergo a formal paraesophageal hernia repair, we perform a laparoscopic assisted endoscopic hernia reduction with placement of two percutaneous endoscopic gastrostomy (PEG) tubes to secure the stomach to the anterior abdominal wall [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/9\">",
"     9",
"    </a>",
"    ]. This procedure prevents the occurrence of a gastric volvulus and a formal hernia repair can be performed later if needed. This method can be used for patients in an emergency setting, but each patient requires an individual assessment for the ideal procedure. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016808\">",
"    <span class=\"h1\">",
"     TECHNICAL INSIGHTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general principles of a paraesophageal hernia repair (PEHR) include the following: dissection of the sac, which consists of hernia reduction, complete sac excision from the mediastinum, and esophageal mobilization; hiatal (crural) defect closure; an antireflux procedure (fundoplication); and gastric fixation, such as anterior gastropexy. These operative principles are the same for laparoscopic and open approaches to the repair.",
"   </p>",
"   <p>",
"    This section reviews the basic technical principles for performing either laparoscopic or an open laparotomy PEHR. If performing the procedure laparoscopically, strategic placement of the instruments is imperative for adequate visualization of the hiatus. Traditionally, five ports for insertion of the components of the laparoscope are placed in the following positions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first port, used for the 10 mm 30&ordm; scope, is placed approximately 14 cm distal to the xiphoid process and 3 cm to the left of the midline.",
"     </li>",
"     <li>",
"      The second and third ports, used for stomach and liver retractors, are placed lateral to the first port in the left and right mid-clavicular line.",
"     </li>",
"     <li>",
"      The last two ports, used for dissection and suturing instruments, are placed approximately 6 cm from midline under the costal margins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The instruments, patient positioning, and initial surgical technique for laparoscopic procedures are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/1/31770?source=see_link\">",
"     \"Abdominal access techniques used in laparoscopic surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/40/14984?source=see_link\">",
"     \"Devices for dissection and hemostasis in laparoscopic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016822\">",
"    <span class=\"h2\">",
"     Dissection of the hernia sac",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial step for a PEHR is to gently dissect the stomach and any other organs from the hernia sac (",
"    <a class=\"graphic graphic_picture graphicRef61860 \" href=\"UTD.htm?39/16/40193\">",
"     picture 1",
"    </a>",
"    ). Dissection of the hernia sac requires great care to avoid bleeding and injury to adjacent organs (eg, mediastinal pleura, pericardium, and aortic adventitia).",
"   </p>",
"   <p>",
"    The following principles are followed when performing the dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An incarcerated stomach, if present, can be friable and should be handled with care.",
"     </li>",
"     <li>",
"      The dissection is performed within the plane between the hernia sac and the adjacent tissues.",
"     </li>",
"     <li>",
"      The peritoneal covering of the abdominal side of the crus for the repair is preserved when dividing the gastrohepatic omentum from the right crus of the diaphragm (",
"      <a class=\"graphic graphic_picture graphicRef70549 \" href=\"UTD.htm?12/11/12466\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A Penrose drain is placed around the esophagus to facilitate the dissection of the posterior wall of the hernia sac. Using gentle upward traction on the Penrose drain, the dissection begins at the right crus and proceeds posteriorly to the left crus (",
"      <a class=\"graphic graphic_picture graphicRef51462 \" href=\"UTD.htm?6/54/7010\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The hernia sac must be completely removed from the mediastinum.",
"     </li>",
"     <li>",
"      Dividing the short gastric vessels will increase mobilization of the stomach. This will facilitate a fundoplication and improve exposure of the operative site.",
"     </li>",
"     <li>",
"      The esophagus must be mobilized to the level of the aortic arch or until at least 4 cm of intra-abdominal esophagus is mobilized without tension (",
"      <a class=\"graphic graphic_picture graphicRef60194 \" href=\"UTD.htm?8/24/8577\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The amount of electrocautery should be limited when mobilizing the esophagus, since the potential risk of damage to the esophagus is high. An esophageal lengthening procedure is rarely required for an initial repair.",
"     </li>",
"     <li>",
"      Injury or transection of the vagal nerves should be avoided to reduce the risk of delayed gastric emptying.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016829\">",
"    <span class=\"h2\">",
"     Closure of hiatal defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;The closure of the hiatal defect is one of the most critical steps in the repair of a paraesophageal hernia. The repair must be tension-free and can be performed as a primary suture repair or, if the defect is large, using mesh.",
"   </p>",
"   <p>",
"    After complete dissection of the esophagus, the pillars of the crura of the diaphragm are closed inferiorly and posteriorly to the esophagus. If a primary repair is performed, we typically use three to four interrupted nonabsorbable sutures tied intra-corporeally (",
"    <a class=\"graphic graphic_picture graphicRef72939 \" href=\"UTD.htm?25/59/26545\">",
"     picture 5",
"    </a>",
"    ). If the defect is large or cannot be closed without tension, then we use a biologic prosthetic reinforcement such as a porcine dermal matrix or a porcine small intestinal submucosa graft. Defining what is a large defect, or when enough laxity is present is difficult, and often relies on surgical judgement and experience. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11799?source=see_link&amp;anchor=H5#H5\">",
"     \"Reconstructive materials used in surgery: Classification and host response\", section on 'Types of reconstructive materials'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016843\">",
"    <span class=\"h2\">",
"     Fundoplication",
"    </span>",
"    &nbsp;&mdash;&nbsp;An antireflux procedure, such as the Nissen fundoplication, can be performed at the time of the paraesophageal hernia repair. While there are no randomized trials to support this additional procedure, a fundoplication benefits patients who have symptomatic gastroesophageal reflux disease (GERD) by restoring competency to the gastroesophageal sphincter [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/11\">",
"     11",
"    </a>",
"    ]. Additional reasons to consider an antireflux procedure include reducing the risk of postoperative GERD (which can occur following extensive dissection around the crura) and reducing herniation recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In our practice, we frequently perform a fundoplication, typically in the form of Nissen fundoplication. Patients with severe preoperative dysphagia often undergo a partial fundoplication to minimize the potential for worsening symptoms postoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016850\">",
"    <span class=\"h2\">",
"     Anterior gastropexy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural combination of positive intra-abdominal pressure and negative thoracic pressure serves to enhance the risk of reherniation. As previously discussed, there is a high recurrence rate following both open and laparoscopic paraesophageal hernia repair. (See",
"    <a class=\"local\" href=\"#H613238126\">",
"     'Patient outcomes'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p>",
"    The ideal hernia repair should result in a permanent gastric fixation in the abdominal cavity. An anterior gastropexy can be used to reduce the risk of gastric reherniation into the thoracic cavity by fixing the stomach to the abdominal wall. Fixation can be achieved using primary sutures between the stomach and abdominal wall or by a percutaneous endoscopic gastrostomy (PEG) tube.",
"   </p>",
"   <p>",
"    There are no randomized trials comparing the rates of hernia recurrence with or without an anterior gastropexy procedure and the available data from observational studies are limited.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective series of 28 patients undergoing a laparoscopic paraesophageal hernia repair with an anterior gastropexy, all patients had a normal postoperative video esophagram at 12 months and were asymptomatic, and there were no recurrences at 2 years of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In our series of 11 patients, hernia reduction and intra-abdominal fixation was achieved using the flexible endoscope and a double percutaneous endoscopic gastrostomy (PEG) tube in nine patients, and laparoscopic assisted PEG placement in two [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/9\">",
"       9",
"      </a>",
"      ]. At two years of follow-up, only one patient had recurrence of the hernia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016864\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing surgical repair of a paraesophageal hernia are admitted to the hospital and, if laparoscopic repair is performed, most are discharged on the second postoperative day. Patients managed with an open repair remain hospitalized until bowel function returns, which occurs at approximately five days [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/14\">",
"     14",
"    </a>",
"    ]. Delayed gastric emptying is generally self-limiting, but can result in postoperative emesis, disruption of the hernia repair, and early hernia recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/15\">",
"     15",
"    </a>",
"    ]. To minimize this risk, we maintain our patients on anti-nausea medication for the first 24 hours postoperatively.",
"   </p>",
"   <p>",
"    A",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    swallow is performed on the first postoperative day to assess for possible esophageal leak and early hernia recurrence, and to evaluate gastric emptying and motility. Patients with a long-standing paraesophageal hernia often have delayed gastric emptying after the repair. Proposed mechanisms include atrophic gastric musculature or vagal neural praxia during dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/16\">",
"     16",
"    </a>",
"    ]. If the barium swallow study shows an adequate repair, patients are started on a clear liquid diet and advanced to soft solids as tolerated. Patients are instructed to follow a low residue diet for two to three weeks following discharge from the hospital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H613238126\">",
"    <span class=\"h1\">",
"     PATIENT OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The operative technique to repair a paraesophageal hernia has changed significantly over the last few decades, from a simple approach of reducing the hernia with a cruroplasty to a more detailed resection of the hernia sac, mobilization of the esophagus, and use of mesh or implants in the repair [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/1-3,17\">",
"     1-3,17",
"    </a>",
"    ]. This section discuss the results of laparoscopic repair compared with an open repair, and the risks and benefits of incorporating mesh or biologic materials with the repair, and the mortality and morbidity associated with a paraesophageal repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H613238133\">",
"    <span class=\"h2\">",
"     Laparoscopic versus open repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technical options for performing a paraesophageal hernia repair include the laparoscopic approach, open laparotomy, and open thoracotomy. These operations are complex and the optimal approach remains controversial due to findings of higher recurrence rates with the laparoscopic approach [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/14,18,19\">",
"     14,18,19",
"    </a>",
"    ]. There are no randomized trials comparing the laparoscopic with an open procedure, and despite this, many surgeons prefer the laparoscopic approach [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our practice, we prefer a laparoscopic approach for the repair of a paraesophageal hernia for most patients in the elective and emergent settings. We prefer the open laparotomy approach in patients who have had multiple previous upper abdominal surgeries, and consider open thoracotomy approach in patients after a failed open abdominal approach. &nbsp;",
"   </p>",
"   <p>",
"    Two important endpoints for assessing outcomes include control of symptoms and recurrence of the hernia. Initial reports suggest that laparoscopic repairs are effective in treating symptoms associated with a paraesophageal hernia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/19,21,22\">",
"     19,21,22",
"    </a>",
"    ]. The following retrospective studies evaluating the laparoscopic repair support the efficacy of the procedure:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective review of 83 patients undergoing a laparoscopic repair of a paraesophageal hernia found a significant reduction in moderate to severe symptoms (eg, chest pain, dysphagia, heartburn, and regurgitation) compared with preoperative symptoms (range 5 to 7 percent versus 34 to 47 percent prior to surgery) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/21\">",
"       21",
"      </a>",
"      ]. There were nine intraoperative complications, five early postoperative complications, three deaths, and three conversions to an open procedure.",
"     </li>",
"     <li>",
"      A meta-analysis of 13 retrospective studies included 965 patients undergoing a laparoscopic repair and reported an overall hernia recurrence rate of 10.2 percent (range 3 to 33 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/17\">",
"       17",
"      </a>",
"      ]. However, the true recurrence rate was 25 percent when a video",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      esophagram was used to assess the repair. There was no significant association between recurrence rate and learning curve for performing the laparoscopic procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data are limited on the relative outcomes with laparoscopic versus open paraesophageal hernia repairs. In different small series, the rate of recurrence varied from 0 to 44 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/14,18,23,24\">",
"     14,18,23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H613238140\">",
"    <span class=\"h2\">",
"     Mesh repairs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mesh has been incorporated into the paraesophageal hernia repair to reduce the relatively high rate of recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. Mesh should be considered for large diaphragmatic defects or defects that cannot be closed without tension when using a primary suture repair. The following studies illustrate the significantly reduced short-term rates of recurrence of a paraesophageal hernia when it is repaired with mesh or biologic materials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial of 72 patients with a giant paraesophageal hernia (greater than one-third of the stomach herniated into the chest [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/29\">",
"       29",
"      </a>",
"      ]) found that patients treated with a Nissen fundoplication with a posterior cruroplasty and onlay of polytetrafluoroethylene (PTFE) mesh had significantly fewer recurrences compared with no mesh (0 versus 22 percent at a mean follow-up of three years [range six months to six years]) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/25\">",
"       25",
"      </a>",
"      ]. A low rate of recurrence in giant hernias (4 percent) was also noted in a retrospective review of 52 consecutive patients [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a multicenter randomized trial of 108 patients undergoing laparoscopic repair of a paraesophageal hernia, patients treated with a small intestinal submucosa biologic prosthesis had significantly fewer recurrences at six months compared with no biologic material (9 versus 24 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/27\">",
"       27",
"      </a>",
"      ]. There were no mesh-related complications. However, at a mean followup of 58 months, there was no statistically significant difference in complication rates, side effects, or quality of life between patients undergoing a primary or a mesh repair [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While mesh repair may reduce the rate of recurrence, serious complications (eg, intraluminal mesh erosion, esophageal stenosis, dense fibrosis) and reoperations (eg, esophagectomies, partial and total gastrectomies, esophageal stent placement) have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/31\">",
"     31",
"    </a>",
"    ]. There was no significant association between the rate of complications and the type of mesh used (eg, polypropylene, PTFE, biologic mesh) or the placement of mesh (eg, heart-shaped, keyhole, bridge, horseshoe).",
"   </p>",
"   <p>",
"    Our current practice involves selective use of mesh at the hiatus in cases where the crural fibers are disrupted during dissection or there are large defects or tenuous closures under tension. A decision analysis model concluded that the differences between mesh repair and primary repair may be clinically inconsequential [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22821743\">",
"    <span class=\"h2\">",
"     Mortality and morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative mortality and morbidity rates for both laparoscopic and open paraesophageal hernia repair (PEHR) techniques are low. Retrospective reviews of 662 patients and 354 patients undergoing a nonemergent laparoscopic PEHR reported a 30-day mortality rate of 1.7 percent and 0.8 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. The major adverse morbidity outcomes included pneumonia (4.0 percent), pulmonary embolism (3.4 percent), heart failure (2.6 percent), and postoperative leak (2.5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mortality",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    morbidity rates following",
"    <strong>",
"     laparoscopic",
"    </strong>",
"    PEHR are increased in patients who are elderly, have undergone emergent repair, or have comorbid illnesses as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elderly patients age &ge;70 years old had a significantly higher mortality (2.4 versus 0 percent) and morbidity rates (24.4 versus 10.1 percent) compared with patients under age 70 years [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a multivariate analysis, patients age &ge;70 years old and having a PEHR with anterior gastropexy had a significantly higher rate of overall morbidity (38.8 versus 10.5 percent) compared with younger patients undergoing a PEHR with anterior gastropexy [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients undergoing an emergent repair procedure had a higher mortality rate compared with patients undergoing an elective procedure (7.5 versus 0.5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with an American Society of Anesthesiologists (ASA) physical status classification system score Grade 3 and 4 had a significantly higher rate of morbidity compared with patients with an ASA score Grade 1 and 2 (26.0 versus 11.2 percent) but no significant difference in mortality rate (2.1 versus 0.4 percent) (",
"      <a class=\"graphic graphic_table graphicRef78084 \" href=\"UTD.htm?9/5/9307\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An observational study of 1005 patients &ge;80 years of age undergoing an",
"    <strong>",
"     open",
"    </strong>",
"    (transabdominal) PEHR found that emergency surgery, which was performed in 43 percent, was associated with significantly higher mortality and morbidity rates compared with elective repairs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/35\">",
"     35",
"    </a>",
"    ]. Those undergoing an emergent procedure had a seven-fold higher mortality rate compared with patients undergoing elective repair (15.7 versus 2.4 percent). In multivariate analysis, an emergent repair was the sole predictor of inpatient mortality following an open PEHR in patients &ge;80 years of age (odds ratio [OR] 7.1, 95% CI 1.9-26.3).",
"   </p>",
"   <p>",
"    Based upon these observations, comorbid conditions and previous abdominal surgery, rather than age alone, should guide the surgeon in deciding to perform a PEHR by the laparoscopic or open approach. Elderly patients who remain asymptomatic can be managed non-surgically, however, emergent procedures are associated with a higher mortality in this population. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9790711\">",
"    <span class=\"h1\">",
"     REOPERATIVE CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients requiring reoperation for a symptomatic paraesophageal hernia recurrence present a significant technical challenge. Asymptomatic recurrences identified by an esophagram do not require a reoperation. The following studies illustrate the reoperation rate following laparoscopic and open repairs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A review of 31 patients who had a",
"      <strong>",
"       laparoscopic",
"      </strong>",
"      repair of paraesophageal hernia identified a recurrence in 10 patients (32 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/22\">",
"       22",
"      </a>",
"      ]. Despite this high recurrence rate, all patients had an improvement in their symptoms at the time of follow up. Heartburn was significantly more common in patients with a hernia recurrence compared with patients who did not have a recurrence (60 versus 14 percent). Two of the ten patients with a hernia recurrence required a repeat repair to control symptoms.",
"     </li>",
"     <li>",
"      A prospective study of 72 patients undergoing an",
"      <strong>",
"       open",
"      </strong>",
"      laparotomy paraesophageal hernia repair identified a hernia recurrence in 11 (18 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/14\">",
"       14",
"      </a>",
"      ]. Eight of the recurrences were less than 2 cm sliding hernias, and none required reoperation.",
"     </li>",
"     <li>",
"      A retrospective review of 25 patients undergoing an",
"      <strong>",
"       open",
"      </strong>",
"      paraesophageal hernia repair (transabdominal or transthoracic) found a significantly higher rate of recurrences compared with 70 patients undergoing a",
"      <strong>",
"       laparoscopic",
"      </strong>",
"      repair (16 versus 6 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19128/abstract/36\">",
"       36",
"      </a>",
"      ]. Reoperation was performed for two patients treated with the open repair at 5 days and 6 years following the initial repair. No patients undergoing a laparoscopic repair required a reoperation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    From a technical viewpoint, each patient provides a unique challenge at the time of reoperation, which can be complicated by a previous mesh repair. These procedures should be performed by experienced esophageal surgeons. If the initial approach is laparoscopic, there should be low threshold for conversion to an open procedure, especially in the setting of perforation, ischemia, or uncontrollable blood loss. In complex reoperative cases, a transthoracic approach can provide an undissected plane for repair.",
"   </p>",
"   <p>",
"    A shortened esophagus is one of the challenges following a paraesophageal recurrence, since a lengthening procedure may be necessary. In our experience, we have encountered a shortened esophagus in less than 1 percent of patients. If sufficient esophageal length cannot be obtained after adequate esophageal dissection, we perform a Collis gastroplasty procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=see_link&amp;anchor=H18#H18\">",
"     \"Surgical management of gastroesophageal reflux in adults\", section on 'Shortened esophagus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/33/37393?source=see_link\">",
"       \"Patient information: Hiatal hernia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16016871\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A paraesophageal hernia is an uncommon type of hiatal hernia with a peritoneal layer that forms a true hernia sac. The management of paraesophageal hernias has changed significantly over the last few decades. Surgical management is indicated when medical management fails to control gastroesophageal reflux disease (GERD) associated with a paraesophageal hernia, or in the presence of a gastric volvulus, uncontrollable bleeding, or respiratory compromise secondary bronchial compression. (See",
"    <a class=\"local\" href=\"#H16016779\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indications for an emergent repair of a paraesophageal hernia include gastric volvulus, bleeding, obstruction, strangulation, perforation, and respiratory compromise secondary to the hernia. (See",
"      <a class=\"local\" href=\"#H16016794\">",
"       'Indications for surgical repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An elective paraesophageal hernia repair is reserved for symptomatic patients (eg, dysphagia, early satiety, postprandial pain). (See",
"      <a class=\"local\" href=\"#H16016794\">",
"       'Indications for surgical repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Elective repairs are offered to symptomatic patients and can be performed laparoscopically or by an open technique. (See",
"      <a class=\"local\" href=\"#H613238133\">",
"       'Laparoscopic versus open repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Regardless of the approach, the basic tenets of mediastinal hernia sac reduction, esophageal mobilization, stable crural closure, antireflux procedure, and intra-abdominal gastric fixation are all important aspects of the procedure. (See",
"      <a class=\"local\" href=\"#H16016808\">",
"       'Technical insights'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The role of mesh in the paraesophageal repair can be considered for large diaphragmatic defects or defects that cannot be closed without tension using a primary suture repair. While the short-term risk of recurrence is low with the use of mesh repairs, the long-term benefit remains uncertain. In addition, there are serious risks with mesh repairs (eg, intraluminal mesh erosion and esophageal stenosis). (See",
"      <a class=\"local\" href=\"#H613238140\">",
"       'Mesh repairs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who are elderly or frail, we perform a laparoscopic assisted endoscopic hernia reduction with double PEG tube placement to serve as an anterior gastropexy. A formal paraesophageal repair can be performed later as indicated by the patient&rsquo;s condition. (See",
"      <a class=\"local\" href=\"#H16016850\">",
"       'Anterior gastropexy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For elderly patients, the mortality rate for an emergent repair is higher than an elective repair. However, those who are entirely asymptomatic can be observed. (See",
"      <a class=\"local\" href=\"#H22821743\">",
"       'Mortality and morbidity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      swallow should be performed on the first postoperative day to assess for a possible esophageal leak, early hernia recurrence, and assess gastric motility. (See",
"      <a class=\"local\" href=\"#H16016864\">",
"       'Postoperative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An anti-emetic should be administered for the first 24 postoperative hours to reduce the risk of postoperative emesis that may result in disruption of the repair and early recurrence. (See",
"      <a class=\"local\" href=\"#H16016864\">",
"       'Postoperative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Operative management of recurrent paraesophageal hernias is reserved for symptomatic patients and needs to be tailored to the individual setting. (See",
"      <a class=\"local\" href=\"#H9790711\">",
"       'Reoperative considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/1\">",
"      Hill LD. Incarcerated paraesophageal hernia. A surgical emergency. Am J Surg 1973; 126:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/2\">",
"      Skinner DB, Belsey RH. Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients. J Thorac Cardiovasc Surg 1967; 53:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/3\">",
"      Stylopoulos N, Gazelle GS, Rattner DW. Paraesophageal hernias: operation or observation? Ann Surg 2002; 236:492.",
"     </a>",
"    </li>",
"    <li>",
"     Diaphragm. In: Surgical Foundations: Essentials of thoracic surgery, Kaiser, LR, Singal, S. (Eds), Elsevier Mosby, Philadelphia 2004. p.294.",
"    </li>",
"    <li>",
"     Miller, JI, Jr. Chapter 89. Bacterial infections of the lungs and bronchial compressive disorders. In: General thoracic surgery, 7, Shields, TW, LoCicero,J, Reed, CE, Feins, RH. (Eds), Wolters Kluwer/Lippincott Williams &amp; Wilkins, Philadelphia 2009. Vol 1, p.294.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/6\">",
"      Kahrilas PJ. Hiatus hernia causes reflux: Fact or fiction? Gullet 1993; 3(Suppl):21.",
"     </a>",
"    </li>",
"    <li>",
"     Peridikis G, Hinder RA. Paraesophageal hiatal hernia. In: Hernia, Nyhus LM, Condon RE (Eds), JB Lippincott, Philadelphia 1995. p.544.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/8\">",
"      Davis SS Jr. Current controversies in paraesophageal hernia repair. Surg Clin North Am 2008; 88:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/9\">",
"      Kercher KW, Matthews BD, Ponsky JL, et al. Minimally invasive management of paraesophageal herniation in the high-risk surgical patient. Am J Surg 2001; 182:510.",
"     </a>",
"    </li>",
"    <li>",
"     Pierre, AF, Luketich, JD. Laparoscopic repair of giant paraesophageal hernias. The cardiothoracic surgery network. www.ctsnet.org/sections/clinicalresources/thoracic/expert_tech-9.html (Accessed on February 09, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/11\">",
"      Casabella F, Sinanan M, Horgan S, Pellegrini CA. Systematic use of gastric fundoplication in laparoscopic repair of paraesophageal hernias. Am J Surg 1996; 171:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/12\">",
"      Kr&auml;henb&uuml;hl L, Sch&auml;fer M, Farhadi J, et al. Laparoscopic treatment of large paraesophageal hernia with totally intrathoracic stomach. J Am Coll Surg 1998; 187:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/13\">",
"      Ponsky J, Rosen M, Fanning A, Malm J. Anterior gastropexy may reduce the recurrence rate after laparoscopic paraesophageal hernia repair. Surg Endosc 2003; 17:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/14\">",
"      Low DE, Unger T. Open repair of paraesophageal hernia: reassessment of subjective and objective outcomes. Ann Thorac Surg 2005; 80:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/15\">",
"      Puri V, Kakarlapudi GV, Awad ZT, Filipi CJ. Hiatal hernia recurrence: 2004. Hernia 2004; 8:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/16\">",
"      de la Fuente SG, Khuri SF, Schifftner T, et al. Comparative analysis of vagotomy and drainage versus vagotomy and resection procedures for bleeding peptic ulcer disease: results of 907 patients from the Department of Veterans Affairs National Surgical Quality Improvement Program database. J Am Coll Surg 2006; 202:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/17\">",
"      Rathore MA, Andrabi SI, Bhatti MI, et al. Metaanalysis of recurrence after laparoscopic repair of paraesophageal hernia. JSLS 2007; 11:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/18\">",
"      Ferri LE, Feldman LS, Stanbridge D, et al. Should laparoscopic paraesophageal hernia repair be abandoned in favor of the open approach? Surg Endosc 2005; 19:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/19\">",
"      Hashemi M, Peters JH, DeMeester TR, et al. Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg 2000; 190:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/20\">",
"      Frantzides CT, Carlson MA, Loizides S, et al. Hiatal hernia repair with mesh: a survey of SAGES members. Surg Endosc 2010; 24:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/21\">",
"      Mattar SG, Bowers SP, Galloway KD, et al. Long-term outcome of laparoscopic repair of paraesophageal hernia. Surg Endosc 2002; 16:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/22\">",
"      White BC, Jeansonne LO, Morgenthal CB, et al. Do recurrences after paraesophageal hernia repair matter? : Ten-year follow-up after laparoscopic repair. Surg Endosc 2008; 22:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/23\">",
"      Carlson MA, Condon RE, Ludwig KA, Schulte WJ. Management of intrathoracic stomach with polypropylene mesh prosthesis reinforced transabdominal hiatus hernia repair. J Am Coll Surg 1998; 187:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/24\">",
"      Geha AS, Massad MG, Snow NJ, Baue AE. A 32-year experience in 100 patients with giant paraesophageal hernia: the case for abdominal approach and selective antireflux repair. Surgery 2000; 128:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/25\">",
"      Frantzides CT, Madan AK, Carlson MA, Stavropoulos GP. A prospective, randomized trial of laparoscopic polytetrafluoroethylene (PTFE) patch repair vs simple cruroplasty for large hiatal hernia. Arch Surg 2002; 137:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/26\">",
"      M&uuml;ller-Stich BP, Holzinger F, Kapp T, Klaiber C. Laparoscopic hiatal hernia repair: long-term outcome with the focus on the influence of mesh reinforcement. Surg Endosc 2006; 20:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/27\">",
"      Oelschlager BK, Pellegrini CA, Hunter J, et al. Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: a multicenter, prospective, randomized trial. Ann Surg 2006; 244:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/28\">",
"      Lee YK, James E, Bochkarev V, et al. Long-term outcome of cruroplasty reinforcement with human acellular dermal matrix in large paraesophageal hiatal hernia. J Gastrointest Surg 2008; 12:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/29\">",
"      Mitiek MO, Andrade RS. Giant hiatal hernia. Ann Thorac Surg 2010; 89:S2168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/30\">",
"      Oelschlager BK, Pellegrini CA, Hunter JG, et al. Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial. J Am Coll Surg 2011; 213:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/31\">",
"      Stadlhuber RJ, Sherif AE, Mittal SK, et al. Mesh complications after prosthetic reinforcement of hiatal closure: a 28-case series. Surg Endosc 2009; 23:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/32\">",
"      Obeid NM, Velanovich V. The choice of primary repair or mesh repair for paraesophageal hernia: a decision analysis based on utility scores. Ann Surg 2013; 257:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/33\">",
"      Luketich JD, Nason KS, Christie NA, et al. Outcomes after a decade of laparoscopic giant paraesophageal hernia repair. J Thorac Cardiovasc Surg 2010; 139:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/34\">",
"      Larusson HJ, Zingg U, Hahnloser D, et al. Predictive factors for morbidity and mortality in patients undergoing laparoscopic paraesophageal hernia repair: age, ASA score and operation type influence morbidity. World J Surg 2009; 33:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/35\">",
"      Poulose BK, Gosen C, Marks JM, et al. Inpatient mortality analysis of paraesophageal hernia repair in octogenarians. J Gastrointest Surg 2008; 12:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19128/abstract/36\">",
"      Schauer PR, Ikramuddin S, McLaughlin RH, et al. Comparison of laparoscopic versus open repair of paraesophageal hernia. Am J Surg 1998; 176:659.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15061 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-0E3ADE63EF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19128=[""].join("\n");
var outline_f18_43_19128=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16016871\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16016779\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16017360\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H549701910\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16016787\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16016794\">",
"      INDICATIONS FOR SURGICAL REPAIR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16016808\">",
"      TECHNICAL INSIGHTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16016822\">",
"      Dissection of the hernia sac",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16016829\">",
"      Closure of hiatal defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16016843\">",
"      Fundoplication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16016850\">",
"      Anterior gastropexy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16016864\">",
"      POSTOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H613238126\">",
"      PATIENT OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H613238133\">",
"      Laparoscopic versus open repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H613238140\">",
"      Mesh repairs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22821743\">",
"      Mortality and morbidity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9790711\">",
"      REOPERATIVE CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16016871\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15061\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15061|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/22/25967\" title=\"diagnostic image 1\">",
"      Chest radiograph depicting a retrocardiac mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/36/15939\" title=\"diagnostic image 2\">",
"      Type III hiatal hernia UGI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15061|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/36/37447\" title=\"figure 1\">",
"      Progression of hiatal hernia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15061|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/16/40193\" title=\"picture 1\">",
"      Laparoscopic resection of the stomach from the hernia sac",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/11/12466\" title=\"picture 2\">",
"      Dissection of the paraesophageal hernia sac and right crus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/54/7010\" title=\"picture 3\">",
"      Laparoscopic resection of the crura of the diaphragm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/24/8577\" title=\"picture 4\">",
"      Laparoscopic mobilization of the intra-abdominal esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/59/26545\" title=\"picture 5\">",
"      Laparoscopic primary repair of hiatal defect",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15061|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/5/9307\" title=\"table 1\">",
"      ASA physical status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/1/31770?source=related_link\">",
"      Abdominal access techniques used in laparoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/40/14984?source=related_link\">",
"      Devices for dissection and hemostasis in laparoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44793?source=related_link\">",
"      Gastric outlet obstruction in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7527?source=related_link\">",
"      Hiatus hernia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/11/16568?source=related_link\">",
"      Motility testing: When does it help?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/33/37393?source=related_link\">",
"      Patient information: Hiatal hernia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11799?source=related_link\">",
"      Reconstructive materials used in surgery: Classification and host response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=related_link\">",
"      Surgical management of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_43_19129="Increasing prevalence of asthma and allergic rhinitis";
var content_f18_43_19129=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Increasing prevalence of asthma and allergic rhinitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Thomas A E Platts-Mills, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Scott P Commins, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/43/19129/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/43/19129/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis and asthma are both common chronic diseases that affect the quality of life of patients and have a significant economic impact. The prevalence of allergic rhinitis increased in Westernized countries from the 1870s through the 1950s. The rate of asthma subsequently increased in these countries beginning in the 1960s. Asthma and allergic rhinitis prevalence began increasing in many developing countries in the late 1980s to early 1990s.",
"   </p>",
"   <p>",
"    Changes in genetic factors are unlikely to be the underlying cause of the rise in allergic diseases, since the increases in allergic rhinitis and asthma occurred relatively rapidly. Instead, multiple environmental factors may have played a role. These include improvements in hygiene, eradication of most parasitic worm infections, changes in home heating and ventilation, and a decline in physical activity and alterations in diet due to lifestyle changes.",
"   </p>",
"   <p>",
"    This topic discusses the increase in rates of allergic rhinitis and asthma and the environmental changes that may have led to their alterations in prevalence. Risk factors for the development of asthma are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link\">",
"     \"Risk factors for asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGIC HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seasonal allergic rhinitis was first described in the United States in 1872 (autumnal catarrh or ragweed hay fever) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/1\">",
"     1",
"    </a>",
"    ] and in England in 1873 (catarrhus aestivus) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/2\">",
"     2",
"    </a>",
"    ]. The disease was well recognized in England and Germany by 1900 and in the United States by 1920. The Island of Heligoland in the North Sea was established as a summer refuge for hay fever patients by 1910 and during the early part of the 20th century it became common for sufferers in New England to retreat to resorts in the mountains to escape the pollen. The first paper on immunotherapy against pollen \"toxin\" was published in 1911 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/3\">",
"     3",
"    </a>",
"    ]. At that time, hay fever was considered to be a disease of the affluent and was rarely reported among working-class people, especially farmers.",
"   </p>",
"   <p>",
"    By the 1930s, allergic rhinitis became sufficiently common to allow the development of the subspecialty of allergy. In 1935, the University of Virginia appointed a professor of Allergy and Rheumatology. In 1946, the city of New York initiated a ragweed eradication campaign that was designed to help control hay fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/4\">",
"     4",
"    </a>",
"    ]. However, by the early 1950s, 10 percent of New Yorkers were reported to suffer from allergic rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/5\">",
"     5",
"    </a>",
"    ] and in 1952, the campaign was abandoned because it was not possible to control pollen levels [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/6\">",
"     6",
"    </a>",
"    ]. Similar high rates of hay fever were documented in Tecumseh, Michigan in the 1960s [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The general view is that both allergic rhinitis and asthma increased between 1960 and 1990 in Westernized countries. However, evidence suggests that the prevalence of allergic rhinitis was relatively stable at around 15 percent over that time period [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/8\">",
"     8",
"    </a>",
"    ]. The prevalence has continued to remain relatively stable since then, and may even be falling in some countries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The International Study of Asthma and Allergies in Childhood (ISAAC) compared time trends in symptom prevalence of rhinoconjunctivitis between around 1994 to 1995 for Phase I and 2002 to 2003 for Phase III [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/9\">",
"     9",
"    </a>",
"    ]. They found similar prevalence rates of around 15 to 20 percent in most Westernized countries during this time period. The symptom prevalence of allergic rhinoconjunctivitis generally decreased between the two study phases in countries with the highest prevalence in the first phase, including most English-speaking countries. In contrast, some of the countries that had low prevalence in the mid 1990s had increased rates in the early 2000s.",
"   </p>",
"   <p>",
"    An increase in asthma was first reported in 1970, among school children in Birmingham, England, between 1958 and 1968 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/10\">",
"     10",
"    </a>",
"    ]. A higher prevalence of asthma was seen among the children of West Indian immigrants and there was a strong association with sensitization to dust mites. A rise in asthma prevalence was reported in New Zealand, Australia, and Japan over the next 10 years. In each of these countries, dust mite allergens were the most common sensitization associated with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. By the late 1970s, there was a widespread view that the increase in asthma in the United Kingdom had occurred at least in part because of the increase in dust mites in homes between 1955 and 1975 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the 1960s through the 1980s, there were still elements of doubt about the increasing prevalence of asthma in Westernized countries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/17\">",
"     17",
"    </a>",
"    ]. It did not become clear until approximately 1990 that increases in asthma prevalence had occurred in Westernized countries worldwide (",
"    <a class=\"graphic graphic_figure graphicRef71920 \" href=\"UTD.htm?24/57/25502\">",
"     figure 1",
"    </a>",
"    ). Looking back it appears that the rise in the number of children and young adults reporting wheezing began between 1955 and 1965 in these countries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Increases were also seen in asthma-related hospitalization and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. The growth in asthma prevalence was seen even in countries where dust mites were not important allergens, such as Finland [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/22\">",
"     22",
"    </a>",
"    ]. Over the period from 1960 to 2000, there was at least a 10-fold increase in asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. However, there was wide variability in this increase in absolute terms. In some countries, numbers rose from 2 to 20 percent, while in others the rate increased from 0.5 to 5 percent. The rates appear to have peaked, and may even be declining, in many of these countries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/25-34\">",
"     25-34",
"    </a>",
"    ]. This leveling off is seen even in countries in which rates of sensitization to aeroallergens continue to increase [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Asthma prevalence began increasing in developing countries in the late 1980s to early 1990s, mainly in more affluent urban populations [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. Gains in the prevalence of self-report of wheeze in the past year in children occurred between the mid 1990s to early 2000s, mainly in non-English speaking countries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/25\">",
"     25",
"    </a>",
"    ]. These increases were seen both in regions that had high to intermediate symptom prevalence rates in the 1990s, such as Latin America and Eastern Europe, and in countries that had low rates in the initial survey, such as Asian-Pacific (particularly Indonesia and China) and African countries. A concomitant increase in symptom prevalence of rhinoconjunctivitis was also seen in many of these countries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/9\">",
"     9",
"    </a>",
"    ]. In contrast, there are still rural villages in developing or undeveloped countries, such as Ethiopia, Papua New Guinea, Kenya, and Nepal, where asthma remains rare [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/36,37,39-41\">",
"     36,37,39-41",
"    </a>",
"    ]. In addition, an association between allergen sensitization and respiratory symptoms or abnormal lung function is not always seen in these populations [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ENVIRONMENTAL CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiologic findings raise the question: What changes occurred in Westernized countries during the 20th century when the rise in prevalence of allergic rhinitis and then asthma were seen that are now occurring in developing countries?",
"   </p>",
"   <p>",
"    The changes in prevalence are too sudden to be attributed to genetic factors. The gene-environment interactions that lead to the development of atopic diseases such as allergic rhinitis and asthma are complex [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. More than 100 genes have been associated with the development of asthma, and we assume that each gene product interacts with multiple environmental factors.",
"   </p>",
"   <p>",
"    The contrasts between children living in the villages of Papua New Guinea or Kenya on the one hand and children raised in Central New York or the suburbs of Auckland on the other are so great that it is unlikely that a single environmental difference is responsible for the major differences in the burden of asthma. It is also unlikely that identical environmental factors influenced the development of both allergic rhinitis and asthma.",
"   </p>",
"   <p>",
"    Multiple environmental changes occurred gradually from the mid 1800s onward in Westernized countries and these changes are now occurring, often more rapidly and simultaneously, in developing countries. Many of these changes may have influenced the development of allergic rhinitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    asthma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mid to late 1800s",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two major events occurred during the latter half of the 19th century that may be relevant to the increase in allergic rhinitis during this time period [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There was complete separation of drinking water from sewage in the major North American and European cities by 1900, and a consequent progressive decline in enteric diseases.",
"     </li>",
"     <li>",
"      Reform of the Corn Laws in England in 1846 led to a dramatic decline in growing of wheat, which was gradually replaced by Italian rye grass that was used to feed the expanding herds of cattle. Italian rye grass pollinated much more heavily than the traditional field grasses [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/45\">",
"       45",
"      </a>",
"      ]. Similar changes occurred in grass growing in Northern Germany, and it is thought that the extension of agriculture in the United States after 1865 led to major increases in both ragweed and grass pollen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Early to mid 1900s",
"    </span>",
"    &nbsp;&mdash;&nbsp;After 1900, there were further improvements in hygiene in Europe and the United States, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A final decline in farm animals living in towns and in the use of horses for transportation",
"     </li>",
"     <li>",
"      Universal wearing of shoes",
"     </li>",
"     <li>",
"      Chlorination of water",
"     </li>",
"     <li>",
"      Eradication of helminths and malaria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These changes were paralleled in the United States by an almost 90 percent decline in deaths from infectious disease, mainly enteric disease and tuberculosis, over the period from 1900 to 1940 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Since 1960",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many discussions of the rise in asthma prevalence assume that this increase is a direct consequence of the general increase in allergic disease. As a result, the various theories focus on causes of the supposed increase in T helper cell type 2 (Th2) immunity with associated increase in IgE (the allergic phenotype). However, as we have discussed, there is a substantial body of evidence that allergic rhinitis was already common before 1960 and rates had leveled off by then.",
"   </p>",
"   <p>",
"    Thus, our approach is to also consider the reasons why asthma increased among the allergic population [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/47\">",
"     47",
"    </a>",
"    ]. The list of incriminated factors is long and includes the introduction and widespread use of broad spectrum antibiotics, a further decline in hepatitis A virus infection, increased immunization of children for multiple diseases, and the major changes in lifestyle linked to the introduction of new forms of sedentary entertainment. We have chosen to group these possible contributing factors into three general categories (",
"    <a class=\"graphic graphic_table graphicRef79803 \" href=\"UTD.htm?5/63/6140\">",
"     table 1",
"    </a>",
"    ), while recognizing that the effects of many of these changes overlap and other changes have occurred that may not fit neatly into one of these groups [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We believe that epidemic asthma with the highest prevalence and severity (Model A) (",
"    <a class=\"graphic graphic_figure graphicRef71920 \" href=\"UTD.htm?24/57/25502\">",
"     figure 1",
"    </a>",
"    ) requires the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Improved hygiene to allow allergic disease to develop",
"     </li>",
"     <li>",
"      High concentrations of one of the major non-mammalian indoor allergens",
"     </li>",
"     <li>",
"      Decline in physical activity, which removes a protective effect of repeated expansion of the lungs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Improved hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early life exposure to infectious pathogens, as well as normal gut microbiota, may influence the development of the immune system. The hygiene hypothesis postulates that better hygiene, resulting in decreased microbial exposure, leads to an increase in allergic disease (",
"    <a class=\"graphic graphic_table graphicRef79803 \" href=\"UTD.htm?5/63/6140\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. The hygiene hypothesis is like the Hydra from Greek mythology: As soon as one explanation of the effect is disputed, it rapidly reappears in a different form.",
"   </p>",
"   <p>",
"    When the hypothesis was first proposed in 1989, it was based upon the observation that rates of allergic disease were lower among British children with one or more older siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/52\">",
"     52",
"    </a>",
"    ]. This prompted clinical researchers to focus on the effects of repeated viral infections, since this was one of the primary consequences of having older siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/53\">",
"     53",
"    </a>",
"    ]. This approach was supported by evidence that American children who attended daycare during the first six months of life had a decreased risk of asthma at age six years despite increased episodes of infection early in life [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/54\">",
"     54",
"    </a>",
"    ]. However, the number of children in daycare increased over the period when asthma was rising most rapidly. Furthermore, a report from Denmark documented early bacterial colonization of children as a risk factor for development of asthma, and they found a higher prevalence of asthma among children with older siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/55\">",
"     55",
"    </a>",
"    ]. In addition, another study found that the risk of persistent or late-onset asthma varied in a quadratic fashion, with toddlers exposed to few or no other children at highest risk, followed by those exposed to 13 or more children [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/56\">",
"     56",
"    </a>",
"    ]. This effect was independent of the number of respiratory tract infections reported, suggesting other protective mechanisms were involved.",
"   </p>",
"   <p>",
"    The next version of the hygiene hypothesis was based upon the findings of an inverse association between skin sensitivity to Mycobacterium tuberculosis and asthma in Japanese schoolchildren [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/57\">",
"     57",
"    </a>",
"    ]. The authors of this high-profile article suggested that Bacillus Calmette-Guerin (BCG) vaccination could reduce the risk of allergic disease. Their observation sparked a series of studies with different strains of mycobacteria, including M. vaccae [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. However, the primary observations were not confirmed in other studies and it is not clear that rates of asthma are lower in countries with routine use of BCG. In addition, tuberculosis (TB) was still a major scourge even in upper levels of society during the period when hay fever first became a common disease among affluent families in Northern Europe. Furthermore, the major decline in TB occurred between 1900 and 1940, before effective antibiotic therapy was available (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    in 1948) and before the rise in asthma began.",
"   </p>",
"   <p>",
"    The hygiene hypothesis also reappeared in relation to hepatitis A virus (HAV) serology. The initial evidence about a negative association between allergic disease and positive HAV serology among army recruits in Italy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/60\">",
"     60",
"    </a>",
"    ] was followed by similar evidence from the National Health and Nutrition Examination survey (NHANES) data in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/61\">",
"     61",
"    </a>",
"    ]. In addition, susceptibility to allergic disease was associated with genetic variants of the receptor for HAV [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/62\">",
"     62",
"    </a>",
"    ]. It is well accepted that the prevalence of positive HAV serology declined over the period with which we are concerned (ie, 1960-1990) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/63\">",
"     63",
"    </a>",
"    ]. However, it had already begun to decline before that [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/46\">",
"     46",
"    </a>",
"    ], and the idea that one enteric virus could dominate the immune response seems simplistic. Furthermore, HAV infection remains common in African cities where asthma is increasing.",
"   </p>",
"   <p>",
"    Overall, there are several major issues with the hygiene hypothesis. First, the major changes in hygiene in Northern European cities occurred long before any evidence for the increase in asthma in children, although those changes were associated with the earlier appearance of hay fever. Second, the increase in asthma in Africa is observed in cities where the standards of hygiene are less advanced than those in New York, London, or Berlin in 1910. Thus, improvements in hygiene do not relate temporally to the increase in asthma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Increased indoor allergen exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes in homes and lifestyles that led to increased indoor allergen exposure include increased insulation, increased indoor temperature, the nearly universal adoption of fitted or wall-to-wall carpeting (which began in the 1930s), and increased time spent indoors (",
"    <a class=\"graphic graphic_table graphicRef79803 \" href=\"UTD.htm?5/63/6140\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conditions for dust mite growth in homes in London improved between 1955 and 1975 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/16\">",
"     16",
"    </a>",
"    ]. These changes were mirrored in Australia and New Zealand. Prior to 1950, homes in England were heated mainly with open coal fires and coal gas. Both of these presented a significant risk of carbon monoxide poisoning. For this reason, there were strict regulations about ventilation that virtually assured that homes were both \"drafty\" and cold.",
"   </p>",
"   <p>",
"    Coal fires were largely eliminated after the United Kingdom's worst air pollution event, the Great Smog of 1952, when an estimated 12,000 Londoners died as a result of this pollution episode. Coal gas was replaced by natural gas in the 1960s. It was safer to make homes more airtight after these changes took place. The primary effect was an increase in the temperature of homes during the cooler seasons.",
"   </p>",
"   <p>",
"    Dust mites thrive in a warmer, more humid environment. By the early 1980s, when it became possible to measure the dust mite allergen levels in environmental samples from homes, the allergen was found not only in beds, but also in carpets, sofas, drapes, and clothing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/65\">",
"     65",
"    </a>",
"    ]. In turn it became clear that the level of dust mite exposure was an important predictor of dust mite allergen sensitization and development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The increase in indoor allergen exposure was followed by a decrease in pollen exposure as air filtration and air conditioning became available during the 1950s and 1960s. Pollen exposure was greater prior to this, both because people generally spent more time outdoors and because there was greater exposure to pollen indoors due to open windows with or without window fans. This may explain, at least in part, the leveling off of allergic rhinitis seen since the mid-1960s.",
"   </p>",
"   <p>",
"    Several developments during the 1980s made it clear that increases in dust mite alone were not sufficient to explain the increase in asthma:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First, the upsurge in asthma had occurred in countries where mites were not a significant indoor allergen [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/22\">",
"       22",
"      </a>",
"      ]. In these settings, asthma was often associated with the dominant indoor allergens in that region. The rise in asthma prevalence was particularly severe among populations in the United States where cockroach was the dominant indoor allergen [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/67,68\">",
"       67,68",
"      </a>",
"      ]. Asthma was related to cat and dog sensitivity in New Mexico, where there were no mites or cockroaches in homes [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/69\">",
"       69",
"      </a>",
"      ]. Decreased ventilation in homes leads to increased airborne quantities of cat and dog allergens. Small particles, which remain airborne, are generally removed by ventilation so that low ventilation rates will tend to increase the quantities of cat allergen remaining airborne [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/48,49,70-72\">",
"       48,49,70-72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Second, the prevalence and severity of asthma continued to increase well beyond when the environmental changes in homes conducive to dust mite growth had occurred. Major changes in houses had finished by approximately 1975, but increases in asthma in the United Kingdom (UK) continued for another 20 years. In a prospective study, there was no significant increase in dust mite allergens in the UK between 1979 and 1989 [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/66\">",
"       66",
"      </a>",
"      ]. In addition, with increasing awareness of dust mites, families started to change their homes in such a way that dust mite numbers decreased. These changes have been most obvious in The Netherlands, where some estimates suggest that mite allergen levels have decreased as much as 10-fold between 1980 and 2000 [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/73,74\">",
"       73,74",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Third, the increase in asthma has occurred in poor urban populations in which no major change in housing or indoor allergen load have occurred during the same time period [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/20,68\">",
"       20,68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fourth, whether increased time indoors represents an important cause of increased allergen exposure is not clear. A shift to increased time spent indoors began in the 1950s, although the course has been variable. It was previously typical to spend 18 to 20 hours per day indoors, and this has increased to 23 or more hours per day (ie, by 25 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/75,76\">",
"       75,76",
"      </a>",
"      ]. By contrast, the time spent \"playing\" outdoors has decreased 80 percent or more.",
"     </li>",
"     <li>",
"      Finally, the argument that increased allergen exposure was an important cause of the increase in allergic disease assumed that there was a linear relationship between exposure and disease. While this may be true for allergens derived from dust mites, cockroach, Alternaria, and pollens, there is considerable evidence that high exposure to cat or dog allergens can induce a form of tolerance [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/48,49,71,72\">",
"       48,49,71,72",
"      </a>",
"      ]. Asthma has increased in countries where the major allergens were those derived from cats or dogs. This raises major questions about increasing exposure causing the rise in asthma prevalence. Initially, it was proposed that the protective effect of an animal in the home was an example of the cleanliness or hygiene hypothesis, in which the animal was a source of endotoxin. However, the presence of a cat in the home does not increase airborne endotoxin. It seems more probable that cat allergens induce a tolerant response, including IgG and IgG4 antibodies, at high doses because they are mammalian in origin (ie, evolutionarily less foreign than other major allergens).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Changes in air pollution may well be relevant to increasing asthma prevalence in some areas. There is extensive evidence about the effects of vehicular pollution, including both the products of gasoline engines and diesel particulates, on allergic respiratory disease in areas such as Los Angeles [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/77\">",
"     77",
"    </a>",
"    ]. However, a significant negative correlation between pollution and asthma mortality was documented in Philadelphia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/78\">",
"     78",
"    </a>",
"    ]. In addition, there are areas of the world with very high asthma prevalence and severity where air pollution is negligible (eg, New Zealand). Furthermore, the original increase in asthma occurred at the time when traditional coal and sulfur pollution was declining in both England and the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Lifestyle changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to 1950, there were few reasons for children to play primarily indoors. Normal behavior included two to four hours per day of outdoor play [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/75\">",
"     75",
"    </a>",
"    ]. Starting in the mid-1950s, television programs were targeted at children with increasing success, so that over a period of 15 years it became normal for children to sit indoors watching a screen for the same period of time [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/76\">",
"     76",
"    </a>",
"    ]. That this change has had negative consequences for the health of children is not in doubt. The most obvious consequence (or parallel change) has been the rise in obesity. The rise in obesity reflects both decreased physical activity and changes in diet, but weight and height are much easier to measure than either activity or diet. Thus, many studies only include reliable data on weight and height. The decrease in physical activity and increased time spent sitting are closely linked, although the possible consequences for lung physiology and asthma are not the same. Putting it simply: is sitting still harmful or is prolonged activity outside protective?",
"   </p>",
"   <p>",
"    Evidence that sitting still for long periods of time is harmful has come from several different types of studies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/79\">",
"     79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First, epidemiologic studies have shown that children who spend longer hours watching television have an increased risk of developing both obesity and asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/76,80\">",
"       76,80",
"      </a>",
"      ]. Two hours per day at age 3 years doubles the risk of asthma at age 11 [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Second, there is a long series of experiments showing that full expansion of the lungs can decrease lung resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/81,82\">",
"       81,82",
"      </a>",
"      ]. The normal pattern of breathing includes intermittent deep breaths or sighs, and there is good evidence that sigh rates decline significantly during periods sitting watching a screen [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/83\">",
"       83",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Third, in vitro studies on bronchial smooth muscle show that this muscle does not obey Starling's law and will contract from a shorter length if it is not stretched regularly [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/84\">",
"       84",
"      </a>",
"      ]. The authors of those studies argued that normal human sigh rates were only just sufficient to maintain normal tone. Further research is need to determine if prolonged periods of sitting still with low sigh rates allow the lungs to go into bronchospasm [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/83,85\">",
"       83,85",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Assessing the relevance of physical activity is complex. Two to four hours per day playing outside is not the same as aggressive training for sports two to three times per week [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/86\">",
"     86",
"    </a>",
"    ]. The latter type of activity is associated with an increased incidence of new diagnoses of asthma in areas with high ozone. Furthermore, it is well established that exercise can induce acute bronchospasm in patients with asthma. Worse still, there are children whose normal lives include so little activity that any exercise induces breathlessness or \"wheezing\". Indeed, it may be so difficult to diagnose asthma in obese children that the data on the association between asthma and obesity cannot be evaluated. Overall, we would argue that prolonged exercise is beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/87\">",
"     87",
"    </a>",
"    ], although the data is confusing because so many children are poorly conditioned and develop breathlessness when they exercise vigorously.",
"   </p>",
"   <p>",
"    The secondary consequences of sedentary entertainment are also complex. More time indoors could increase exposure to indoor allergens. However, it seems unlikely that the amount of increased indoor allergen exposure due to a change from 18 to 23 hours indoors is sufficient to explain the rise in asthma prevalence. Moving indoors has decreased the exposure to sunlight with a consequent decrease in production of vitamin D. However, the relationship between vitamin D deficiency and allergic disease requires further investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=see_link\">",
"     \"Vitamin D and extraskeletal health\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dietary changes have included decreased consumption of fresh fruits and vegetables; increased intake of snack foods, convenience foods, and soft-drinks; and larger portion sizes. However, proving that specific diet contributes to asthma has been difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/90\">",
"     90",
"    </a>",
"    ]. In one study, a higher intake of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    was associated with a decreased risk of sensitization to common food and inhalant allergens in school-aged children, but there was no relationship between beta-carotene intake and current wheeze or wheezing phenotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Farms, villages, worms, and other parasites &mdash; Exposure to farm animals early in life is negatively associated with the development of allergic disease [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/92-94\">",
"       92-94",
"      </a>",
"      ]. In addition, the diversity of environmental microorganisms exposure is inversely associated with the risk of asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/95\">",
"       95",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The movement away from an agrarian society started at the time of the industrial revolution and was approximately 90 percent complete by 1940. There were only small further declines in the number of families directly associated with farming between 1960 and 2000. This shift in lifestyle progressively decreased the number of children exposed to farm animals. Today, less than one percent of children in the United States have contact with farm animals during childhood.",
"      <br/>",
"      <br/>",
"      Some have tried to compare life in rural villages in the developing world with farm life. In both settings, children are exposed to animals from early childhood with the probable protective effects of endotoxin. However, there are major differences as well. Both in rural Africa and Papua New Guinea, where asthma rates are low, the children run in bare feet and are exposed to helminths and ectoparasites. In addition, water quality remains poor in these regions and is frequently contaminated. The children in these villages are physically active, with low average body fat, and generally do not spend much time indoors. These children tend to have high total serum IgE, in keeping with the high rate of parasitic infections [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/36,37\">",
"       36,37",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      It was assumed for a long time that the IgE induced by parasites was either irrelevant to inhalant allergy or that it acted by blocking binding of allergen-specific IgE [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/96\">",
"       96",
"      </a>",
"      ]. The discovery of IgE specific for the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) altered this assumption [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/97\">",
"       97",
"      </a>",
"      ]. This IgE antibody binds to any protein that carries the alpha-gal carbohydrate epitope, including proteins from all mammals except primates and humans (eg, it binds to pork thyroglobulin and cat IgA) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/98\">",
"       98",
"      </a>",
"      ]. IgE specific for alpha-gal is associated with anaphylactic reactions to red meat [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/99\">",
"       99",
"      </a>",
"      ]. The important finding for the present discussion is that high IgE titers to cat or dog allergens are not associated with respiratory symptoms upon exposure to animals in individuals with alpha-gal-specific IgE [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/99\">",
"       99",
"      </a>",
"      ]. The implication is that IgE antibodies to a hapten (such as alpha-gal) could help to explain how children in African villages can have high total serum IgE without allergic symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?18/43/19129/abstract/37,100\">",
"       37,100",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31848?source=see_link\">",
"       \"The biology of IgE\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rise in allergic rhinitis began in the 1870s in Westernized countries, and leveled off by the 1950s at a prevalence of around 15 to 20 percent. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiologic history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prevalence of asthma did not begin increasing in Westernized countries until the 1960s. There was at least a 10-fold increase in asthma by 2000, with a wide range in absolute differences. The rates appear to have peaked, and may even be declining, in many of these countries. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiologic history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Asthma and allergic rhinitis prevalence began increasing in many developing countries in the late 1980s to early 1990s. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiologic history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple environmental changes occurred gradually from the mid 1800s onward in Westernized countries and these changes are now occurring, often more rapidly and simultaneously, in developing countries. These include improvements in hygiene, eradication of most parasitic worm infections, changes in home heating and ventilation, and a decline in physical activity and alterations in diet due to lifestyle changes. Many of these changes may have influenced the development allergic rhinitis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      asthma. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Environmental changes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The gene-environment interactions that lead to the development of atopic diseases such as allergic rhinitis and asthma are complex. In any model as complex as this, one would expect to have studies with highly discrepant results. At this point we have only hypotheses, with evidence to both support and refute them, not definitive conclusions. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Environmental changes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Wyman M. Autumnal catarrh (hay fever), Huro &amp; Houghton, Cambridge, MA 1872.",
"    </li>",
"    <li>",
"     Blackley CH. Experiments and researches on the causes and nature of catarrhus aestivas, Balliere, London 1873.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/3\">",
"      Noon L. Prophylactic innoculation for hay fever. Lancet 1911; i:1572.",
"     </a>",
"    </li>",
"    <li>",
"     \"4000 acres that breed sneezes, target in city's hay fever war.\" New York Times, June 3, 1949.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/5\">",
"      RATNER B, SILBERMAN DE. Critical analysis of the hereditary concept of allergy. J Allergy 1953; 24:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/6\">",
"      WALZER M, SIEGEL BB. The effectiveness of the ragweed eradication campaigns in New York City; a 9-year study; 1946-1954. J Allergy 1956; 27:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/7\">",
"      Broder I, Higgins MW, Mathews KP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. IV. Natural history. J Allergy Clin Immunol 1974; 54:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/8\">",
"      Nathan R, Meltzer E, Selner J, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99:S808 (Abstract).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/9\">",
"      Bj&ouml;rkst&eacute;n B, Clayton T, Ellwood P, et al. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/10\">",
"      Smith JM, Disney ME, Williams JD, Goels ZA. Clinical significance of skin reactions to mite extracts in children with asthma. Br Med J 1969; 2:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/11\">",
"      Miyamoto T, Johansson SG, Ito K, Horiuchi Y. Atopic allergy in Japanese subjects: studies primarily with radioallergosorbent test. J Allergy Clin Immunol 1974; 53:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/12\">",
"      Peat JK, Tovey E, Mellis CM, et al. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993; 23:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/13\">",
"      Sears MR, Herbison GP, Holdaway MD, et al. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989; 19:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/14\">",
"      Chapman MD, Platts-Mills TA. Purification and characterization of the major allergen from Dermatophagoides pteronyssinus-antigen P1. J Immunol 1980; 125:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/15\">",
"      Platts-Mills TA, Tovey ER, Mitchell EB, et al. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; 2:675.",
"     </a>",
"    </li>",
"    <li>",
"     Platts-Mills TA, Tovey ER, Chapman MD, Wilkins SR. Airborne allergen exposure, allergen avoidance and bronchial hyperractivity. In: Asthma: Physiology, immunopharmacology and treatment: Third International Symposium, Kay AB, Austen KF, Lichtenstein LM (Eds), Academic Press, London 1984. p.297.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/17\">",
"      Magnus P, Jaakkola JJ. Secular trend in the occurrence of asthma among children and young adults: critical appraisal of repeated cross sectional surveys. BMJ 1997; 314:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/18\">",
"      Beasley R, Pearce N, Crane J. International trends in asthma mortality. Ciba Found Symp 1997; 206:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/19\">",
"      Burney PG. Asthma mortality in England and Wales: evidence for a further increase, 1974-84. Lancet 1986; 2:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/20\">",
"      Crater DD, Heise S, Perzanowski M, et al. Asthma hospitalization trends in Charleston, South Carolina, 1956 to 1997: twenty-fold increase among black children during a 30-year period. Pediatrics 2001; 108:E97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/21\">",
"      Weiss KB, Gergen PJ, Wagener DK. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Annu Rev Public Health 1993; 14:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/22\">",
"      Haahtela T, Lindholm H, Bj&ouml;rkst&eacute;n F, et al. Prevalence of asthma in Finnish young men. BMJ 1990; 301:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/23\">",
"      Beasley R, Crane J, Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000; 105:S466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/24\">",
"      Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/25\">",
"      Pearce N, A&iuml;t-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/26\">",
"      Kalyoncu AF, Sel&ccedil;uk ZT, En&uuml;nl&uuml; T, et al. Prevalence of asthma and allergic diseases in primary school children in Ankara, Turkey: two cross-sectional studies, five years apart. Pediatr Allergy Immunol 1999; 10:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/27\">",
"      Ronchetti R, Villa MP, Barreto M, et al. Is the increase in childhood asthma coming to an end? Findings from three surveys of schoolchildren in Rome, Italy. Eur Respir J 2001; 17:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/28\">",
"      Senthilselvan A, Lawson J, Rennie DC, Dosman JA. Stabilization of an increasing trend in physician-diagnosed asthma prevalence in Saskatchewan, 1991 to 1998. Chest 2003; 124:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/29\">",
"      Braun-Fahrl&auml;nder C, Gassner M, Grize L, et al. No further increase in asthma, hay fever and atopic sensitisation in adolescents living in Switzerland. Eur Respir J 2004; 23:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/30\">",
"      Nowak D, Suppli Ulrik C, von Mutius E. Asthma and atopy: has peak prevalence been reached? Eur Respir J 2004; 23:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/31\">",
"      Toelle BG, Ng K, Belousova E, et al. Prevalence of asthma and allergy in schoolchildren in Belmont, Australia: three cross sectional surveys over 20 years. BMJ 2004; 328:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/32\">",
"      Chinn S, Jarvis D, Burney P, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax 2004; 59:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/33\">",
"      Mommers M, Gielkens-Sijstermans C, Swaen GM, van Schayck CP. Trends in the prevalence of respiratory symptoms and treatment in Dutch children over a 12 year period: results of the fourth consecutive survey. Thorax 2005; 60:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/34\">",
"      Bollag U, Capkun G, Caesar J, Low N. Trends in primary care consultations for asthma in Switzerland, 1989-2002. Int J Epidemiol 2005; 34:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/35\">",
"      R&ouml;nmark E, Bjerg A, Perzanowski M, et al. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 2009; 124:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/36\">",
"      Yemaneberhan H, Bekele Z, Venn A, et al. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997; 350:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/37\">",
"      Perzanowski MS, Ng'ang'a LW, Carter MC, et al. Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr 2002; 140:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/38\">",
"      Addo-Yobo EO, Woodcock A, Allotey A, et al. Exercise-induced bronchospasm and atopy in Ghana: two surveys ten years apart. PLoS Med 2007; 4:e70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/39\">",
"      Anderson HR. The epidemiological and allergic features of asthma in the New Guinea Highlands. Clin Allergy 1974; 4:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/40\">",
"      Keeley DJ, Neill P, Gallivan S. Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children. Thorax 1991; 46:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/41\">",
"      Ma Y, Zhao J, Han ZR, et al. Very low prevalence of asthma and allergies in schoolchildren from rural Beijing, China. Pediatr Pulmonol 2009; 44:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/42\">",
"      Hirvonen A. Gene-environment interactions in chronic pulmonary diseases. Mutat Res 2009; 667:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/43\">",
"      Douwes J, Pearce N. Asthma and the westernization 'package'. Int J Epidemiol 2002; 31:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/44\">",
"      Schwartz DA. Gene-environment interactions and airway disease in children. Pediatrics 2009; 123 Suppl 3:S151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/45\">",
"      Emanuel MB. Hay fever, a post industrial revolution epidemic: a history of its growth during the 19th century. Clin Allergy 1988; 18:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/46\">",
"      Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999; 281:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/47\">",
"      Platts-Mills TA. Asthma severity and prevalence: an ongoing interaction between exposure, hygiene, and lifestyle. PLoS Med 2005; 2:e34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/48\">",
"      Platts-Mills T, Vaughan J, Squillace S, et al. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001; 357:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/49\">",
"      Platts-Mills TA, Perzanowski M, Woodfolk JA, Lundback B. Relevance of early or current pet ownership to the prevalence of allergic disease. Clin Exp Allergy 2002; 32:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/50\">",
"      Okada H, Kuhn C, Feillet H, Bach JF. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010; 160:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/51\">",
"      Fishbein AB, Fuleihan RL. The hygiene hypothesis revisited: does exposure to infectious agents protect us from allergy? Curr Opin Pediatr 2012; 24:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/52\">",
"      Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/53\">",
"      Martinez FD. Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 1994; 49:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/54\">",
"      Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000; 343:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/55\">",
"      Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/56\">",
"      Gurka MJ, Blackman JA, Heymann PW. Risk of childhood asthma in relation to the timing of early child care exposures. J Pediatr 2009; 155:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/57\">",
"      Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/58\">",
"      Walker C, Sawicka E, Rook GA. Immunotherapy with mycobacteria. Curr Opin Allergy Clin Immunol 2003; 3:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/59\">",
"      Brothers S, Asher MI, Jaksic M, Stewart AW. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. Clin Exp Dermatol 2009; 34:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/60\">",
"      Matricardi PM, Rosmini F, Ferrigno L, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997; 314:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/61\">",
"      Matricardi PM, Rosmini F, Panetta V, et al. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002; 110:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/62\">",
"      Umetsu DT, Umetsu SE, Freeman GJ, DeKruyff RH. TIM gene family and their role in atopic diseases. Curr Top Microbiol Immunol 2008; 321:201.",
"     </a>",
"    </li>",
"    <li>",
"     Dienstag JL. Acute viral hepatitis. In: Harrison's principles of internal medicine, 17th ed, Fauci AS, Braunwald E, Kasper DL, et al (Eds), McGraw-Hill, Madrid 2008. p.1932.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/64\">",
"      Platts-Mills TA. How environment affects patients with allergic disease: indoor allergens and asthma. Ann Allergy 1994; 72:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/65\">",
"      Tovey ER, Chapman MD, Wells CW, Platts-Mills TA. The distribution of dust mite allergen in the houses of patients with asthma. Am Rev Respir Dis 1981; 124:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/66\">",
"      Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/67\">",
"      Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997; 336:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/68\">",
"      Call RS, Smith TF, Morris E, et al. Risk factors for asthma in inner city children. J Pediatr 1992; 121:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/69\">",
"      Sporik R, Ingram JM, Price W, et al. Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude. Tickling the dragon's breath. Am J Respir Crit Care Med 1995; 151:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/70\">",
"      Luczynska CM, Li Y, Chapman MD, Platts-Mills TA. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus). Measurements using cascade impactor, liquid impinger, and a two-site monoclonal antibody assay for Fel d I. Am Rev Respir Dis 1990; 141:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/71\">",
"      Hesselmar B, Aberg N, Aberg B, et al. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1999; 29:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/72\">",
"      Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 2002; 288:963.",
"     </a>",
"    </li>",
"    <li>",
"     Aalberse R, University of Amsterdam, personal communication, 2008.",
"    </li>",
"    <li>",
"     Spieksmah F, Leiden University, personal communication, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/75\">",
"      Gortmaker SL, Must A, Sobol AM, et al. Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med 1996; 150:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/76\">",
"      Dennison BA, Erb TA, Jenkins PL. Television viewing and television in bedroom associated with overweight risk among low-income preschool children. Pediatrics 2002; 109:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/77\">",
"      Peterson B, Saxon A. Global increases in allergic respiratory disease: the possible role of diesel exhaust particles. Ann Allergy Asthma Immunol 1996; 77:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/78\">",
"      Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. N Engl J Med 1994; 331:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/79\">",
"      Platts-Mills TA, Sporik RB, Chapman MD, Heymann PW. The role of domestic allergens. Ciba Found Symp 1997; 206:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/80\">",
"      Sherriff A, Maitra A, Ness AR, et al. Association of duration of television viewing in early childhood with the subsequent development of asthma. Thorax 2009; 64:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/81\">",
"      Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995; 96:2393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/82\">",
"      Fish JE, Ankin MG, Kelly JF, Peterman VI. Regulation of bronchomotor tone by lung inflation in asthmatic and nonasthmatic subjects. J Appl Physiol 1981; 50:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/83\">",
"      Hark WT, Thompson WM, McLaughlin TE, et al. Spontaneous sigh rates during sedentary activity: watching television vs reading. Ann Allergy Asthma Immunol 2005; 94:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/84\">",
"      Fredberg JJ, Inouye D, Miller B, et al. Airway smooth muscle, tidal stretches, and dynamically determined contractile states. Am J Respir Crit Care Med 1997; 156:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/85\">",
"      Fredberg JJ. Airway smooth muscle in asthma: flirting with disaster. Eur Respir J 1998; 12:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/86\">",
"      McConnell R, Berhane K, Gilliland F, et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet 2002; 359:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/87\">",
"      Lucas SR, Platts-Mills TA. Physical activity and exercise in asthma: relevance to etiology and treatment. J Allergy Clin Immunol 2005; 115:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/88\">",
"      Brehm JM, Celed&oacute;n JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009; 179:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/89\">",
"      Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 2007; 85:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/90\">",
"      Peat JK, Li J. Reversing the trend: reducing the prevalence of asthma. J Allergy Clin Immunol 1999; 103:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/91\">",
"      Patel S, Murray CS, Woodcock A, et al. Dietary antioxidant intake, allergic sensitization and allergic diseases in young children. Allergy 2009; 64:1766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/92\">",
"      Braun-Fahrl&auml;nder C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/93\">",
"      Illi S, Depner M, Genuneit J, et al. Protection from childhood asthma and allergy in Alpine farm environments-the GABRIEL Advanced Studies. J Allergy Clin Immunol 2012; 129:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/94\">",
"      Genuneit J. Exposure to farming environments in childhood and asthma and wheeze in rural populations: a systematic review with meta-analysis. Pediatr Allergy Immunol 2012; 23:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/95\">",
"      Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/96\">",
"      Godfrey RC, Gradidge CF. Allergic sensitisation of human lung fragments prevented by saturation of IgE binding sites. Nature 1976; 259:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/97\">",
"      Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008; 358:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/98\">",
"      Gr&ouml;nlund H, Ad&eacute;doyin J, Commins SP, et al. The carbohydrate galactose-alpha-1,3-galactose is a major IgE-binding epitope on cat IgA. J Allergy Clin Immunol 2009; 123:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/99\">",
"      Commins SP, Satinover SM, Hosen J, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2009; 123:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/43/19129/abstract/100\">",
"      van den Biggelaar AH, van Ree R, Rodrigues LC, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356:1723.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5548 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-87E6A227E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19129=[""].join("\n");
var outline_f18_43_19129=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGIC HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ENVIRONMENTAL CHANGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mid to late 1800s",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Early to mid 1900s",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Since 1960",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Improved hygiene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Increased indoor allergen exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Lifestyle changes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/5548\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5548|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/57/25502\" title=\"figure 1\">",
"      Changes in wheezing prevalence in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5548|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/63/6140\" title=\"table 1\">",
"      Possible causes for the increase in allergic disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=related_link\">",
"      Risk factors for asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31848?source=related_link\">",
"      The biology of IgE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=related_link\">",
"      Vitamin D and extraskeletal health",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_43_19130="Tear drop cells";
var content_f18_43_19130=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F55274%7EHEME%2F68110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F55274%7EHEME%2F68110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Teardrop-shaped red blood cells (dacrocytes)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 305px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This peripheral smear from a patient with bone marrow fibrosis shows numerous teardrop-shaped red cells (arrows). Note that the teardrops are pointed in several different directions, ruling out an artifact due to preparation of the smear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leukoerythroblastic peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 244px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Leukoerythroblastic peripheral blood smear showing the presence of nucleated red cells and immature white cells. This pattern occurs with marrow replacement, usually due to fibrosis that may be idiopathic (eg, primary myelofibrosis) or reactive to conditions such as metastatic cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19130=[""].join("\n");
var outline_f18_43_19130=null;
var title_f18_43_19131="Criteria for outpatient management of PPROM";
var content_f18_43_19131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested criteria for home management of women with PPROM",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Reliable patient",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dependable transportation and telephone service",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lives near hospital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Evaluation in hospital for 72 hours before discharge home",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient to check her pulse and temperature every 6 hours and notify physician if temperature &gt;98.6 degrees F (37 degrees C) or pulse &gt;100 beats/minute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal kick counts daily and notify physician if fewer than 10 fetal movements in a two hour period",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonstress test and complete blood count twice a week",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weekly ultrasound",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cephalic presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No evidence of infection or labor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Presence of a vertical amniotic fluid pocket &gt;2 cm on ultrasound",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: data in Bartfield MC, Carlan SJ. Clin Obstet Gynecol 1998; 41:503.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19131=[""].join("\n");
var outline_f18_43_19131=null;
var title_f18_43_19132="ASCA pANCA dx IBD";
var content_f18_43_19132=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Test characteristics of anti-saccaromyces cervisiae antibodies (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of inflammatory bowel disease (IBD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antibody",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specificity, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        PPV, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Sensitivity, specificity, and positive predictive value (PPV) in patients with IBD compared to non-IBD controls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ASCA +",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        91",
"       </td>",
"       <td>",
"        88",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pANCA +",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        95",
"       </td>",
"       <td>",
"        69",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ASCA +/pANCA -",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        91",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pANCA +/ASCA -",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        97",
"       </td>",
"       <td>",
"        78",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Sensitivity, specificity, and positive predictive value in differentiating ulcerative colitis (UC) from Crohn's disease (CD) in patients with IBD*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ASCA +/CD +",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        86",
"       </td>",
"       <td>",
"        92",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pANCA +/UC +",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        76",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ASCA +/pANCA -/CD +",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        92",
"       </td>",
"       <td>",
"        95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pANCA +/ASCA -/UC +",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        98",
"       </td>",
"       <td>",
"        88",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Where CD + or UC +, the control group for comparison is the other type of IBD.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Peeters M, Joosens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96:730.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19132=[""].join("\n");
var outline_f18_43_19132=null;
var title_f18_43_19133="Catalase test";
var content_f18_43_19133=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80137&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80137&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Test for production of catalase",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 132px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Catalase splits hydrogen peroxide into water and oxygen. The streptococci (left) are catalase-negative while organisms such as staphylococci (right) are catalase- positive and produce bubbles when mixed with hydrogen peroxide.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19133=[""].join("\n");
var outline_f18_43_19133=null;
var title_f18_43_19134="Left coronary artery in Kawasaki disease";
var content_f18_43_19134=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/53864/ltcorkaw_conv.mp4?title=Left+coronary+artery+in+Kawasaki+disease\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary artery aneurysm in Kawasaki",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left anterior oblique projection from a coronary angiogram shows a large aneurysm of the proximal portion of the left coronary artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19134=[""].join("\n");
var outline_f18_43_19134=null;
var title_f18_43_19135="Epidemiologic algorithm neglect";
var content_f18_43_19135=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53333&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53333&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Hot water burns: epidemiologic algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 468px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This algorithm uses the example of a child who has sustained significant hot water burns to illustrate the relationships between individuals who may identify the manifestations of a child at risk, caretakers and agencies who have responsibility for the child's well-being, and targeted prevention strategies. These strategies include the following: A) Parents/sitter must be educated regarding the risk and outcomes of hot water burns. B) Legal consequences for the parents/sitter may include education or other constructive strategies. C and D) Public health officials must establish standards for safe hot water heater temperatures that can be enforced by housing inspectors. E) Social service agencies must designate state and federal funds to support compliance with public health regulations. F) State and/or federal legislation must establish standards for hot water heater manufacturers regarding settings that adjust water temperature.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Helfer, RE. The Neglect of Our Children. Pediatr Clin North Am 1990; 37:923. Copyright &copy;1990 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_43_19135=[""].join("\n");
var outline_f18_43_19135=null;
